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Abstract 
Chronic pain is a complex condition with a significant social and economic 
impact and a better understanding of the factors affecting improvement is 
required to inform best practice in the management process. Few studies have 
considered the effect of Weinberger et al.’s personality types in the 
management of pain. The four personality types are suggested to respond 
differently to threatening information such as pain, because of their attentional 
and interpretive biases. Using a variety of research methods, the global aim of 
this programme of research was to determine whether the management of 
chronic pain would be enhanced through the use of treatment stratified on the 
basis of personality type. 
  This thesis highlights important differences in the response to pain and 
pain management between the personality types, which are masked if the 
population is analysed homogenously. Defensive high-anxious individuals 
were more prevalent in the patient population compared to the asymptomatic 
control group and attended to pain related information more than the other 
groups. Defensive high-anxious individuals reported greater improvement for 
both pain and disability and showed stronger links between improvements in 
pain and disability and baseline psychological factors than the non-extreme 
individuals. The findings suggest that current treatments are more effective for 
defensive high-anxious patients. Furthermore, the high proportion of defensive 
high-anxious individuals highlights the need for psychologically based 
interventions to be delivered earlier. Stratifying the population may allow for 
more targeted interventions, which could be more cost effective and reduce 
the number of patients remaining in the care system. 
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1.0 Introduction 
Chronic musculoskeletal pain is a complex problem and has significant 
psychological (McInnis et al., 2014), physical (Camacho-Soto et al., 2012) and 
social implications (Stenberg et al., 2013). Pain is defined as “an unpleasant 
sensory and emotional experience associated with actual or potential tissue 
damage, or described in terms of such damage” (Merskey et al., 1979). This 
definition encompasses a range of conditions, such as arthritis, back pain, 
fibromyalgia, neck pain and chronic fatigue syndrome. Approximately 10 
million individuals suffer with chronic musculoskeletal pain with 42% unable to 
work due to their condition and 19% will eventually lose their jobs (Breivik et 
al., 2006). There is also a significant effect on the economy, with an estimated 
cost of £12.3 billion per year for back pain alone (Maniadakis and Gray, 2000). 
These individuals tend to be heavy users of the healthcare system, with almost 
half (44%) of the patient population having to wait over a year to receive a 
diagnosis; and many patients perceive that their pain is not adequately 
managed (Collett et al., 2010).  
Chronic musculoskeletal pain is a subjective experience, which can be 
difficult to manage, particularly as there is often an inconsistent relationship 
between pain and pathology. Although pain management strategies exist, the 
provision of these services is variable across regions. The general awareness 
of chronic pain conditions has grown over the past decade, however, the 
provision of services has not kept up and demand continues to surpass supply 
(British Pain Society, 2005). There is inevitable pressure for hospitals to 
reduce waiting times, treatment efficacy and the number of patients remaining 
in the care system, which creates added pressure for the staff within 
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healthcare services. Given the significant burden upon society and the 
economy, it is important to improve these services and find more effective 
management strategies. The main outcome objective for most chronic pain 
patients is to reduce pain intensity and the resulting disability (Sanderson et 
al., 2012). Numerous guidelines exist, such as those in the UK provided by the 
British Pain Society and the National Institute for Health and Clinical 
Excellence, however, the challenge for clinicians is to identify the correct path 
for each individual patient. The guidelines emphasise the importance of patient 
centred care, which aims to take into account the individual needs and 
preferences of each patient. Current guidelines do not focus on reducing pain 
intensity through physiological or pharmacological interventions but 
emphasize the importance of education and knowledge to equip the patient 
with self-management strategies. Self-management is defined as “the ability 
to manage symptoms, treatment, physical and psychosocial consequences 
and life-style changes inherent in living with a chronic condition”  (Barlow et 
al., 2002).  
The majority of individuals will benefit from an interdisciplinary 
approach, which addresses different aspects of their pain simultaneously 
(Jensen et al., 2007). This may involve activity, social interactions, medications 
and psychological interventions. There is increasing evidence to show that 
cognitive factors are relevant to the development of treatment response and 
clinical outcome from chronic pain (Woby et al., 2008; Bair et al., 2003). Pain 
management programmes (PMPs) are designed to address cognitive factors 
and to provide patients with self-management strategies in order to reduce 
their use of healthcare services. Successful self-management can be difficult 
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for some individuals while others appear able to effectively manage their 
condition at home, and do not regularly utilise healthcare services. The 
mechanisms behind these differences between individuals are poorly 
understood, but have been suggested to be a function of personality type. The 
majority of studies investigating anxiety and pain have primarily investigated 
the association between pain related anxiety or state anxiety and pain 
intensity. Some studies have identified differences between individuals with 
high or low trait anxiety which predispose individuals to respond to pain related 
stimuli differently (Eysenck, 1992). Some of these findings are equivocal and 
may be due to other factors. The inclusion of defensiveness alongside trait 
anxiety (personality type) has highlighted differences in how individuals 
respond to treatment and health outcomes in chronic illness populations 
(Zachariae et al., 2004; Prasertsri et al., 2011; Myers, 2010; Phipps and 
Steele, 2002). To date, no studies have sought to investigate the role of 
defensiveness and the interaction with anxiety in the management of chronic 
pain. 
If patients experience and interpret pain differently, they may also 
require different treatment strategies. The studies within this thesis are 
designed to provide a greater understanding of how the combination of 
defensiveness and trait anxiety influenced outcome within a chronic 
musculoskeletal pain population. This thesis will help to determine whether the 
management of chronic pain would be enhanced through the use of treatment 
stratified based on personality type.  
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2.0 Literature review 
2.1 Definitions and models of pain 
Pain is a noxious experience that is subjective, provides individuals with 
information about body function, and prevents further injury by signalling tissue 
stress. The International Association for the Study of Pain (IASP) classifies 
pain as “an unpleasant sensory and emotional experience associated with 
actual or potential tissue damage, or described in terms of such damage” 
(Merskey et al., 1979). This definition encompasses not only the sensory 
element but also the perception of pain. Chronic musculoskeletal pain is a 
complex condition which has significant psychological (McInnis et al., 2014), 
physical (Camacho-Soto et al., 2012) and social implications (Stenberg et al., 
2013). Chronic pain affects approximately one in five people across Europe 
(Breivik et al., 2006) and has a significant effect on the economy. The specific 
financial costs of managing chronic musculoskeletal pain are unknown, 
however, conditions such as osteoarthritis and low back pain are considered 
the most expensive to manage (Mäntyselkä et al., 2002; Phillips, 2009). Within 
the United Kingdom (UK) specifically, back pain is estimated to cost £12.3 
billion per year (Maniadakis and Gray, 2000), this is the equivalent of 22% of 
the annual NHS budget (2014). Back pain alone is the second most common 
cause of sick leave and approximately 4.1 million days of work are lost each 
year (Collett et al., 2010). 
2.2 Nociceptive pain 
Descartes originally conceived of pain in terms of a ‘stimulus-response’ 
relationship (Melzack and Wall, 1965). Whereby there is a simple response 
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within the brain to a noxious stimulus from the body, this nociceptive 
information is transmitted along defined pain pathways. The biological 
processes involved in pain perception are no longer simply viewed in terms of 
this direct relationship. The perception of pain and its threshold are the result 
of complex interactions between sensory, emotional and behavioural factors. 
Inflammation and nerve injury to the damaged area can reduce pain thresholds 
and increase sensitivity to stimuli. On the other hand, in combat situations, 
soldiers have been reported to experience ‘episodic analgesia’, whereby they 
have no initial awareness of a severe acute injury, suggesting that, in some 
extreme situations, pain thresholds are increased (Hudspith et al., 2006).  
Tissue injuries result in a series of physiological responses as a noxious 
stimulus consisting of nociceptive information informs the processing of pain 
from the damaged tissue. Four basic processes are involved in nociception: (i) 
transduction; (ii) transmission; (iii) perception and (iv) modulation (McCaffery 
and Pasero, 1999; Miller, 2009). Transduction involves the process of 
converting a noxious stimulus, which can be mechanical, thermal or chemical 
into a nervous impulse. The free nerve endings of C fibres and A-delta fibres 
are the primary afferent neurones responsive to noxious stimuli. Nociceptors 
are exposed to noxious stimuli when tissue damage and inflammation occur 
as a result of injury. Transmission involves sending the afferent nerve 
messages to the brain. This occurs in three stages, (i) the pain impulse is 
transmitted from the site of transduction along the nociceptor fibres to the 
dorsal horn in the spinal cord; (ii) from there, the spinal cord transmits the 
stimulus to the brain stem; and (iii) finally through connections linking the 
thalamus, cortex and higher levels of the brain where perception and 
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interpretation of the stimulus happen. The C and A-delta fibres terminate at 
the dorsal horn of the spinal cord: for the pain impulse to be transmitted across 
the synaptic cleft to the nociceptive dorsal horn’s neurones, excitatory 
neurotransmitters are released which bind to specific receptors. The pain 
impulse is then transmitted from the spinal cord to the brain stem via two 
ascending pathways; the spinothalmic and spinoparabrachial pathways. The 
third stage, perception, involves the interpretation of the stimulus into the 
perceived pain once the incoming nervous messages reach the brain. This 
stage is influenced by social and psychological factors, which explains the 
differing perceptions of pain between both individuals and circumstances. 
When the stimuli are transmitted to the brain stem and thalamus, three main 
cortical areas are activated. Firstly, the reticular system is activated which 
involves the autonomic and motor response to pain, warning an individual to 
act. Secondly, the somatosensory cortex is then involved in the perception and 
interpretation of sensations (e.g., intensity and location of pain related to 
previous experiences). Finally, activation within the limbic system is 
responsible for the emotional and behavioural responses to pain. The final 
stage of nociception is modulation; this stage involves changing or inhibiting 
transmission of pain impulses in the spinal cord. The complex system involved 
in the modulation of pain is referred to as the descending modulatory pain 
pathways and can lead to either an increase in the transmission of pain 
impulses (excitatory) or a decrease in transmission (inhibition). 
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2.3 Models of pain 
Numerous studies have attempted to explain the nature and cause of acute 
pain resulting in a range of theoretical accounts. These include, the Specificity 
Theory (Schiff, 1859; cited in Main and Spanswick, 2000), Central Summation 
Theory (Livingston, 1943), Peripheral Pattern Theory (Weddell, 1955), and 
Gate Control Theory (Melzack and Wall, 1965; Melzack and Casey, 1968). 
The studies within this thesis specifically investigate the influence of 
personality type on clinical outcome and the interactions of other psychological 
variables in individuals with chronic pain. The mechanisms of pain perception 
described above primarily explain the physical aspect of pain, taking little 
account of cognitive and behavioural factors. The Specificity Theory and Gate 
Control Theory, however, place differing emphasis on the moderating 
influence of cognitive factors on the experience of chronic pain. These two 
theories are discussed more fully in the following sections.   
2.3.1 Specificity Theory 
The Specificity Theory (Schiff, 1859) has origins which date back to the ancient 
Greeks and it proposes that pain is a sensory experience signalling tissue 
damage. The theory propositions that pain is experienced when information 
relating to tissue trauma is transmitted from the periphery to the cerebral 
cortex. This explanation of the pain experience appears to be very mechanistic 
and implies the nervous system plays a passive, transmission role within the 
experience of pain, and infers a direct relationship between pathology and the 
pain experienced. Treatments based on this theory assume that correcting the 
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damage to the underlying tissue will result in reduced pain, however, some 
findings have cast doubt over the central tenets of the Specificity Theory.  
The central notion of Specificity Theory identifies the damage to tissue 
as the cause of pain, however, pain can be reported in the absence of any 
noticeable tissue damage (e.g., migraines) (Ashina et al., 2012). In addition, 
in individuals with chronic back pain there are few objective markers of 
pathology and a notoriously poor association between the experienced pain 
and underlying pathology (Hart et al., 1995; Ung et al., 2012). Furthermore, 
Specificity Theory is unable to explain the phenomenon of ‘phantom limb 
syndrome’. In this syndrome, the limb has been amputated, but the patient still 
reports experiencing pain in the missing limb (Vase et al., 2012) even after 
healing of the amputation site. 
 A further limitation to the theory is its inability to explain episodic 
analgesia, the sensation of little or no pain despite significant tissue damage 
(Wall, 1979). Episodic analgesia has been reported in combat situations where 
injured soldiers frequently refuse morphine, reporting little or no pain despite 
significant tissue damage (Beecher, 1959). Beecher argues that such transient 
analgesia is the result of the individual realising that they were unlikely to have 
to return to the battlefield but were still alive, which blocked their reaction to 
the pain. It can be concluded that the input was blocked or modulated by 
cognitive activities that distract attention from the painful stimuli, thereby 
reducing their interpretation of the intensity of pain. This absence of the 
experience of pain is not only seen during combat settings, but also within 
some hospitalised individuals following injury. Melzack et al. (1982) reported 
that 37% of patients experienced little or no pain at the time of injury. These 
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findings cast doubt on the validity of Specificity Theory’s claim that pain reflects 
a direct relationship with underlying pathology.  
The notion of a direct relationship between pain and pathology, as 
postulated by Specificity Theory, has been widely challenged. Studies 
investigating induced muscle damage on the lower back in asymptomatic 
individuals have found no relationship between pain intensity and such muscle 
damage (Bishop et al., 2011). In addition, studies using Magnetic Resonance 
Imaging (MRI) of the lumbar spine have identified 76% of asymptomatic 
individuals with some form of disc herniation in the absence of reports of pain 
(Boos et al., 1995). Furthermore, surgical procedures, designed to inhibit the 
pain transmission by cutting neurological pathways thought to be involved in 
the interpretation of pain, have resulted in different outcomes for the individual, 
despite the patients having similar levels of both tissue damage and identical 
post-operative treatment programmes (Turk and Burwinkle, 2007). As a 
consequence, of the weaknesses in Specificity Theory, research has been 
increasingly directed to the study of psychological factors involved in pain 
perception. 
2.3.2 Gate Control Theory 
Melzack and Wall (1965) attempted to overcome the limitations of Specificity 
Theory by proposing the Gate Control Theory of pain. This theory not only 
described the experience of pain in terms of the mechanisms and transmission 
of nociceptive stimuli, but also the interaction of physiology and psychology in 
the pain experience. It proposes that a mechanism in the dorsal horns of the 
spinal cord act like a ‘gate’, to either facilitate or inhibit transmission from the 
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body to the brain on the basis of the diameters of the active peripheral fibres. 
Transmission through the gate was a result of both the intensity of stimulation 
and descending impulses from the central nervous system. Melzack and 
Casey (1968) expanded upon the theory and proposed three psychological 
dimensions related to the processing of nociceptive stimulation: (i) sensory-
discriminative; (ii) motivational-affective; and (iii) cognitive-evaluative. The 
sensory-discriminative dimension provides perceptual information relating to 
the magnitude, location and spatio-temporal properties of the noxious 
stimulation. The motivational-affective dimension stimulated an individual 
towards either an escape or attack reaction. Finally, the cognitive-evaluative 
dimension provides the individual with information relating to past-experiences 
and the likely outcome of different response strategies. These three 
dimensions interact to influence the mechanisms responsible for the pattern 
of responses associated with the experienced pain.  
Gate Control Theory was the first to implicate central, psychological 
factors in the experience of pain rather than seeing this as solely the result of 
sensory inputs. Pain was suggested to be an integration and interpretation of 
sensory and psychological processes resulting in a perceptual process of a 
range of incoming stimuli (Turk and Gatchel, 1999). The interpretation of this 
stimuli is based on a variety of factors including previous experiences and 
attention to pain related information. Attentional bias is the tendency for 
patients to selectively attend or avoid information relating to their current 
concerns. There are, however, inconsistencies within pain research relating to 
attentional biases towards pain. Some studies have found that patients attend 
to pain related stimuli (Crombez, Viane, et al., 2013; Crombez, Van 
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Ryckeghem, et al., 2013) whereas others have found patients avoid 
threatening information relating to their pain (Lautenbacher et al., 2009). This 
is particularly pertinent as the model has changed the direction of research 
and has helped to re-define the understanding of pain. In particular, 
interventions targeting the modification of attentional and perceptual 
processes involved in the pain experience developed from the assumptions 
underpinning Gate Control Theory (Turk et al., 1983). Gate Control Theory has 
also stimulated research to test the psychological factors involved in the 
processing and moderating of pain.  
2.4 Chronic pain 
Acute pain is the immediate nociceptive experience of pain and is usually 
resolved quickly, however, some conditions do not improve and cause 
disabling pain for many months and years. Chronic pain is clinically defined, 
as a condition which lasts for more than three months. Examples of chronic 
pain conditions include fibromyalgia, chronic fatigue syndrome, 
temporomandibular disorder and chronic low back pain. Although these 
conditions are distinct, they share some similar characteristics and patients 
can be grouped together for the study of responses to and management of 
chronic pain (Burns, 2000; Perry and Francis, 2012; Schoth et al., 2012; 
Wetherell et al., 2011). Over the past decade, researchers have investigated 
factors which contribute to the progression from acute to chronic conditions. 
The physiological reactions to acute pain are designed to warn individuals of 
an immediate danger, however, when conditions become chronic this 
response may no longer be relevant or possible, for example if there is no 
noticeable pathology (Calvino and Grilo, 2006). In chronic pain, it has been 
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suggested that long-term changes occur to parts of the central nervous system 
that are involved in the transmission and modulation of pain (Ko and Zhou, 
2004). Other elements such as psychological factors and individual 
differences are important to the development and experience of chronic pain. 
Individual’s beliefs about their pain, attention to or avoidance of such pain, fear 
of pain and pain-related coping have all received attention in research. Studies 
have investigated the relationships between pain and disability and have led 
to the development of the biopsychosocial model of low back pain and 
disability (Waddell, 1987). 
2.5 Biopsychosocial model of low back pain 
The biopsychosocial model developed by Waddell et al. (1987) attempts to 
describe the complex nature of chronic low back pain (CLBP) (Figure 2.1). 
This model doesn’t describe how chronic pain develops, but rather offers a 
description of the factors affecting the experience of pain at any specific time. 
This model incorporates physiological, biological, cognitive, affective, 
behavioural and social factors linked to the experience of pain and disability. 
Such factors are considered to be interdependent and to develop over time. 
Psychological factors may affect the interpretation of physical stimuli and 
perceptions of disability (Main and Watson, 1996) or have an influence on 
hormone production (Bandura et al., 1988; Bandura et al., 1987). The strength 
and type of social factors may reinforce or discourage particular behaviours 
and reactions to painful experiences (McCluskey et al., 2011; Romano et al., 
2000). 
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Figure 2.1. The biopsychosocial model of low back pain and disability (Waddell 
et al., 1987). 
A central tenent of the biopsychosocial model is the distinction between 
illness and disease. Disease has been defined as “a pathological process, 
most often physical and is some deviation from a biological norm. There is 
some objectivity about disease which doctors are able to see, touch, measure, 
smell” (Boyd, 2000). Illness is defined as “a feeling, an experience of unhealth 
which is entirely personal, interior to the person of the patient. Sometimes 
illness exists where no disease can be found” (Boyd, 2000). These definitions 
have important implications for the clinical management of chronic pain, which 
will, in many cases, be more akin to illness than disease. 
 For more than a century, treatments for chronic low back pain (CLBP) 
such as manipulation, massage and heat treatment have been based upon a 
biomedical model, primarily focused on disease. The biomedical model follows 
a similar logic to Specificity Theory, i.e. that correction of pathology is the route 
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to pain reduction. CLBP interventions, based on the biomedical model, have 
often proven to be ineffective (Ostelo et al., 2003). This is unsurprising given 
the limitations of Specificity Theory to adequately explain the processes 
involved in the experience of CLBP. In contrast to biomedical management 
strategies, interventions centred around cognitive-behavioural therapy, which 
are based upon the biopsychosocial model of illness, have shown more 
encouraging results (O'Sullivan et al., 2013; Truchon, 2001). Consequently, 
such interventions are now routinely included in clinical guidelines for chronic 
pain management and are the preferred types of intervention (Levy et al., 
2014; Skinner et al., 2012; Turk and Okifuji, 2002). 
The biopsychosocial model’s focus on illness helps to explain some of 
the more complex aspects of CLBP, for which the biomedical model fails to 
account. For instance, the relationship between pain, disability and 
psychological distress is often inconsistent, particularly when there is no 
observable pathology (Ung et al., 2012). Due to its focus on disease, the 
biomedical model is unable to explain this, however, by focussing on illness, 
the biopsychosocial model can partially explain the relationship between pain, 
disability and psychological distress. The biopsychosocial model suggests that 
the inconsistencies between these three factors are the result of biological 
changes, psychological status and social context, which regulate perception 
and reaction to pain (Covic et al., 2003; O'Sullivan et al., 2013). 
In a review of the management of CLBP, Adams and Dolan (2005) 
highlight the increased research emphasis on psychosocial factors as 
predictors of behaviour within chronic back pain patients. These include the 
effects of pain-related anxiety and depression on decisions to take time off 
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work or to attend treatment sessions. They also highlight the role of biological 
factors such as genetics, ageing and spinal loading history which may increase 
the risk of chronic back pain. Psychological factors also appear important in 
assessing pain behaviour and the management of chronic back pain. Not all 
individuals will develop chronic pain, however, the pain may become more 
chronic with attitudes, beliefs, distress and illness behaviour playing an 
important role in the development of chronicity and disability. The 
understanding and management of chronic conditions have been accepted to 
be biopsychosocial challenges, which frequently vary between individuals. As 
a result, return to work and reductions in pain and disability are used as 
common outcome measures. The biopsychosocial model is a model of illness 
rather than a model of rehabilitation. It does not explain how different 
individuals cope with pain and how some manage to get on with their lives, 
while others become severely disabled.  
2.6 Fear-avoidance model of chronic pain 
One of the most widely used models for explaining how psychological factors 
affect the development of chronic pain is the fear-avoidance model (Letham et 
al., 1983; Vlaeyen et al., 1995). Fear-avoidance beliefs are an exaggerated 
fear of pain leading to an avoidance of physical activities that are anticipated 
to cause pain (Vlaeyen and Linton, 2000). The fear-avoidance model initially 
proposed by Letham, et al. (1983) and then developed by Vlaeyen et al. 
(1995), is a model which offers an explanation of the cognitive and behavioural 
processes involved in the responses to back pain. The model was proposed 
to describe the mechanisms involved in exaggerated pain perception and to 
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explain why some individuals progress from acute to chronic pain conditions. 
The basic structure of the model is presented in Figure 2.2. The figure shows 
how an individual may follow one of two routes depending on how they 
interpret pain, or perceive the risk of their pain. When pain is perceived as non-
threatening, individuals carry on with daily activities making only clinically-
appropriate adaptations until full recovery. In contrast, a catastrophic 
(mis)interpretation of pain leads to the individual developing a disproportionate 
and irrational fear of pain, or its perceived consequences, to a state where fear 
of movement (kinesiophobia) leads to situational avoidance or escape. This 
avoidance of movement, can, if associated with cessation of critical social or 
employment activities, lead to the development of disuse, disability and 
depression which evolve in a vicious cycle.  
 
 
 
 
 
 
 
Figure 2.2. The fear-avoidance model of chronic pain (Vlaeyen et al., 1995). 
The predictions of the fear-avoidance model have been widely 
supported within the literature concerned with chronic back pain (Crombez et 
Confrontation Painful experiences 
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Catastrophising Non-catastrophising 
Disability 
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Depression 
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Injury 
Recovery 
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al., 2012). Support has been provided for the suggestion that pain-related fear 
and catastrophising are significantly related to pain and disability (Grotle et al., 
2010; Picavet et al., 2002). Catastrophising is defined as an exaggerated 
negative mental set due to actual or anticipated painful experiences (Sullivan 
et al., 2001). Correlational studies have demonstrated a relationship between 
catastrophising and intensified pain in various musculoskeletal pain conditions 
(Buer and Linton, 2002). In addition, reduced catastrophising has been found 
to mediate reductions in pain intensity and disability (Smeets et al., 2006).  
Leeuw, Houben et al. (2007) found that levels of pain catastrophising at 
baseline were a precursor of pain-related fear six months later. Smeets et al. 
(2006) suggested that exposure to activities associated with pain challenged 
the patients’ association with pain and threat, thereby causing them to change 
their perception of threat. Mannion et al. (2001), identified that an active 
therapy programme was able to modify fear-avoidance beliefs as a result of 
the positive experience from therapy increasing individuals’ daily activities. 
This finding suggests that individuals who interpret their initial levels of pain 
catastrophically are more likely to experience increased fear of movement as 
time progresses, leading to increased levels of disability and reduced physical 
activity. Whilst catastrophising and fear avoidance beliefs are not always 
related to reported pain intensity, their relationship with disability is well 
established (Gheldof et al., 2010; Woby et al., 2004a).  
Further support for this model has shown that pain-related fear and 
catastrophising are associated with hypervigilance to symptoms and may be 
reflected in increased self-reports of pain and disengagement from activities 
(Vlaeyen and Linton, 2000). Intense or threatening perceptions of pain subvert 
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attentional resources and may interrupt the daily activities of the individual 
(Pincus and Morley, 2001). Hypervigilance to pain symptoms has been shown 
to be dependent on the presence of pain-related fear and has a negative effect 
on performance (Van Damme et al., 2006). This has been suggested to be 
due to such patients allocating attention to bodily signals at the expense of 
performance in a particular task. There has been contradicting evidence to 
this, as when a cognitive distracting task is introduced at the same time (e.g., 
performing a concurrent reaction-time task) physical performance improves in 
patient groups (de Gier et al., 2003). Individual differences in pain 
catastrophising have also been shown to influence attentional interference. 
Individuals who are high catastrophisers have more difficulty disengaging their 
attention from the pain-related stimuli due to the anticipated threat 
(Asmundson, Wright, et al., 2005; Crombez et al., 2005). Interestingly, de Gier 
et al. (2003) found that initial self-reported pain intensity was more predictive 
of physical performance than post-physical activity pain intensity levels. This 
suggests that the anticipation of pain may cause individuals to selectively 
attend to their somatic sensations and interpret them as more painful and 
disabling than attending to the actual task.  
Disability and disuse due to chronic back pain not only affect individuals 
at home but also in the work place. Higher fear-avoidance beliefs have been 
significantly associated with disability, both on self-reported measures 
(Boersma and Linton, 2005; Kovacs et al., 2008) and gait speed (Camacho-
Soto et al., 2012). There are limited studies that have investigated the disuse 
element of the fear-avoidance model. In a recent review, Griffin et al. (2012) 
found that between controls and individuals with chronic pain, there was no 
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significant difference in the amount of physical activity undertaken, however, 
the distribution of activities over the course of the day was found to differ. This 
finding is inconsistent with the fear-avoidance model, however, it is possible 
that patients avoid specific activities without reducing their overall activity. 
Hansenbring et al. (2001) suggested that some individuals fear their pain and 
avoid activities, whereas others ignore their pain and persist with physical 
activity. These differences could be due to differing attentional and interpretive 
biases between individuals. The mechanisms underpinning such differences 
between individuals clearly warrants further investigation. 
In Leeuw, Goossens et al.’s (2007) review of the fear avoidance model, 
they mention two aspects of disuse which seem relevant to the fear-avoidance 
model; physical deconditioning and disordered muscle coordination. As 
expected, lower muscle strength is frequently found in CLBP patients 
compared to asymptomatic controls, however, this reduced maximal 
performance could be due to pain-related fear (kinesiphobia) (Verbunt et al., 
2005). Buer and Linton (2002) found higher fear-avoidance beliefs more than 
double the risk of reduced activity levels. In contrast, increases in activity levels 
are often associated with decreases in pain-related fear, disability and pain 
vigilance (Vlaeyen et al., 2002). Some cross-sectional studies have found 
patients with low physical activity to have significantly higher scores in both 
fear-avoidance beliefs and pain catastrophising compared to individuals with 
higher physical activity (Elfving et al., 2007). Longitudinal studies have 
questioned the validity of the fear-avoidance model in explaining the transition 
from acute to chronic low back pain, in particular the disuse aspect inherent 
within the model (Leonhardt et al., 2009; Sieben et al., 2005). Previous studies 
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have shown that hyperactivity and muscle guarding would be more likely to 
occur during a movement task that would be perceived as more threatening to 
the patient. Leonhardt et al. (2009) conducted both cross-sectional and 
longitudinal studies to identify whether fear-avoidance beliefs were associated 
with physical activity levels. Their results failed to support the disuse prediction 
within the fear-avoidance model, which suggests disuse in daily activities. 
They found that after one-year, individuals with chronic pain increased their 
activity levels and initial fear-avoidance beliefs did not predict final physical 
activity levels. The authors suggested that fear-avoidance beliefs may 
represent a cognitive schema that does not limit general activity but is directed 
to the avoidance of specific movements for the individual. Once individuals 
begin to adapt to coping with a chronic condition they may become more 
confident in completing daily tasks (e.g., washing, shopping etc.). Therefore, 
other psychological factors, such as self-efficacy, play a crucial role in reducing 
fear-avoidance beliefs for specific activities. Consequently, a more detailed 
assessment of these activities appears important upon first assessment to 
identify which activities individuals are avoidant of and whether fear-avoidance 
beliefs are associated with them. 
Pincus et al. (2006) concluded that there is little evidence for fear-
avoidance as a key predictor of poor clinical outcomes in both the short (three 
months) or longer term (12 months), with other factors such as depression and 
distress appearing more important predictors of outcome. Boersma and Linton 
(2005) employed a cross-sectional design comparing patients at three 
different stages of pain duration (< 1 year; 1-3 years; > 3 years). Interestingly, 
no relationship was found between fear-avoidance beliefs and function when 
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pain had lasted less than 1 year in duration. Pain intensity was not significantly 
related to fear-avoidance at any stage of pain duration, however, depression 
was associated with function, irrespective of chronicity. This suggests that 
fear-avoidance may be important when applied to specific activities, although, 
other psychological factors (e.g., depression) appear more likely to contribute 
to the development of chronic pain. In addition, differences in pre-disposition 
to attention and prior experience of pain may be important to identify how 
individuals respond to the development of chronic pain. There is a need to 
consider these factors in relation to this model and to enable more effective 
comparison between results. 
Whilst there is experimental evidence in support for this model, 
observational studies have shown contradictory results (Pincus et al., 2010). 
Although there is evidence of heightened pain-related fear following 
catastrophising about pain (Leeuw, Houben, et al., 2007), not all individuals 
complete the full, negative cycle predicted by the fear-avoidance model. Other 
factors such as re-occurrence of pain, pain intensity, initial levels of disability, 
social factors, treatment and genetic factors should also be taken into 
consideration. If it were possible to identify, at an earlier stage, those patients 
at greatest risk of maladaptive responses to their pain, treatment guidelines 
could be more specifically targeted to those individuals. Further research is 
required to establish criteria for identification of these individuals.  
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2.7  Pain management 
Pain is a complex phenomenon with the interaction between biological, 
psychological and social factors influencing the individual. Individuals with 
chronic pain are regular healthcare users, often seeking relief from their 
symptoms, particularly if it affects their day to day living. Due to the poor link 
between pathology and experienced pain, pain management is often focussed 
on addressing how to live with symptoms and does not necessarily aim to 
address the cause or underlying pathology. Therefore, it is important for 
treatment programmes to not only address the biological factors, but to also 
consider the psychological and social factors which may have an impact on the 
individual. 
2.7.1 Guidelines 
Individuals with chronic pain often present to pain clinics with a range of co-
morbid conditions, such as depression, anxiety, insomnia, isolation or overuse 
of medicines (Breivik et al., 2006). The importance of a biopsychosocial 
approach in the management of chronic pain was highlighted in the previous 
section. To enhance the rehabilitation of chronic musculoskeletal pain 
conditions, many interventions attempt to address biological, psychological 
and social factors. These interventions are often underpinned by cognitive 
behavioural techniques and include an exercise programme, educational 
component and goal setting exercises. Cognitive behavioural techniques are 
based on the idea that a person’s affective responses and behaviours are 
determined by their beliefs and cognitions. Three of the studies within this 
thesis focus on general chronic musculoskeletal pain conditions and one study 
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specifically investigates patients with chronic low back pain. Therefore, the 
main recommendations of the current Pain Management Programme (PMP) 
guidelines (British Pain Society, 2013) and the more specific National Institute 
for Health and Clinical Excellence (NICE) low back pain guidelines (National 
Institute for Health and Clinical Excellence (NICE), 2009) are described within 
this review. 
2.7.2 British Pain Society guidelines 
The British Pain Society has recently updated its guidelines for Pain 
Management Programmes (PMP) (British Pain Society, 2013) applicable to 
any chronic musculoskeletal pain condition. A PMP is a psychologically group 
based rehabilitative intervention for people with chronic pain, which remains 
unresolved by other treatments. The guidelines suggest that PMPs should last 
circa 36 hours, with the aim to improve the physical, psychological, emotional 
and social dimensions of quality of life for people with persistent pain. PMPs 
focus on the patient’s physical and psychological wellbeing, rather than 
seeking to treat a disease or biomedical damage. PMPs are not designed to 
focus on pain relief, but aim to improve quality of life, working towards 
improving function and self-reliance for patients to manage their pain. By 
improving these factors, patients have reported improvements in pain intensity 
(King and Robinson, 2014), return to work and function, which are all important 
goals for patients (Morley et al., 1999). In order to achieve these goals PMPs 
consist of an education element and guided practice.  
Education is often provided by a multidisciplinary team focused on pain 
physiology, pain psychology, healthy function and self-management of pain. 
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The aim of the education element is to allow patients to discuss difficulties they 
have in particular situations and to explore ways to resolve them. Patients are 
informed about pain mechanisms such as anatomy and physiology of pain 
pathways, negative affect and avoidance, exercise for better health and 
improved function, advantages and disadvantages of using medications and 
self-management of flare-ups and set-backs. Other information introduces 
treatment principles and rationales by linking the above pain mechanisms to 
guided practice. This may include cognitive strategies to deal with 
psychological effects of persistent pain, principles of goal setting, cues and 
reinforcement to change habits and maintain those changes as well as 
strategies to improve sleep. PMPs are an opportunity for patients to practice 
these methods through guided practice with a clinician and to help patients 
build a more positive way of thinking. Patients are generally encouraged to 
practise these methods at home, particularly through goal setting, and then to 
review their progress and goals with staff at the next session. The guided 
practice element of PMPs also encourages patients to exercise and improve 
fitness and mobility. The group environment adopted by PMPs helps patients 
to improve their confidence in movement which, in turn, leads to improved 
function. Using various cognitive therapeutic methods, clinicians help the 
patient to identify, elaborate and challenge appraisals, beliefs and processing 
biases related to pain and activity. In addition, patients are provided with 
attentional control methods which allow patients to undertake a graded 
increase in safe, but feared activities, based on each patient’s level of anxiety. 
The PMP guidelines recognise that rehabilitative and physical 
treatments are beneficial, and suggests that when the patient’s experience of 
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pain is more complex, the psychological components of pain are best 
addressed in a PMP which is based on cognitive behavioural principles (e.g., 
cognitive behavioural treatment (CBT)) (Koes et al., 2006). PMPs have been 
shown to be effective (Morley et al., 1999; van Tulder et al., 2001; Williams et 
al., 2012).  
A number of systematic reviews have shown PMPs, which include CBT, 
to significantly reduce negative affect and disability and to significantly 
enhance coping and improve physical performance (Morley et al., 1999; 
Williams et al., 2012). The design of psychological treatments has been 
informed by theories of human behaviour focused on psychological processes 
thought to underlie or significantly contribute to pain, distress and disability. 
Psychological interventions focussed on improving physical functioning and 
encouraging self-management are used regularly within modern pain 
management practice (Hill et al., 2011). It has been suggested that if delivered 
at an earlier stage these interventions can be more effective for the patient 
and more cost-effective (Linton, 2000; Linton, 2005; Pincus et al., 2002).  
Healthcare commissioners and patients expect clinicians to deliver 
PMPs effectively. There is no single, a priori, defined outcome for a course of 
treatment as each patient’s goals are determined by the individual. The British 
Pain Society guidelines suggest that the following outcomes should be 
evaluated as standard practice; emotional wellbeing, physical functioning, 
social activities, pain experience, changes in healthcare use, changes in work 
status, and quality of life (Turk et al., 2008). Although there are studies which 
demonstrate the effectiveness of PMPs and that they can reduce pain-related 
healthcare usage (Clare et al., 2013), successful outcome is by no means 
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universal and some patients appear to improve more than others. Therefore, 
more research is needed to identify the underlying mechanisms and define 
subgroups which may benefit more from particular elements of the current 
treatment guidelines (Airaksinen et al., 2006). 
2.7.3 Low back pain guidelines 
The National Institute for Health and Care Excellence (NICE) has produced a 
set of guidelines for clinicians including recommendations for the treatment 
and management of non-specific low back pain (National Institute for Health 
and Clinical Excellence (NICE), 2009). The guidelines are applicable to the 
management and treatment of the early phases of recurrent, non-specific back 
pain that has lasted between 6 weeks and 12 months (Savigny et al., 2009). 
The guidelines encourage initial attempts to engage the patient in the self-
management of their condition. Where this is not possible or is unsuccessful, 
one or more courses of exercise, physical, manual or alternative (e.g., 
acupuncture) therapy can be prescribed. Similar to PMPs, education about 
their condition is highlighted as a key component to encourage patients to self-
manage their pain. Clinicians are also encouraged to highlight information 
about the nature of the patient’s back pain and encouraging them to be 
physically active and to carry on with their normal activities where possible. 
Where the initial treatment is unsuccessful in alleviating symptoms and 
associated disability and where patients demonstrate psychological distress, 
the NICE guidelines suggest they be considered for referral for a combined 
psychological and physical treatment programme, typically consisting of up to 
100 hours of intervention often hospital based (National Institute for Health 
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and Clinical Excellence (NICE), 2009). The progression of patients through the 
stages of treatment and ultimately to specialist back pain management 
programmes is largely determined by the persistence of the patient in 
repeatedly presenting their case to clinical service providers and continued 
self-report of disability. 
Although the NICE guidelines suggest patients with low back pain who 
present with a high level of disability and distress should have a combination 
of physical and psychological treatment, there are no specific guidelines on 
when or how to measure such levels of disability or distress. As a result, 
decision making for referral can be inconsistent. Hill et al. (2008) developed 
the Keele STarT Back Screening Tool as a short, primary-care questionnaire 
designed to stratify the need for treatment based on low, medium and high 
psychosocial risk in low back pain patients. Low risk patients are individuals 
with few negative prognostic indicators, suitable for primary care management 
according to best-practice guidelines (e.g., analgesia, advice, education). 
Medium risk patients are individuals with an unfavourable prognosis with high 
levels of physical prognostic indicators, appropriate for physiotherapy. The 
high-risk subgroup consists of patients with a very unfavourable prognosis, 
with consistently high levels across psychosocial prognostic indicators, 
appropriate for management by a combination of physical and cognitive 
behavioural approaches.  
Hill et al. (2011) reviewed the STarT Back tool in a randomised control 
trial comparing the clinical effectiveness and cost effectiveness of stratified 
primary care (intervention) with non-stratified, current best practice (control). 
Firstly, patients were allocated into one of the three risk groups (low, medium 
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and high) using the STarT Back tool. Second, the three groups were allocated 
into either an intervention or the control group. Demographic data and clinical 
outcomes were gathered before randomisation, four, and 12 months later. The 
primary outcome measure was disability (measured using the Roland Morris 
disability questionnaire) at 12 months post intervention. Secondary outcomes 
were referral for further physiotherapy, pain intensity, pain catastrophising, 
fear avoidance, anxiety, depression and health related quality of life, STarT 
Back Screening tool risk-subgroup reduction, perception of overall change in 
back pain, healthcare resource use and costs over 12 months, number of days 
off work and satisfaction with care. At four and 12 months post-intervention, 
the stratified care group showed a significant reduction in disability compared 
to the control group, although the effect sizes were very low. At four months, 
the secondary outcome measures were significantly in favour of the 
intervention for pain intensity, catastrophising, fear, anxiety, depression, 
general health, STarT Back tool risk reduction, and global change. At 12 
months, there were also significant changes in favour of the intervention group 
for catastrophising, fear, depression, general health and risk reduction. The 
patients in the intervention group were more likely to be satisfied and took 
fewer days off work because of back pain. Over the 12 month period the 
societal benefit, from fewer work days lost because of back pain, 
corresponded to a mean cost saving of £675 for the intervention group 
compared to the control group. Hill et al. (2011) propose that a substantial 
number of referrals based on clinical judgement alone (control group) may be 
unnecessary and that many low risk patients were receiving unnecessary 
treatment in current practice. In this trial, only 7% of the low risk intervention 
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patients were referred compared to 49% in the low risk control group. In 
contrast, 40% medium risk and 32% high risk patients in the control group 
were not offered further treatments which is likely to have contributed to their 
relatively small change in disability compared to the intervention group at four 
and 12 months. These results highlight the benefit of the use of psychologically 
informed stratification for patients. Further research is needed to establish how 
these benefits can be sustained long term as not all measures continued to 
improve. Current research has shown the benefits of using this tool within a 
primary care setting to identify patients who are more likely to have an 
unfavourable outcome at four months (Von Korff et al., 2014) and to identify 
those who may benefit from different treatment regimes (Fritz et al., 2011; 
Main et al., 2012). This was the first trial to provide an evidence-based 
stratified management approach to target the provision of primary care. 
Further research needs to be done to identify the best factors upon which to 
base the stratification of patients. In addition, it would be beneficial to identify 
if there are underlying mechanisms, which may predispose individuals to be 
classified into one of the risk groups. Identifying these factors may lead to 
improved healthcare costs in secondary care.  
2.8 Satisfaction with pain management 
Treatment guidelines provide a useful tool for clinicians to have a structured 
approach to treatment. More recently, there has been an increase in research 
investigating patient satisfaction with treatment for chronic pain (Beattie et al., 
2005; Butler and Johnson, 2008; Casserley-Feeney et al., 2008; Dworkin et 
al., 2011; Henschke et al., 2013). The majority of studies indicate that a high 
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proportion (68%-91%) of patients with chronic musculoskeletal pain report 
they were satisfied with treatment (Stephens and Gross, 2007). From this 
research has come a clearer understanding of the reference points patients 
use to identify their satisfaction with the care they received. The findings have 
shown that relationships with professionals, therapist characteristics, clinical 
outcome and treatment process are strong predictors of patient satisfaction 
(Fitzpatrick, 1991; Trentman et al., 2012; Wensing et al., 1994). Patients tend 
to determine these factors based on pre-conceived expectations of treatment 
and if the services they receive match these expectations. George and Hirsh 
(2005) investigated whether patients were satisfied with their symptoms (e.g., 
their level of pain) after physical treatment for low back pain. They identified 
that the main predictor of patient satisfaction with symptoms at six months 
post-treatment was whether or not treatment expectations were met. Initially, 
patients rated their expectations for complete symptom relief (range 1 (not 
likely) to 5 (extremely likely)). At six months patents rated whether their 
expectations for symptom relief had been met (range, 1 (definitely not) to 5 
(definitely yes)). All three satisfaction measures (satisfaction with symptoms, 
overall results of treatment, and whether or not they would undergo the same 
treatment again) were significantly associated with whether treatment 
expectations were met at six months. Some individuals may be more optimistic 
about treatment, and feel less satisfied if their higher expectations are not met. 
It may therefore be beneficial for clinicians to try to manage the treatment 
expectations of patients, particularly as some individuals may be more 
pessimistic or optimistic about their treatment, which could then impact on 
treatment satisfaction. Although only 40% of patients were satisfied with their 
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symptoms, 90% of patients indicated they would have the same treatment 
again.  This study highlights the importance of differentiating the domains of 
patient satisfaction and of treating satisfaction as a multidimensional concept. 
The relationship between the therapist and patient has been shown to 
be an important factor in the treatment process, particularly for individuals with 
chronic pain (Hills and Kitchen, 2007). Satisfied patients have been shown to 
be more likely to follow their prescribed path of care and have a better 
relationship with their healthcare practitioner (Beattie et al., 2005; Fitzpatrick 
and Hopkins, 1981). On the other hand, dissatisfied patients perceive their 
healthcare services as less effective and, as a result, have a higher attrition 
rate from rehabilitative care (Orton et al., 1991). Casserley-Feeney et al. 
(2008) specifically investigated patient satisfaction with physiotherapy care for 
musculoskeletal pain. They identified that greater satisfaction with care was 
associated with friendly, polite staff who were professional and knowledgeable 
and whom the patients thought were approachable and showed that they 
cared. Other studies have reported the ability of the therapist to communicate 
effectively as an important factor when rating satisfaction (Cooper et al., 2008; 
Cousin et al., 2012). This was particularly the case when explaining the 
condition in more detail and providing self-management strategies (May, 2001; 
Hills and Kitchen, 2007). Through the use of patient interviews, Cooper et al. 
(2008) investigated factors which were important to the patient in their 
physiotherapy care for chronic low back pain. They identified that the 
communication of the therapist was a key factor that also influenced other 
dimensions of care, which were important to them (e.g., individual care, 
decision-making, information, and organisation of care). Participants were 
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particularly satisfied with their therapist’s communication when treatments and 
the reason for these treatments were explained. Cooper et al. (2008) 
highlighted the importance for adapting communication styles based on the 
individual characteristics of the patient. Studies have found that some patients 
want to be actively involved with their decision making and treatment planning, 
whereas others do not want to be involved and would prefer to be prescribed 
a treatment programme (Chewning et al., 2012). These individual differences 
may be linked to the personality type of patients and may allow clinicians to 
tailor their approach, resulting in higher patient satisfaction and possibly better 
outcome.  
When evaluating the efficacy of treatment regimes not only is it 
important to specify the type of patient satisfaction, but also the timing of when 
patient satisfaction is measured. Patient satisfaction is often measured at the 
end of treatment, with a focus on outcome and as a result there may be 
memory bias. Whereby, patients may forget any initial improvements they had 
at the start of treatment and only focus on their current level of pain, rather 
than the whole treatment experience. Towards the end of treatment, patients 
may be experiencing lower levels of pain as a result of developing more 
effective coping strategies. Therefore, they may report high satisfaction if the 
question is primarily focussed on outcome, rather than the treatment process. 
Patients who have not seen a change in pain may be dissatisfied with 
outcome, even though the treatment process was good. Patients who do not 
see a change in their pain, may be more likely to drop-out at an earlier stage 
of treatment, this could be due to patient expectations not being met. Research 
using qualitative methods has highlighted that patient expectations of 
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treatment are not solely based on an improvement in pain, but mainly the 
quality of the process and the therapist’s characteristics (May, 2001).  
Higher satisfaction is sometimes, but not always, related to an 
improvement in pain symptoms (Hills and Kitchen, 2007; May, 2001), with 
differences often shown between acute or chronic pain patient groups. 
Individuals with acute pain are generally more optimistic of a positive outcome, 
whereas individuals with a chronic condition are more doubtful that they will 
receive any improvement in their symptoms (Hills and Kitchen, 2007). Hills and 
Kitchen (2007) conducted a series of focus groups with acute and chronic pain 
patients. The authors found that in contrast to acute pain patients, individuals 
suffering from chronic pain had unrealistically high expectations or were 
uncertain of the treatment process but continued to expect improvement in 
their symptoms. In addition, they found that patients, either with chronic pain 
or with a negative outcome, tended to report a more impersonal relationship 
with the therapist. In particular, if the patient felt they were not involved in the 
treatment process this was associated with a negative impression of the 
treatment and affected their relationship with the clinician. From the therapist’s 
perspective, this can lead to the patient being perceived as a ‘problem patient’, 
particularly if they are unwilling to take part in self-management strategies or 
continue to return for treatment (Thomson, 2000).  
The quality and efficiency of how care is organised is a key factor of 
patient satisfaction (Casserley-Feeney et al., 2008; Cooper et al., 2008; Hills 
and Kitchen, 2007; May, 2001). Patients were more satisfied if the clinic 
provided flexible hours, parking and approachable support staff. Satisfaction 
was lower if the overall standard of the premises was low, poor appearance of 
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staff or if there were long waiting times. Although these are important factors 
to the overall rating of satisfaction (Hush et al., 2011) and influence patients’ 
perceptions of treatment, it is unlikely that these factors will have a direct 
impact on their level of reported pain or disability. Although those factors may 
influence levels of anxiety and negative affect, which are known to lead to 
negative reporting of symptoms, resulting in lower outcome scores. Therefore, 
it is important to consider the organisation and accessibility of factors 
surrounding the clinical environment. 
The relationship between patient satisfaction and treatment outcome 
has provided equivocal results, with few longitudinal studies investigating 
chronic pain patient groups. As previously mentioned, patients generally report 
high satisfaction with care; however, satisfaction with symptoms (outcome) 
tends to be lower. Henschke, et al. (2013) found that 76% of patients were 
satisfied with the care they received whereas only 55% were satisfied with 
their symptoms at 12 months. Unsurprisingly, satisfaction with symptoms has 
been significantly associated to treatment outcome (pain intensity and 
disability) at six and 12 months post intervention (George and Hirsh, 2005; 
Hazard et al., 1994). Patients who are satisfied with their symptoms reported 
higher physical functioning and lower pain intensity at six months than patients 
who were dissatisfied with their symptoms (George and Hirsh, 2005). May 
(2001) identified that although an improvement in pain intensity was an 
important issue, patients also expressed a satisfaction with outcome when 
they were taught self-managing strategies which meant they did not have to 
seek further treatment. In May’s (2001) study, patients accepted they had a 
chronic condition that could not be cured, but recognised that an important 
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outcome was an improvement in daily functioning. In particular, the self-
management strategies taught to them by the therapist during the care 
process gave more consistency to daily life by reducing the number of ‘bad’ 
pain days. Such research suggests that once a patient comes to terms with 
the fact they have a long-term condition, pain no longer becomes the main 
issue, with their ability to cope becoming more important. Poor coping skills 
have been associated with increased anxiety associated with the performance 
of daily tasks often linked to an increased fear of movement associated with 
such activities (Linton and Shaw, 2011). This can lead to the avoidance of 
certain tasks and a consequential cycle of disuse, disability and a greater 
feeling of isolation. In turn, this tends to heighten their movement-related 
anxiety and depression and reduce the likelihood of successful rehabilitation 
(see fear avoidance model section 2.6). 
Considering the high volume of research demonstrating the complex 
interaction between chronic pain, anxiety and depression, it appears likely that 
these psychological factors may affect patient satisfaction with treatment. 
McCracken et al. (2002) found that depression and pain-related anxiety were 
unique predictors of treatment satisfaction at six months in a heterogeneous 
pain population. In support of these findings, Henschke et al. (2013) 
investigated predictors of satisfaction with care and symptoms in patients with 
acute low back pain. At 12 months, pain intensity and lower depression had a 
strong association with satisfaction of outcome. Hirsh et al. (2005) investigated 
the predictors of patient satisfaction with treatment and the relationship 
between satisfaction and compliance with treatment recommendations in a 
group of chronic pain patients. Patients completed questionnaires assessing 
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ratings of pain, depression, anxiety, compliance with treatment, and 
satisfaction with treatment at first assessment and at six-month follow-up. The 
clinicians involved with the treatment programme also completed the Health 
Professional Compliance Evaluation, to assess whether the patient had been 
compliant with the treatment recommendations.  In line with previous findings, 
ratings of satisfaction with care were significantly higher (77%) than ratings of 
satisfaction with improvement in pain intensity (56%). Patients who were more 
satisfied with their improvement in pain intensity were more compliant with 
treatment recommendations, measured both by the therapists and the 
patients’ own compliance ratings. Patient and clinician interaction, pain relief 
and anxiety at treatment onset explained 50% of the variance in ratings of 
satisfaction with care. Suggesting that patients’ levels of anxiety at the start of 
treatment may affect their perception of the care they receive, with higher pre-
treatment anxiety leading to lower levels of satisfaction with care. Patients who 
enter the treatment process with heightened anxiety were more likely to feel 
they have an impersonal relationship with their therapist (Hills and Kitchen, 
2007). Hirsh et al. (2005) found that patient and clinician interaction and pain 
relief accounted for 56% of the variance in ratings of satisfaction with 
improvement.  
The results from the three studies discussed suggest that distinguishing 
between the different elements of patient satisfaction is important, however, it 
also highlights the contribution of psychological factors such as anxiety and 
depression to ratings of patient satisfaction. Where measured, psychological 
variables have consistently been shown to be an important factor in predicting 
treatment outcome and more generally the satisfaction with the care process 
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(Lewis, Holmes, et al., 2012; Linton, 2001). Early interventions aimed at 
reducing patients’ anxiety and depression at the onset of treatment could also 
influence factors such as the patient-therapist relationship, thereby potentially 
improving overall satisfaction which may, in turn, influence treatment outcome. 
2.9  Psychological factors 
Both anxiety and depression have been identified as predictors of satisfaction 
with care and outcome from treatment (measured through reductions in pain 
intensity and disability). Over the past decade it has become widely accepted 
that chronic pain disorders are not solely physical problems, with psychological 
factors playing an important role in both the response and management 
(Linton, 2000; Woby, Roach, et al., 2007). Specifically, the interpretation of 
how patients respond to pain and disability is generally understood and 
managed using the biopsychosocial model as a key theoretical reference point 
(Pincus et al., 2013). 
Psychological factors are relevant throughout the treatment and 
management for chronic pain, however there is a complex relationship 
between such factors and clinical outcome (Bair et al., 2013; Woby et al., 
2008). Chronic musculoskeletal pain tends to have a notoriously poor 
association between reports of pain and underlying pathology, which can 
make it difficult for patients to understand the nature of their condition (Hart et 
al., 1995). Some patients report how their expectations and satisfaction with 
treatment change throughout the process as they develop effective coping 
strategies which focus on psychological factors. Psychological factors, such 
as anxiety, catastrophising, kinesiophobia, self-efficacy, and depression, are 
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all widely recognised as important predictors of clinical outcome, supporting 
the need for them to be considered within treatment regimes. The evidence 
relating to the role of these factors is considered in the following sections. 
2.9.1 Catastrophising 
Catastrophising is defined as the existence of exaggerated, negative worry 
during or in anticipation of an upcoming event (Sullivan et al., 2001). As 
discussed earlier, pain catastrophising has been proposed to play an 
important role in the fear-avoidance model and is one of the most robust 
psychosocial predictors of the experience of pain. Studies have found a strong 
relationship between catastrophising and other measures of pain sensitivity in 
experimental pain testing paradigms, both in asymptomatic groups and within 
various chronic pain groups (Edwards et al., 2006; Sullivan et al., 2001). 
Catastrophising has also been associated with increased reports of pain, 
increased visits to healthcare professionals and heightened attention to 
somatic symptoms (Graves et al., 2014; Turner, Brister, et al., 2005). Pain 
catastrophising has been consistently demonstrated to be associated with 
negative pain-related outcomes in diverse patient groups including mixed 
chronic pain (Severeijns et al., 2002), low back pain (Wertli et al., 2014), 
arthritis (Edwards et al., 2011), neck pain (Thompson et al., 2010), 
fibromyalgia (Campbell et al., 2012) and asymptomatic individuals 
participating in experimental pain procedures (Sullivan et al., 1997).  
Pain catastrophising has been suggested to have three components, 
magnification, rumination and helplessness and has been applied in the 
context of Lazarus and Folkman’s (1984) transactional model of stress and 
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coping. A main tenent of this model is the distinction between primary and 
secondary appraisal and reappraisal which act in a transactional manner to 
shape the resulting cognitive and behavioural coping strategies (Lazarus and 
Folkman, 1984). Primary appraisals relate to judgements about whether a 
potential threat is ambiguous or stressful. Secondary appraisals relate to 
beliefs about ability to cope with the current situation taking into account 
resources available. The reappraisal process involves the constant monitoring 
of the stimulus situation and coping strategies, with the primary and secondary 
appraisals being modified if necessary. Severeijns et al. (2004) suggested that 
magnification and rumination reflected primary appraisals, whereas 
helplessness may reflect secondary appraisals of the inability to cope.  
It has been proposed that pain catastrophising is also associated with 
attention and information processing biases. Specifically, higher levels of 
catastrophising are associated with an amplification of the pain experience via 
exaggerated attentional biases and negative information processing. Van 
Damme et al. (2004) conducted a study using a cueing paradigm task in a 
group of pain-free individuals. The cueing paradigm used by Van Damme et 
al. (2004) involved cues which were either pain or tone stimuli, and was 
designed to investigate whether participants are more likely to engage or 
disengage from pain (e.g., electrocutaneous stimuli through an electrode on 
the forearm) when performing an attention demanding task. Participants were 
initially given a cue (either pain stimuli or tone stimuli) followed by a target 
word on the computer screen (either the word pain or tone) to which they 
responded on a reaction time key. It was proposed that difficulty disengaging 
from pain cues would result in a slower reaction time to either target word. Van 
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Damme et al. (2004) found that patients experiencing high catastrophising had 
difficulty disengaging from pain, suggesting that catastrophic thinking 
enhances the attentional demand towards pain. In support of this, Vancleef 
and Peters (2006) examined performance on an auditory discrimination task 
during electrocutaneous stimulation in a group of healthy, pain free individuals. 
They investigated the potential influence of anxiety sensitivity, injury/illness 
severity and catastrophising on attentional interference. Attentional 
interference was defined as a performance decrement on the auditory 
discrimination task during electrocutaneous stimulation. Only pain 
catastrophising and not anxiety sensitivity or injury/illness severity was 
correlated with attentional interference and performance decrement. Both of 
these studies demonstrate the role catastrophising plays in the control of 
attention in the presence of potential sources of pain and the potential effects 
on concurrent cognitive activities and performance. The evidence from such 
experimental studies has also been replicated to some degree in real world 
settings, with many patients with chronic musculoskeletal conditions showing 
high levels of catastrophising, reporting frequent episodes where their pain 
interferes with activities of daily living. To-date, no study has investigated 
systematically how catastrophising may influence the attentional biases to 
pain in a chronic musculoskeletal pain group. 
Originally, catastrophising was suggested to be a stable trait, which was 
considered to be a dimension of personality (Sullivan et al., 1995). Studies 
have shown, however, that when patients are involved in cognitive behavioural 
therapy, levels of catastrophising can be modified and decreased. In addition, 
pre- to post- treatment reductions in catastrophising are associated with 
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reductions in pain severity (Jensen et al., 2001). Research demonstrates that 
reduced levels of catastrophising are correlated with reductions in depression 
and increased mobility (Jensen et al., 1994). In addition, strategies to 
encourage early reduction in catastrophising in patients during treatment 
regimes have been associated with improvements in pain later in treatment 
compared to individuals whose catastrophising was not reduced (Spinhoven 
et al., 2004).  
2.9.2 Self-efficacy 
Functional self-efficacy is defined as an individual’s confidence in their ability 
to be successful in a specific task (Woby, Urmston, et al., 2007). Patients with 
chronic musculoskeletal pain frequently present with dysfunctional beliefs, 
attitudes and behaviours, related to their experiences of pain. Some patients 
believe physical activity will aggravate their injury and they lack confidence in 
their ability to complete tasks associated with daily life (Stenberg et al., 2013). 
For most patients, a chronic musculoskeletal pain condition can affect their 
ability to work, or delay return to work. De Vries et al. (2013) investigated self-
reported work ability and work performance in a group of individuals with non-
specific, chronic musculoskeletal pain. They found that self-efficacy 
contributed to both an individual’s ability to work and work performance. 
Interestingly, pain intensity and fear-avoidance beliefs did not contribute to 
either ability to work or work performance.  
In addition, self-efficacy can have an impact on treatment outcome, and 
explain a significant amount of variance in disability. Within a study by Denison 
at al. (2004), in a primary care based chronic musculoskeletal pain group, in 
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addition to fear-avoidance and pain intensity, self-efficacy explained an 
additional 24% of the variance in disability. Self-efficacy was not initially 
included in the fear-avoidance model as there was a limited amount of 
research linking self-efficacy to fear-avoidance. More recent studies, however, 
have reported a strong association between self-efficacy, fear-avoidance and 
disability (Thompson et al., 2010; Woby, Urmston, et al., 2007). Such findings 
suggest that high self-efficacy may enable patients to overcome high fear-
avoidance for specific tasks and potentially increase physical activity. 
Cross-sectional studies have found that self-efficacy mediates the 
relationship between pain intensity and disability (Arnstein et al., 1999). In 
support of this, Costa et al. (2011) found that, over a 12-month period only 
improvements in self-efficacy beliefs (and not fear of movement) mediated the 
relationship between changes in pain and changes in disability. Suggesting 
the importance of interventions which aim to improve self-efficacy. Woby, 
Urmston et al. (2007) found that self-efficacy mediated the relationship 
between pain-related fear and pain intensity, and between pain-related fear 
and disability. These mediation effects suggest elevated pain related fear 
might not lead to increased pain intensity and disability when self-efficacy is 
high. When self-efficacy is low, increased pain related fear may lead to 
amplified pain intensity and disability. Miro et al. (2011) is one of only a limited 
number of studies to investigate the mediating role of self-efficacy and sleep 
dysfunction on pain intensity, anxiety, depression and daily functioning within 
a group of fibromyalgia patients. Although chronic pain is the primary symptom 
in this group, disturbed sleep is a major factor for patients with fibromyalgia. 
Miro et al. (2011) found that self-efficacy mediated the relationship between 
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pain intensity and daily functioning. Higher levels of self-efficacy were 
associated with less pain, emotional distress and better sleep quality and daily 
functioning. In addition, both self-efficacy and sleep dysfunction was found to 
mediate the relationship between pain and anxiety and depression, suggesting 
that the interpretation of pain is just as important as the pain itself (Miro et al., 
2011).  
Both of the previous studies (Miro et al., 2011; Woby, Urmston, et al., 
2007) provide valuable insight into the role of self-efficacy in mediating factors 
which are considered to be important for patients suffering from chronic pain 
(e.g., sleep disturbance, daily functioning). The main limitation of both of these 
studies was their cross-sectional design, resulting in difficulty explaining the 
mediation of these relationships as causal. Longitudinal studies would provide 
a greater insight into explaining some of these relationships and should be 
considered for future research.  
2.9.3 Depression 
Depression is defined as a pervasive low mood, and loss of interest in usual 
activities (Bair et al., 2003; Woo, 2010). Unsurprisingly, chronic 
musculoskeletal pain patients tend to report more depression related 
symptoms than individuals within the general population without pain (Magni 
et al., 1993).  Studies have demonstrated strong correlations between ratings 
of depression and reports of pain, with evidence showing that depression has 
an important influence on reports of daily activity impairment, irrespective of 
the stage of chronicity (Boersma and Linton, 2005). In addition, there are 
physiological similarities between the symptomology of pain and depression 
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(e.g., sleep disturbance, fatigue, change in appetite) and it has been 
suggested that they follow the same descending pathway of the central 
nervous system. The biochemical theory of depression proposes that 
depression is the result of a neurochemical imbalance of key neurotransmitters 
serotonin, noradrenaline and dopamine (Fields, 2000). Key brain structures 
involved in the modulation of pain are the periaqueductal gray and the on- off- 
cells in the rostral ventromedial medulla which determine negative affect and 
attention to peripheral systems (Bair et al., 2003). These systems supress 
signals coming from the body to allow more attention to be paid to external 
information. With deficits of serotonin and noradrenaline, as shown in 
depression, this system may lose its modulatory effect, leading to an 
amplification of pain signals and result in more attention and emotion applied 
to them. This may help to explain why patients with higher depression describe 
multiple pain symptoms and why their pain is associated with increased 
attention and anxiety.  
A patient’s level of depression plays an important role in the chronic 
pain experience, as patients with greater depression have been found to report 
higher levels of pain (Knaster et al., 2012), disability (Perry and Francis, 2012) 
and are generally less active (Haythornthwaite et al., 1991). Furthermore, 
depression has been found to be a strong predictor of the onset and future risk 
of chronic pain (Carroll et al., 2004; Linton, 2005). In addition, depression is a 
strong predictor of pain and disability, both cross-sectionally (Bair et al., 2008) 
and longitudinally at six and twelve months (Cherkin et al., 1996; Sieben et al., 
2005). In addition, higher levels of depression pre-treatment are predictive of 
poorer treatment outcomes (Bair et al., 2003; Linton, 2000; McCracken and 
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Turk, 2002). Glombiewski et al. (2010) investigated cross-sectional and 
longitudinal associations of depression and chronic pain in patients taking part 
in cognitive-behavioural therapy. Regression analyses showed higher pre-
treatment depression scores predicted higher pain intensity and disability 
scores at pre-treatment even after controlling for other psychological variables 
(e.g., fear avoidance beliefs). In addition, reductions in depression from pre- 
to post-treatment explained variance in the reductions in both pain intensity 
and disability. Woby et al. (2008) investigated a group of patients attending a 
physiotherapist-led intervention (Interactive Behavioural Modification Therapy 
(IBMT)) which was based on cognitive-behavioural principles. Pre- to post-
intervention changes demonstrated reductions in disability, fear of movement, 
catastrophising and depression, and an increase in self-efficacy, control over 
pain and ability to decrease pain, however, there was no significant change in 
pain intensity.  Changes in disability explained 28% of the variance in changes 
in depression. Although changes in disability were strongly related to changes 
in depression, this was not the case for pain intensity. Woby et al. (2008), 
suggested that pain intensity is indirectly related to depression via the 
mediating role of  interference with daily activities. Although depression may 
not be a direct consequence of pain, there in now a general acceptance of the 
consequence theory, suggesting that pain precedes depression (Arnstein et 
al., 1999; Knaster et al., 2012). Longitudinal studies have shown that 63% of 
depressive disorders appeared after the onset of pain (Knaster et al., 2012).  
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2.9.4 Anxiety 
Anxiety is defined as “a psychophysiological state characterised by cognitive, 
somatic, emotional and behavioural components that produce fear and worry” 
(Woo, 2010). The co-occurrence of movement-related anxiety and chronic 
pain is not surprising and has received substantial interest over the past 20 
years. Anxiety is comprised of two separate components; state anxiety refers 
to the experience of feelings when confronted with specific situations, or a 
particular object or event and trait anxiety is the individuals predisposition to 
be anxious and general tendency to respond to perceived threats in the 
environment. The experience of anxiety involves both a mental aspect termed 
cognitive anxiety, or worry, and perceptions of physiological symptoms, known 
as somatic anxiety (Liebert and Morris, 1967; Martens et al., 1990). Cognitive 
anxiety is defined as “negative expectations and cognitive concerns about a 
situation and potential consequences” (Martens et al., 1990). Somatic anxiety 
is an individual’s perception of their physiological arousal symptoms, such as 
heart palpitations, increased sweating, shortness of breath or muscular 
tension (Morris et al., 1981).  
Individuals with chronic pain frequently experience anxiety about 
movement and may avoid activities of daily living. As a consequence, the pain 
symptoms linked to their condition persist. The triad of chronic pain, anxiety 
and depression has been found to be the leading cause of functional 
impairment, work related disability and lower levels of quality of life (Kroenke 
et al., 2013). Numerous studies have suggested that pain-related anxiety 
predicts how patients adapt to chronic pain and is an important component of 
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pain management (Kroenke et al., 2013). Bair et al. (2013) investigated 
whether baseline and early change (three months post-baseline) anxiety 
predicted 12-month reports of depression and pain severity in a general 
chronic musculoskeletal pain population. The authors found that anxiety at 
baseline predicted pain severity and depression at 12 months. Secondly, 
reductions in anxiety severity from baseline to three months were predictive of 
depression at 12 months but not pain severity. This study demonstrates the 
importance of anxiety as an independent predictor of depression and pain 
severity at 12 months, and that reductions in anxiety will influence levels of 
depression. The findings have important implications for treatment, since 
interventions that lessen anxiety symptoms may relieve depression and pain. 
Particularly in patients whose pain or depression are not improving with 
treatment. 
Cognitive factors, such as a patient’s attention to physical stimuli or 
inappropriate attributions as to the cause of their pain, may play a role in 
increasing the pain experience (McCracken, 1997). Clinical studies have 
shown that patients scoring high on pain-related anxiety also report high levels 
of attention to pain sensations (Arntz et al., 1991) and tend to over-predict the 
amount of pain they are likely to experience. Differences in attention to pain 
symptoms have also been found between high and low trait anxious 
individuals. McCracken et al.  (1993) investigated predictions of pain intensity, 
reports of pain-related anxiety symptoms and range of motion during passive 
straight leg raising in high and low-anxious participants suffering from chronic 
back pain. Participants were asked to rate the intensity of pain they expected 
to experience on a leg raise, then after the task they were asked to rate, the 
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actual level of pain and anxiety they experienced. Interestingly, high-anxious 
individuals tend to initially over-predict their rating of pain and reported higher 
pain related anxiety, whereas, low-anxious individuals under-predicted their 
pain. Heightened pain-related anxiety may produce an increased vigilance to 
somatic symptoms (e.g., sweating, increased heart rate) in high-anxious 
individuals linked to possible pain, causing them to over-predict the intensity 
of pain they will experience (Eysenck, 1997). Higher predictions of pain 
severity were also related to a lower range of motion. McCracken et al. (1993) 
suggested that individuals who expect more pain, terminate the leg raise 
earlier as a result of the fear and anxiety, than those who expect less pain. 
These anxiety-based differences in the anticipation of pain are of particular 
interest to clinicians when developing pain management programmes, which 
could include trait anxiety differences.  
2.10 Personality type 
Researchers have been investigating individual differences relating to 
personality for decades. McCrae and Costa (1985) identified the following five, 
core personality traits: extraversion; agreeableness; conscientiousness; 
neuroticism; and openness. One of these ‘big five’ factors, neuroticism, has 
shown consistently strong correlations with measures of trait anxiety 
(Eysenck, 1997). Questionnaire measures assessing neuroticism and trait 
anxiety typically show correlations of between 0.68 and 0.70 (Watson and 
Clark, 1984; Flett et al., 1989). Trait anxiety is considered to be an important 
dimension of personality and is included in most theories as a major 
personality factor (Digman, 1990). Other theories (Eysenck, 1992; Williams et 
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al., 1988) have primarily focussed on the role of the cognitive system (e.g., 
attentional biases) and trait anxiety when attempting to explain individual 
differences in the experience of potentially threatening situations.   
 Eysenck (1992) proposed a cognitive theory of trait anxiety based on 
the premise that the function of anxiety is to facilitate the early detection of 
impending danger in potentially threatening environments. Since it is the 
attentional system, which is involved in threat detection, individuals high and 
low in trait anxiety should differ in terms of their pre-attentive and attentional 
functioning. Eysenck proposed that variations in trait anxiety are reflected in a 
range of ‘cognitive biases’, which influence processing of ambiguous or threat-
related stimuli. These biases include a selective attentional bias, interpretive 
bias, and negative memory bias. It was also assumed that these biases are 
more evident when situational (e.g., state) anxiety is high. High-anxious 
individuals are predicted to selectively attend to threat-related stimuli rather 
than neutral stimuli. They are also more likely to interpret ambiguous stimuli 
as threatening and show a negative memory recall bias in explicit memory. 
Thus, they are significantly more likely to remember more threat-related than 
non-threatening events of both a social (e.g., social rejection) and physical 
(e.g., physical wounds) nature (Eysenck, 1992). Attentional biases have been 
implicated in both the cause and maintenance of emotional disorders and can 
cause the exacerbation of anxiety (Koster et al., 2010). Of particular interest 
to the current research, is the finding that, an attentional bias to pain related 
symptoms in chronic pain populations may lead to the causation or 
maintenance of pain. Excessive vigilance, may be associated with pre-
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occupation with pain, resulting in a tendency for patients to avoid activities 
which are deemed threatening to their condition (Schoth et al., 2012). 
Numerous experimental paradigms have been used to investigate 
attentional and interpretive biases, including, the emotional Stroop task 
(Stroop, 1935), the dot probe task (MacLeod et al., 1986), the spatial cueing 
task (Posner et al., 1978) and the visual search task. In recent years, there 
has also been an increase in the use of eye-tracking technology in conjunction 
with these experimental paradigms. Studies investigating cognitive biases 
have primarily used either the dot probe paradigm or the Stroop test.  
The emotional Stroop task presents emotional or threatening stimuli 
(typically words) to participants in different colours. Participants are required 
to colour name each stimulus as quickly as possible while ignoring the actual 
meaning of the word. Performance times on emotional trials are often 
compared to trials with non-emotional or neutral stimuli (Epp et al., 2012). 
Slower response times to colour naming in emotional over the neutral stimuli 
are suggested to reflect an attentional bias towards threating stimuli. The 
emotional Stroop task was initially the most widely used paradigm to 
investigate threat-related attentional biases, however, it has provided mixed 
results in patient populations. Some studies have found evidence of a specific 
pain-related bias in patients with chronic pain compared to healthy controls 
(Snider et al., 2000), whereas others have reported no bias (Asmundson, 
Wright, et al., 2005; Pincus et al., 1998) or found a bias to some but not all 
pain related words (Crombez et al., 2000). In a meta-analysis of data from five 
studies using the Stroop paradigm, Roelofs et al. (2002) identified significant 
mean differences from both sensory and affective pain words, indicating 
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chronic pain patients attend to pain stimuli significantly more than healthy 
controls. Given the limited number of studies and the conflicting findings, the 
authors recommended that a more robust test (e.g., the dot probe paradigm) 
should be used in future studies to assess attentional biases in pain patients. 
MacLeod et al. (1986) designed a computer based dot probe task, 
where, following an initial fixation point, two stimuli (one emotional and one 
neutral) are presented (for between 100ms to 2000ms) on the screen (either 
above or below, or to the left or right of the fixation point). Studies have also 
varied in using either pictorial or word stimuli, however, researchers often 
consider pictorial stimuli to be more ecologically valid and have greater 
meaning to the individual (Dear et al., 2011). After initial exposure, the two 
stimuli are then removed and a visual probe (e.g., a dot, either : or ..) replaces 
one of the stimuli. Participants are required to indicate the type or location of 
the dot as quickly and accurately as possible using either a keyboard or 
response keys. Congruent trials feature the probe replacing the emotional 
stimulus and in incongruent trials the probe replaces the neutral stimulus. 
Faster response times to a probe location are assumed to reflect the focus of 
visual attention. Averaged response times are calculated for congruent and 
incongruent trials and then converted into an index of attentional bias with 
shorter reaction times to congruent trials reflecting an attentional bias to 
threatening stimuli.  
Research using the dot probe paradigm within both general and chronic 
pain populations has investigated the time-course of the bias, focussing on 
both the orienting and maintenance of attention in individuals with chronic pain 
and healthy control participants (Asmundson, Carleton, et al., 2005; Khatibi et 
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al., 2009; Roelofs et al., 2005). Evidence of attentional biases towards 
threatening stimuli in chronic pain patients has been consistently 
demonstrated with the use of the dot probe task using pictures rather than 
words (Dehghani et al., 2003; Hou et al., 2008; Schoth and Liossi, 2010). A 
general limitation of the findings from such studies is that the evidence of 
attentional bias towards threat is drawn from only a ‘snapshot’ of visual 
attention at stimulus offset and at the exposure duration used (Mogg and 
Bradley, 2005). This limitation has recently been addressed by the use of eye-
tracking equipment which allows the researcher to record the number and 
location of visual fixations and gaze duration across trials thus providing insight 
into the temporal aspects of the distribution of visual attention (Derakshan et 
al., 2009). This said, previous research has found a concordance between the 
attentional bias shown from probe reaction time data (500ms) and the initial 
shift in gaze towards emotional stimuli (Bradley et al., 2000). 
According to Beck’s Schema Theory (Beck et al., 1985), high-anxious 
individuals have a dysfunctional schema relating to personal harm or threat, 
resulting in an increased propensity to be distracted by or attend to threat 
related stimuli. In particular, this bias may be enhanced when state anxiety is 
high or when the threat is more personally relevant. The majority of research 
suggests that high-anxious individuals will demonstrate an attentional bias 
towards threatening information (Mogg and Bradley, 1998). The results 
suggest that high-anxious individuals have a bias in the processing of threat 
which facilitates processing of negatively-valenced information over pleasant 
or neutral stimuli (Mogg et al., 2000). Bradley et al. (1998) investigated the 
attentional bias of high-anxious and low-anxious individuals from the general 
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population when they were presented with threatening, happy and neutral 
stimuli for varying durations. In both 500ms and 1250ms conditions, high-
anxious participants were significantly more vigilant for threat and avoidant of 
happy faces. The low-anxious individuals, showed no bias in either condition. 
Following this study, Mogg and Bradley (1999) attempted to replicate their 
findings using the same dot probe method as in their 1998 study but with only 
a 500ms exposure condition. The high-anxious group showed exactly the 
same pattern, showing vigilance for threat over neutral faces. The low-anxious 
group showed a significant vigilance for happy over neutral faces. 
Interestingly, in the threat condition the low-anxious group showed no bias for 
threat or neutral faces. In contrast to these studies, Rohner (2002) found that 
both low and high-anxious individuals attended to angry more than happy 
faces when stimuli were presented for 0-1000ms. When images were 
presented for a longer stimulus duration (2000-3000ms) high-anxious 
individuals avoided threatening stimuli more than happy. Fox (2002) identified 
that low-anxious individuals demonstrated no bias towards fearful faces, and 
showed vigilance for happy faces. Koster et al. (2006) found high-anxious 
individuals showed an attentional avoidance of threatening images when they 
were presented at relatively short (i.e. 200ms and 500ms) and longer 
(i.e.1250ms) exposures. Interestingly, in the 500ms condition, low-anxious 
individuals also attended to the threatening images.  
Individual differences in anxiety, and their link to variations in selective 
attention to threat may be of significance to the treatment and management of 
chronic pain. Some of the contradictory findings within high and low anxious 
individuals in previous studies suggest there may be an additional cognitive 
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mechanism causing these differences. Sub-dividing the low-anxious and high-
anxious group based on measures of trait anxiety and defensiveness may 
provide greater insight into the attentional processes of individuals in chronic 
pain. 
2.10.1 Weinberger et al.’s personality classifications 
Differences between individuals in the tendency to experience anxiety appears 
an important distinction in clinical environments. Weinberger et al. (1979) 
originally investigated the combination of trait anxiety and defensiveness to 
explain differences between physiological and behavioural reports of anxiety. 
These differences reflected variations between individuals in the concordance 
of different measures of anxiety. Research showed that some individuals 
reported low levels of self-reported anxiety despite exhibiting elevated levels 
of physiological anxiety. Defensiveness is regarded as a coping behaviour 
which causes individuals to avoid negative affect and has been related to 
emotional and physical health and prevention of threat to self-esteem 
(Weinberger, 1990). Weinberger et al. (1979) proposed four personality 
profiles: high-anxious (HA); defensive high-anxious (DHA); low-anxious (LA); 
and repressor (REP) types. High-anxious individuals score high on trait anxiety 
and low on defensiveness; defensive high-anxious individuals score high on 
trait anxiety and defensiveness; low-anxious individuals score low on both trait 
anxiety and defensiveness; and repressor individuals score low on trait anxiety 
and high on defensiveness. The four personality profiles are believed to show 
different behaviours when confronted with stressful situations. Weinberger et 
al. (1979) reported that although repressors report low levels of distress, their 
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physiological anxiety is similar to individuals who have high-anxiety profiles 
(Fahrenberg, 1992; Gudjonsson, 1981).  In contrast, low-anxious individuals 
do not appear to show any differences between their self-report measures and 
physiological measures of anxiety. Weinberger (1990) conducted an extensive 
review of the repressive personality type and concluded that repressors do not 
deliberately report low levels of anxiety in order to be considered more socially 
desirable, but because they genuinely believe they are not experiencing 
negative affect. These findings suggest cognitive factors such as 
defensiveness can moderate anxiety responses and thus may also influence 
pain responses.  
2.10.2 Eysenck’s Four-factor Theory 
Following Eysenck’s (1992) theory of trait anxiety, he later (1997) proposed 
the Four-factor Theory. The Theory suggests that the emotional experience of 
anxiety depends on the processing of four different sources of information 
(Figure 2.3). One source is related directly to the cognitive appraisal of the 
degree of threat presented by a situation. Eysenck (1997) argued that this was 
the most important determinant of anxiety; the other three sources of 
information depend indirectly on the cognitive appraisal of the situation. These 
are: the individual’s interpretation of (i) their physiological activity; (ii) their 
prevailing action tendencies and behaviour; and (iii) the individual’s own 
cognitions and pattern of thought (e.g., worry about the future). 
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Figure 2.3. Eysenck’s Four-factor Theory of anxiety. 
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The level of physiological anxiety is influenced by the cognitive 
appraisal of the situation. The impact of this physiological reaction to the 
experience of anxiety depends on two types of cognitive process: (i) selective 
attention either toward or away from the physiological activity (attentional 
bias); and (ii) the interpretation of the physical activity as either threatening or 
non-threatening (interpretive bias). In relation to selective attentional bias, 
studies have shown that attention to pain (which may be perceived as 
threatening) increases the pain experience and distraction from the pain 
reduces it (Arntz et al., 1991). 
Studies investigating group differences in cognitive biases have 
primarily focussed on high-anxious individuals and repressors with respect to 
the four sources of information. In some studies, low-anxious individuals are 
not distinguished from repressors due to the self-report measures used. 
Similarly, high-anxious individuals are not always differentiated based on their 
levels of defensiveness, which has provided some inconsistent findings 
(Eysenck et al., 1987; MacLeod and Mathews, 1988). Eysenck (1997) 
proposed that the four personality groups differ in dispositional anxiety as a 
result of their cognitive biases, which lead them to either magnify or minimize 
the four sources of information. Schemas within long-term memory are 
assumed to be the source of cognitive biases that operate on all four factors 
within this theory. High-anxious individuals are predicted to have cognitive 
biases leading them to be vigilant to all threatening information. High-anxious 
individuals also show interpretive biases which lead them to interpret 
ambiguous stimuli as threatening. In contrast, low-anxious individuals were 
assumed not to exhibit any such biases in cognition whilst repressors were 
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predicted to show an avoidant bias to threatening stimuli. Repressors are also 
suggested to have opposite interpretive bias, which leads them to interpret 
ambiguous stimuli as non-threatening. Eysenck (1997) did not initially predict 
any specific cognitive biases about defensive high-anxious individuals, 
however, he suggested that they would show similar cognitive bias to high-
anxious individuals. This may have been due to a lack of evidence, given the 
relative scarcity of defensive high-anxious individuals in the normal population, 
but seems at odds with the proposed interactional effect of defensiveness and 
anxiety seen in the repressors. 
Derakshan and Eysenck (1997) investigated the physiological anxiety 
symptoms shown by the four groups during public speaking. They 
subsequently asked the participants to attribute the extent to which increases 
in heart rate during the task reflected their level of excitement or distress. In 
accordance with the Four-factor Theory, high-anxious and defensive high-
anxious individuals attributed the changes in heart rate to the talk being 
threatening, whereas repressors believed that the increased heart rate 
reflected excitement during the task. Derakshan and Eysenck (2001b) 
subsequently assessed physiological activity and self-reported anxiety within 
the four personality types when the focus of attention (self or other) was 
manipulated in a public speech task. In the self-focus condition, one of the 
researchers talked to the participant about the feelings and emotions they 
were experiencing during public speaking. In the other focus condition, the 
participant listened to the researcher speaking about his emotions or feelings. 
Both the participant’s and the researcher’s heart rate were measured, and the 
researcher’s speech indicated high levels of anxiety. Immediately after each 
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condition, the participants rated their perceived level of physiological and 
behavioural anxiety, experienced anxiety and level of social performance. 
Repressors consistently demonstrated an opposite interpretive bias in both 
conditions, whereby they had the lowest level of self-reported anxiety but 
consistently greater physiological anxiety in all conditions. The high-anxious 
group were consistent with predictions that their self-reported anxiety was 
greater than their physiological anxiety, particularly in the self-focus condition. 
In contrast to their previous paper (Derakshan and Eysenck, 1997), Derakshan 
and Eysenck (2001b) found no significant differences between self-reported 
and physiological anxiety in the defensive high-anxious group. This finding 
suggests that the defensive high-anxious individuals differ from the high-
anxious group in stressful situations, however the mechanisms behind these 
differences need to be investigated further. 
The Four-factor Theory suggests that the four personality types also 
differ in their own patterns of cognition, such as worries about future events. 
Eysenck (Eysenck, 1997; Eysenck, 2000) suggests that these worries are 
normally based on autobiographic information stored in the long-term memory. 
Eysenck and Derakshan (1997) compared the difference between the four 
personality types’ predictions of various positive and negative examination 
related events happening to them or other students in the run up to exams. 
Despite the finding that the actual examination result did not differ between the 
repressors and other three groups, repressors believed that negative 
examination related events were significantly less likely to happen to them 
than other students. In addition, the high-anxious and defensive high-anxious 
individuals were significantly more pessimistic and predicted they would 
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achieve a worse score than they actually did, they also predicted significantly 
more negative outcomes for themselves than for others. In terms of 
examination worry, the high-anxious group and defensive high-anxious group 
differed. High-anxious individuals reported worrying significantly more than 
their friends, whereas defensive high-anxious individuals didn’t report any 
differences. The varying results for defensive high-anxious individuals suggest 
that their defensive coping style is partially successful, as they do not spend 
time worrying about negative future events than others and they do not worry 
more intensely about those events. 
Research investigating the effects of trait anxiety and defensiveness on 
attentional biases is mixed, and primarily focuses on high-anxious, low-
anxious and repressor individuals in the general population. Mogg et al. (2000) 
used a dot probe task to assess the attentional patterns of repressors, high-
anxious and low-anxious individuals. In line with previous predictions, the 
repressor group demonstrated avoidance of both social threat and physical 
threat words relative to neutral words and the low-anxious group showed no 
bias.  Ioannou et al. (2004) were the first group to investigate the attentional 
biases of all four personality groups. They used the dot probe paradigm with 
angry and happy faces presented for 500 and 1250ms. The high-anxious 
participants were more vigilant of threatening faces in the 500ms condition 
compared to both the low-anxious and defensive high-anxious group. 
Interestingly, and contrary to predictions, defensive high-anxious individuals 
showed an attentional bias towards happy faces relative to neutral faces. This 
finding may explain why the attentional bias for threat-related information in 
non-clinical high-anxious groups is equivocal. In addition, the repressor group 
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did not follow previous predictions and demonstrated no attentional bias for 
happy or threatening faces. Studies investigating the attentional biases of 
individuals within a chronic musculoskeletal condition have tested the group 
as a whole and not differentiated them based on anxiety or social desirability. 
Further research needs to consider the combination of anxiety and 
defensivness when investigating attentional bias. As mentioned before, the 
defensive high-anxious group are often omitted from studies, therefore the role 
of defensiveness in the processes for selective attention have not been fully 
established within the literature. Within the repressor group, it has been 
demonstrated that the interaction of defensiveness with low trait anxiety 
causes individuals to avoid threatening information following initial vigilance. It 
would be of interest to identify whether high anxiety interacts with 
defensiveness to influence the attentional pattern.  
2.10.3 Vigilance-avoidance Theory 
The Four-factor Theory originally suggested that repressors exhibit an 
avoidant cognitive bias at all stages of threat-related processing.  There is 
evidence which demonstrates that repressors tend to show physiological 
(Derakshan and Eysenck, 1997) and behavioural symptoms of anxiety, which 
suggest that the processing of threat-related information does occur at some 
level. Earlier work by Calvo and Eysenck (2000) investigated the time-course 
of interpretive biases in processing threat-related stimuli, in repressor, low-
anxious and high-anxious individuals. Repressive coping was associated with 
facilitated early processing of threat but inhibited late processing. Whereas 
64 
 
high-anxious individuals sustained vigilance for threat at all three time points 
(50ms, 550ms, and 1050ms). 
Derakshan et al. (2007) proposed the Vigilance-avoidance Theory 
(VAT) of anxiety that was specifically relevant for repressor individuals. The 
VAT suggests that when repressors experience self-relevant threat by a 
stimulus or situation, there are two distinct stages of processing involved. The 
first is the vigilance stage, which occurs rapidly and involves an automatic and 
non-conscious reaction. This stage also involves knowledge, which is 
situationally accessible and is reflected in the initial, vigilant reaction. During 
this rapid and early processing stage, repressors are more likely to notice self-
relevant threats and exhibit both attentional and interpretive biases. 
Derakshan et al. (2007) suggest that repressors demonstrate vigilance to 
information due to self-relevant negative schemas stored in long-term memory 
(e.g., previous experience of low back pain due to an occupational injury). The 
second stage proposed by Derakshan et al. (2007) is the avoidance stage, 
which reflects a more consciously controlled and strategic process focused on 
verbally accessible knowledge linked to an avoidant coping strategy. In the 
context of the current research this may be reflected in repressors avoiding 
negative, self-relevant information such as pain. Derakshan et al. (2007) 
proposed that repressors use three types of cognitive biases: an avoidant 
attentional bias; an avoidant interpretive bias and an avoidant memory bias 
that can be applied to both internal (i.e., bodily) and external (i.e., 
environmental) stimuli. These biases are proposed to aid repressors in their 
avoidance of negative affect. Repressors appear to use these cognitive biases 
after a situation or stimulus has been identified as a threat (Brosschot et al., 
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1999). They also tend to become more defensive when they perceive 
themselves to be under psychological or physiological self-relevant threat. 
Derakshan et al. (2007) predicted that the differences between 
psychophysiological, behavioural and self-report measures of anxiety viewed 
in repressors are apparent because the psychophysiological and behavioural 
measures are mainly dependent on the initial, vigilance stage of processing, 
whereas the self-report measures depend mainly on the avoidance stage 
(Loney et al., 2005). Within VAT, repressors are expected to demonstrate an 
initial attentional bias towards the threat-related stimuli, followed by an 
avoidance bias for the stimuli. Prasertsri et al. (2011) found that patients 
identified as repressors reported significantly lower levels of pain quality (e.g., 
the experienced sensations of pain, ‘stabbing’ etc.) compared to the high-
anxious and defensive high-anxious groups although their pain intensity (e.g., 
how much pain someone is experiencing) was not significantly different. 
Prasertsri et al. (2011) suggested that a repressive coping style was a positive 
adjustment to chronic pain, as it was associated with less depression, 
catastrophising and pain. Therefore, these patients had initially attended to the 
pain and been referred to a treatment programme but then perceived 
themselves to have less debilitating symptoms. We would expect defensive 
high-anxious participants to continue to highlight their pain and interpret this 
as serious or threatening and thus seek different types of treatment.  
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2.11 Personality type and pain 
There is a large body of literature investigating the repressive personality type 
within both the general population and chronic pain. Defensive high-anxious 
individuals are often excluded from studies due to low numbers. A relatively 
high proportion of repressors have been observed within a number of chronic 
illness populations, such as those with heart disease (20%) and cancer (36%) 
(Mund and Mitte, 2012; Myers, 2010). Although defensive high-anxious 
individuals are relatively few in the general population (~7-10%), Creswell and 
Chalder (2001) found that 46% of Chronic Fatigue Syndrome patients were 
classified as defensive high-anxious. Lewis, Fowler et al. (2012) also identified 
a high prevalence (39%) of the defensive high-anxious personality type within 
a group of patients with chronic back pain referred to an active rehabilitation 
programme. It is interesting to note the difference in repressor and defensive 
high-anxious numbers reported by these studies. In comparison to studies 
investigating chronic illness populations, e.g., heart disease, cancer (Denollet 
et al., 2008; Phipps and Steele, 2002), where the numbers of repressors are 
high, there was a relatively low number of repressors (~9%) in the populations 
of Chronic Fatigue Syndrome and chronic back pain. A potential explanation 
for this difference is the recruitment of participants with a pathologically 
determined illness and those with a more insidious and non-specific condition. 
It could be speculated that individuals who are defensive high-anxious are 
more likely to interpret their pain in a negative manner and thus present for 
treatment than repressors. With chronic back pain or Chronic Fatigue 
Syndrome, repressors may be able to avoid their pain and self-manage 
treatment, an option not available for conditions with a more clearly defined 
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biomedical diagnosis and treatment pathway. Phipps and Steele (2002) 
investigated the prevalence of repressors within a population of children with 
chronic illness (e.g., cancer, juvenile rheumatoid disorders, diabetes mellitus 
and cystic fibrosis). They found that repressors showed a reluctance to seek 
social support and engage effectively in psychotherapy. This evidence 
supports the notion that repressors are more likely to wish to self-manage their 
condition, as they perceive the associated threat of the condition more 
positively (Eysenck, 2000; Myers, 2010). In addition, they tend to be overly 
optimistic about their future performance or treatment outcome (Franklin et al., 
2015; Jones et al., 2004) and may be more likely to report a negative 
association with any treatment they receive.  
2.12 Summary 
Chronic pain clearly has significant, widespread consequences for the pain 
sufferer, their family and the wider economy. Nationally, there are guidelines 
for referral into PMPs, which aim to provide individuals with strategies to cope 
with their pain and reduce use of healthcare services. There are still a 
significant number of patients who continue to utilise healthcare services after 
attendance at PMPs (Jensen et al., 2005; Thomsen et al., 2002).  
It is clear that psychological factors such as kinesiophobia, 
catastrophising, self-efficacy and depression play an important role in the 
development and maintenance of chronic musculoskeletal pain. All of these 
factors are widely recognised as important predictors of clinical outcome 
(Linton, 2000). High trait anxious patients are more likely to attend to 
threatening stimuli (e.g., their pain intensity) which can increase the 
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individual’s perception of negative affect (e.g., catastrophising). Leading to the 
individual reporting higher disability and being more likely to seek ongoing 
treatment.  
Over the past 30 years there has been substantial research exploring 
the repressive personality type as they make up approximately 40% of certain 
populations and are considered an essential group for health psychologists to 
study (Myers, 2010). Repressors may be better at coping with health 
behaviours that are perceived to be under their control compared to defensive 
high-anxious individuals. Considering the defensive high-anxious group 
account for up to 46% of a chronic musculoskeletal pain population it would 
seem necessary to understand more about how they interpret and respond to 
chronic pain. High defensiveness may be a contributory factor in patient 
persistence in the care system. To-date, there is a paucity of research that has 
looked at personality types in chronic musculoskeletal pain. The limited 
evidence available from the clinical environment provides a prima facia case 
that personality type interacts with various psychological factors known to 
influence clinical outcome. Identifying the mechanisms involved may provide a 
foundation for targeted interventions to improve clinical outcome. 
2.13 Aims  
Global aim: To determine whether the management of chronic pain would be 
enhanced through the use of treatment stratified based on personality type. 
Research aim: To establish if personality type influences clinical outcome in 
individuals with chronic pain and the mechanisms by which anxiety and 
defensiveness interact to influence pain and disability. 
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Objectives: 
1) to identify the key factors that influence patient satisfaction in the 
management of chronic pain; 
2) to establish the attentional biases of defensive high-anxious individuals 
to threatening stimuli in a chronic back pain population; 
3) to identify whether there are differences in the distribution of personality 
type between those with and without chronic pain;  
4) to determine whether personality type affects the relationships between 
cognitive factors and both pain and disability. 
5) to identify whether there are any differences between personality types 
in the minimally clinical important change from baseline to three and six 
months for pain and disability. 
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3.0 General method 
3.1 Design structure 
The purpose of this programme of research is to investigate whether the 
interaction between anxiety and defensiveness (personality type) can help to 
explain the responses of individuals with chronic pain. The studies within this 
thesis have adopted a mixed methods approach, to help understand the 
complex relationship between personality type, psychological factors and 
treatment outcome. The thesis comprises a questionnaire study with both 
cross-sectional and longitudinal analyses and two further studies to explore 
issues arising from these studies. The first objective, to identify the key factors 
that influence patient satisfaction in the management of chronic pain, is 
addressed through interviews with a cross-section of patients (Study 1) to 
provide insight and understanding of the patient population and the factors 
important to them in order to enhance the discussion of the quantitative 
findings. 
Within the current literature, there is an absence of a clear hypothesis 
as to the attentional biases evident in defensive high-anxious individuals. In 
order to provide insight into the mechanisms underlying the responses 
observed in the questionnaire data within this thesis it was necessary to 
explore the attentional biases of defensive high-anxious individuals. In relation 
to the second objective a dot probe study was employed to determine the 
nature of attentional biases for the different personality types with in a group 
of patients with chronic pain (Study 2). The outcomes from this study fill a 
critical void in the body of knowledge relating to personality type. 
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 In relation to the third objective, identifying whether there are 
differences in the distribution of personality type between those with and 
without chronic pain, a cross-sectional questionnaire design is employed to 
identify the distribution of personality types in a population of patients with 
chronic pain and to contrast this with that seen in asymptomatic individuals 
(Study 3). This study was conducted to establish whether the greater 
prevalence of defensive high-anxious individuals in clinical populations, 
observed by Lewis et al. (2012) and Cresswell and Chalder (2001), was 
substantiated for those within general pain management. In relation to the 
fourth objective, to determine whether personality type affects the 
relationships between cognitive factors and both pain and disability; the cross-
sectional questionnaire data were further analysed to identify whether 
personality type influenced the relationships between cognitive factors and 
disability in the chronic pain group. Furthermore, patients were tracked over a 
12 month period to determine whether changes in pain, disability and 
satisfaction were influenced by personality type (Study 4). Patients initially 
utilised in the cross-sectional study were contacted at three further points 
throughout a year (three, six, and 12 months after first sample). Changes in 
key outcome measures as well as any differences in relationships between 
cognitive factors were examined at each time point. In relation to the fifth 
objective, to identify whether there are any differences between personality 
types in the minimally clinical important change (MCIC) from baseline to three 
and six months for pain and disability, the longitudinal disability and pain 
intensity data were further analysed to investigate these differences between 
the personality types over time (Study 4). 
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Ethical approval was granted by The Proportionate Review Sub-
committee of the National Research Ethics Service (NRES) Committee North 
East - Newcastle and North Tyneside 2 for studies 1,3, and 4 and by the NRES 
Committee North West - Greater Manchester Central for study 2. All studies 
within this thesis also received ethical approval from the Exercise and Sport 
Science Departmental Ethics Committee of Manchester Metropolitan 
University.  
3.2 Patient population  
All studies involved NHS patients who had been referred to a hospital for pain 
management. Six hospitals were initially recruited into the study (Table 3.1), 
however, only the patients from five hospitals responded to the questionnaires. 
The duration of pain ranged from three months to 20 years, and all patients 
were suffering from a chronic musculoskeletal pain condition (e.g., chronic 
back pain, fibromyalgia, arthritis chronic fatigue syndrome). As there is no 
defining start point for the onset of chronic pain, participants were recruited at 
their first appointment with the clinician at their current treating hospital, rather 
than a particular point in their pain journey (Study 1, 3 and 4). NHS patients 
were recruited by asking clinicians to distribute to all new patients information 
packs containing a participation information sheet, invitation letter, return 
envelope and informed consent form (Appendix 1). If patients opted to take 
part, they were asked to return the informed consent form along with their 
contact details in the return envelope. Once patients had opted in, they were 
sent the first questionnaire with a return envelope. Participants were asked to 
complete a set of validated questionnaires at baseline (first contact with the 
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clinician), three, six and 12 months after they were recruited into the study. If 
the participant did not return a questionnaire, they were sent one reminder 
pack and were then assumed to have withdrawn from the study. Participants 
were only sent the next questionnaire pack if they had completed the previous 
one. 
Table 3.1 Number and response rate of patients to the first questionnaire from 
the six participating hospitals. 
Hospital 
Number of patients 
interested in the 
study 
Number of 
individuals 
completed the 
first 
questionnaire 
Response 
rate (%) 
Pennine Acute 
Hospital 
Manchester 
41 33 80 
Frimley Park 
Hospital 
32 24 75 
Stockport 
Hospital 
26 19 73 
Robert Jones and 
Agnes Hunt 
Hospital, 
Oswestry 
6 3 50 
Kings college 
London 
1 0 0 
Lewisham 
Healthcare Trust 
0 0 0 
Total 106 79 74 
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3.3 Asymptomatic population (Study 3) 
Asymptomatic individuals were recruited using a ‘buddy referral system’ and 
contacts within the general public for the questionnaire part of the study. The 
‘buddy referral system’ involved asking individuals within the chronic pain 
population to ask a friend of a similar age and sex to take part in the study. 
Participants were excluded if they had, at any time, experienced a recurring 
chronic pain condition or if they had been referred to a chronic pain clinic. 
Participants filled in the same questionnaires as individuals who have chronic 
pain, with the exception of the pain intensity and treatment satisfaction 
questions. 
3.4 Measures 
Appendix 3 contains copies of each of the validated questionnaires used within 
this study. A self-report item was considered incomplete if three or more scale 
items were missing. Participants completed all questionnaires at each time 
point, with the exception of the satisfaction questions, which were only asked 
at three, six and 12 months. 
3.4.1 a) Defensiveness  
The 10-item short form of the Marlowe-Crowne Social Desirability Scale (MC-
SDS) (Strahan and Gerbasi, 1972) was used to assess defensiveness and to 
discriminate defensive high-anxious from high-anxious individuals. The scale 
consists of items that are culturally approved but unlikely to occur. A 
correlation coefficient of r = 0.9 (p< 0.001) has been reported between the 10 
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item MC-SDS and the original 33 item MC-SDS (Crowne and Marlowe, 1960) 
with an internal consistency of α= 0.66 (Reynolds, 1982). 
3.4.1 b) Trait anxiety  
The trait sub-scale of the State-Trait Anxiety Inventory (STAI) (Spielberger et 
al., 1983) was used to assess trait-anxiety. The scale consists of 20 
statements (e.g., “I lack self-confidence”) that participants rate on a scale of 1 
(not at all) to 4 (very much so), with a score range of 20 to 80. The trait 
component of the STAI has a test-retest reliability of between α=0.73 and 0.86 
(Spielberger et al., 1983). 
3.4.1 c) Personality type  
Studies have differed over time on the method for defining the cut offs of the 
four groups. Some studies use median splits, which has the benefit of including 
all of the recruited population, however, the location of the medial cut-off are 
skewed by the data spread in the population, making comparison with other 
studies difficult. In addition, it can lead to relatively small differences between 
the determined classifications. Some studies have used quartile or tertiary 
splits, whereby ranked data based on the specific population are used to 
identify the top and bottom 25% or 33% from each group. A limitation is that 
this method is subject to the same sampling effects as using median values, 
whereby the absolute values of anxiety and defensiveness would differ 
depending upon the sample population. Other studies have used criterion 
splits, where they set the scores that will be taken for high or low 
defensiveness and anxiety. Based on previous research within the general 
population (Franklin et al., 2014), personality type was assessed based on 
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criterion splits (Figure 3.1) on the trait subscale of the STAI (Spielberger et al., 
1983) and the MC-SDS (Strahan and Gerbasi, 1972). Repressors (REP) were 
defined as scoring above 8 on the MC-SDS and lower than 30 on the STAI. 
Low-anxious (LA) individuals scored lower than 4 on the MC-SDS and lower 
than 30 on the STAI. Defensive high-anxious (DHA) individuals were classified 
as scoring above 8 on MC-SDS and above 42 on the STAI. Finally, high-
anxious (HA) individuals scored lower than 4 on the MC-SDS and above 42 
on the STAI. The ‘non-extreme’ (NE) group scored between 5-7 on the MC-
SDS and 31-41 on the STAI.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Diagram to demonstrate criterion splits of the personality types. 
> 42 < 30 
< 4 
> 8 
78 
 
3.4.2 Catastrophising  
The Pain Catastrophising Scale (PCS) (Sullivan et al., 1995) is a 13 item self-
report measure of catastrophic thinking associated with pain. These items 
relate to different thoughts and feelings that individuals may experience when 
they are in pain. The PCS instructs participants to reflect on their painful 
experiences and to indicate the degree to which they experienced the 13 
thoughts or feelings on a 5-point Likert scale ranging from 0- ‘not at all’ to 4- 
‘all the time’. There is an overall score of catastrophic feelings and thought and 
three separate subscales: (i) rumination; (ii) magnification; and (iii) 
helplessness. The questionnaire has high internal consistency across its factor 
structure, with coefficient alphas showing: total PCS= 0.87, rumination= 0.87, 
magnification= 0.66, and helplessness= 0.78 (Sullivan et al., 1995). 
3.4.3 Depression  
The Centre for Epidemiologic Studies Depression Scale (CES-D) (Radloff, 
1977) is a 20 item self-report measure of depression symptoms. Each item 
asks participants how frequently a specific symptom was experienced in the 
past week (e.g., I did not feel like eating: my appetite was poor) ranging from 
0 (not even one day) to 3 (daily). Scores range from 0-60, the higher the score 
the more sever the frequency and severity of symptoms relating to depression. 
High internal consistency has been reported with coefficient alpha scores 
ranging from  0.85-0.92 (Radloff, 1977). 
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3.4.4 Disability  
The Roland Morris Disability Questionnaire (RDQ) (Roland and Morris, 1983) 
is a 24 item self-report measure where participants answer either ‘true’ or 
‘false’ to each statement about how they are feeling today (e.g., “I stay at home 
most of the time because of my pain”). Scores range from 0 to 24, with higher 
scores reflecting greater disability. This measure has an excellent level of 
reliability with a correlation coefficient of 0.91 (Roland and Morris, 1983) and 
internal consistency of α= 0.90 (Roland and Fairbank, 2000). Researchers 
have made modifications to the terminology used in the questionnaire, 
changing a statement from “because of my back” to “because of my pain” 
(Jensen et al., 1992; Turner, Ersek, et al., 2005). This has made the 
questionnaire more suitable for a general chronic pain population rather than 
specifically back pain. 
3.4.5 Functional self-efficacy  
The Chronic Pain Self-efficacy Scale (CPSS) (Anderson et al., 1995) is a 
modified version of The Arthritis Self-efficacy Scale (ASE), specifically 
designed to measure the self-efficacy of individuals coping with chronic pain. 
The original CPSS has three separate sub-scales; (i) Self-efficacy for coping 
with symptoms (CSE); (ii) Self-efficacy for pain management (PSE); and (iii) 
Self-efficacy for physical function (FSE). Coefficient alphas for internal 
reliability were 0.88 (PSE), 0.87 (FSE) and 0.90 (CSE).  
Functional self-efficacy refers to an individual’s confidence in their own 
ability to complete daily functional tasks successfully. The purpose of including 
a self-efficacy questionnaire within this study was to understand how chronic 
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pain affected the individual’s confidence in completing daily tasks.  Therefore, 
in order to keep the questionnaire pack as short as possible, only the functional 
sub-scale of the questionnaire was utilised. In addition, the functional subscale 
of the CPSS has been identified as a significant predictor of pain intensity, 
daily interference due to pain and general activity level (Anderson et al., 1995). 
The original CPSS-FSE is scored on a ten point Likert scale with higher scores 
reflecting higher levels of self-efficacy. Similar to Woby et al.’s  (2008) study, 
this study used a 9 item self-report measure where participants responded on 
how confident they were to perform certain tasks (e.g., “lift a 10lb box?”). With 
written indicators labelled as 0= Totally Unconfident, 4= Moderately Confident, 
and 8= Totally Confident. Scores range from 0-72, with higher scores reflecting 
greater self-efficacy. Woby et al. (2007) assessed the psychometric properties 
of this scale in a group of 111 chronic low back pain patients. They reported 
excellent internal consistency (α = 0.88) and test-retest reliability over a three 
day period (ICC= 0.88 [CI; 0.80- 0.93]). 
3.4.6 Kinesiophobia  
The Tampa Scale of Kinesiophobia (TSK) (Miller et al., 1991) aims to measure 
fear of movement or (re)injury in individuals with pain. The original 
questionnaire consisted of 17 items that patients rate on a 4-point Likert scale 
ranging from strongly agree to strongly disagree. Woby et al. (2005) 
investigated the psychometric properties of the TSK and of a shorter TSK with 
only 11 items (TSK-11). Both items demonstrated good internal consistency 
(TSK: α = 0.76; TSK-11: α = 0.79) and test-retest reliability (TSK: ICC = 0.82; 
TSK-11: ICC = 0.81). Both items were responsive to change, demonstrating 
that they are suitable measures to be used when assessing pain-related fear 
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of movement. In the context of the current study, and to help keep the 
questionnaire pack as short as possible, the 11-item TSK was utilised. 
3.4.7 Pain intensity  
As this study utilised paper based and online questionnaires a numerical rating 
scale was used to assess pain intensity. Participants were asked to rate their 
pain over the past 24 hours on a scale from (0) “no pain” to (10) “worst possible 
pain”. Pain intensity is a subjective interpretation of the pain experience and 
the patient’s assignment of the value to the numerical rating scale. 
Methodological studies have indicated that investigating pain intensity over 
time has acceptable validity (Von Korff et al., 2000) and reliability of the 11-
pont NRS. In addition, this scale is recommended by Initiative on Methods, 
Measurement, and pain assessment in Clinical Trials (IMMPACT) to assess 
chronic pain intensity (Dworkin et al., 2005).  
3.4.8 Patient satisfaction  
Participants were also asked to rate their satisfaction with treatment outcome 
and with treatment care on a scale ranging from (0) “not satisfied at all” to (10) 
“very satisfied”. Three questions were asked at the three, six and 12 month 
time points: 1) How would you rate your satisfaction with the treatment you 
have received over the last three months? 2) Reflecting on the treatment you 
have received over the past 3 months how satisfied are you with the 
improvement in your ability to cope with pain. 3) How satisfied are you with 
your current level of pain. 
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3.5 Semi-structured interviews 
A subset of participants (n= 8) who took part in the questionnaire element of 
the study were invited to take part in semi-structured interviews to gain a 
qualitative understanding of the questionnaire outcomes. Approximately six 
months after the start of data collection a preliminary statistical analysis of the 
cross-sectional data was completed. Outcomes from this statistical analysis 
were used to form the basis of the semi-structured interviews aimed at 
exploring more deeply the relationships found. Interviews, used in parallel with 
other methods, enriched the information gained, particularly about patient 
preference and perception. Themes identified from patient interviews identified 
were triangulated with the questionnaire outcomes, to highlight potential 
factors associated with treatment outcome. In addition, it allowed further 
investigation into how personality type could affect compliance and 
satisfaction.  
Semi-structured interviews were conducted either face-to-face (n= 2) or 
over the telephone (n=6) depending on patient preference. A topic guide was 
developed from a literature review and the aims of the study to ensure that the 
same general questions were covered in each interview. The interview guide 
(Appendix 4) used open-ended questions and the conversation was flexible 
and responsive to allow the interviewees to elaborate and to gain richer 
information of each individual’s experience (Pope and Mays, 2006). 
Interviews ranged in length from 35 to 65 minutes. All interviews were 
audio recorded with a Dictaphone and transcribed verbatim. Face-to-face 
interviews were conducted at the clinic the patient was attending for treatment 
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and telephone interviews were conducted in the participant’s home. 
Interviewing continued until saturation was reached and there was repetition 
of the same issues. 
3.6 Sample size 
Previous research investigating the variance in pain pre- and post-treatment 
has demonstrated effect sizes for the decrease in pain of ~0.4 (Burns et al., 
2003). Other research has shown effect sizes between anxiety and disability 
of ~0.5 and between defensiveness and disability of ~0.35 (Denollet, 1991). 
Correlations between anxiety and other psychological variables such as 
depression and self-efficacy are typically between 0.4 and 0.8. Based on these 
correlations, a power calculation using GPower, setting alpha at 0.05, power 
at 0.80 and effect size between 0.35 and 0.4 suggested that a sample size of 
between 34 and 45 participants was needed to detect a medium effect (Faul 
et al., 2009). Therefore, in the cross-sectional and longitudinal studies, a 
recruitment target of approximately 35 participants was set for each 
personality type.  
Previous research investigating attentional bias towards pain-related 
information within a chronic pain group has demonstrated an effect size of 0.45. 
Research investigating initial attention towards pain-related information in 
chronic pain patients using a stimuli presentation time of 500ms has found an 
effect size of 0.38 (Schoth et al., 2012). Other research has found correlations 
between attentional bias and defensiveness of 0.43 (Mogg et al., 2000) and trait 
anxiety as 0.34 (Liossi et al., 2009). Based on these correlation results a priori 
power analysis demonstrated a sample size of between 26 and 39 participants 
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would be required to achieve power of 0.8. As within a clinical population, 
research has found 35-45% of individuals are DHA. To ensure there were 
enough defensive high-anxious individuals within the population, a recruitment 
target of approximately 100 participants was set for the patient population of the 
dot probe study (Study 2).  
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CHAPTER 4 
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4.0 Study 1: A qualitative investigation of factors that matter to individuals in 
the pain management process. 
4.1 Introduction 
There is a growing body of research investigating how patients perceive their 
pain. Many individuals can find it difficult to come to terms with their pain and 
its consequent impact on their daily life (Dewar et al., 2009). This extends not 
only to their ability to work, but also to complete activities of daily living (e.g., 
cooking, dusting, vacuuming etc.) and to interact socially with family and 
friends. 
Patient behaviour is an important determinant of the maintenance and 
development of chronic pain and the resultant disability. Patients are often 
referred to specialist Pain Management Programmes (PMPs) if they persist in 
presenting their case to care providers and self-report high levels of disability. 
These programmes aim to change the way patients perceive their pain, to 
reduce threat, promote self-management and reduce the use of health care 
services (Vlaeyen and Morley, 2005). Although PMPs are designed to provide 
the individual with the skills to manage their pain at home without clinician 
intervention, Campbell and Guy (2007) found that their patient population re-
engaged with health care services (suggesting the PMP failed). This may be 
because treatment did not meet patient expectations, or because they had 
developed an over-reliance upon healthcare services to provide them with a 
validation of the pain experience, which may be lacking in other areas of their 
life.  
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The majority of studies investigating PMPs have focussed on 
quantitative techniques to assess treatment effectiveness (Hoffman et al., 
2007; Koes et al., 2006; Williams et al., 2012). It is also important to 
understand how patients perceive the treatment experience and what factors 
contribute to their expectations and satisfaction with treatment. Previous 
studies have identified that relationships with health professionals, therapist 
characteristics, clinical outcome and treatment process (Fitzpatrick, 1991; 
Trentman et al., 2012; Wensing et al., 1994) affect patient reports of 
satisfaction with treatment. Patients tend to judge these factors based on pre-
conceived expectations of treatment and if the services they receive match 
such expectations. There are few studies that utilise qualitative methods to 
provide insight into patient experiences and expectations of pain 
management, and the impact on their daily life (Bunzli et al., 2013), and none 
have applied these findings to the cognitive mechanisms of personality types. 
Addressing the patient perspective is an essential step to enhance the 
relationship between patient and clinicians leading to improved treatment 
outcomes and satisfaction (Zanini et al., 2014).  
Chronic pain is a biopsychosocial problem, with each element having a 
distinct influence upon the other. In order to inform the outcomes from the 
questionnaire studies within this thesis, it is important to understand factors 
that patients believe have influenced their experiences of chronic pain and 
their management preferences. This study was designed to give a better 
understanding of the patient population and the factors which are important to 
them. Through the use of patient interviews, the aim of this study is to identify 
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key factors which have influenced individuals’ experiences in the management 
of their chronic pain. 
4.2 Method 
4.2.1 Participants 
Participants were recruited from the wider population in this thesis based on 
their personality type. The whole population were categorised into personality 
type and participants randomly selected from each group. They were included 
in the study if they were 18 years of age or over, had been suffering from 
chronic musculoskeletal pain for more than three months, and had been 
referred to the hospital for a pain management programme. Participants were 
invited by letter to participate in an interview. Those who replied were then 
contacted by telephone to arrange the interview. Over a three-month period, 
15 letters were sent out and eight participants volunteered to enter the study 
and were interviewed. It was made clear to participants at the start of the 
interview that their involvement would have no impact on the care they 
received from their treating hospital and they had the right to withdraw at any 
time. Demographic patient characteristics are presented in Table 4.1. Of the 
eight participants, six were female and two male, with a mean age of 53.8 
years. All participants had some form of chronic musculoskeletal pain, with a 
mean pain duration of 17.3 years. All participants were either retired or 
unemployed due to health reasons.  
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4.2.2 Data collection 
Semi-structured interviews were conducted either face-to-face (n= 2) or over 
the telephone (n=6) depending on patient preference. An interview guide 
(Appendix 4) was developed from a literature review and the aims of the study 
to ensure that the same general questions were covered in each interview. 
The interviewer, aided by the interview guide, asked open-ended questions to 
explore the key factors which had influenced each individual’s experiences in 
the management of their chronic pain. Further probe questions were asked of 
the participant and the conversation was flexible and responsive to allow the 
interviewees to elaborate on their responses and to gain richer information of 
each individual’s experience (Pope and Mays, 2006). 
The interviews each lasted 35 to 65 minutes and were audio recorded 
with a Dictaphone and transcribed verbatim. Face-to-face interviews were 
conducted at the clinic where the patient normally attended for treatment. 
Telephone interviews were conducted in the participant’s home. Each 
interview continued until there was repetition of the same issues. 
4.2.3 Data analysis 
The steps for qualitative content analysis and interpretation were guided by 
the thematic analysis described by Braun and Clarke (Braun and Clarke, 2006; 
Guest et al., 2012). Coding and data management were facilitated using 
qualitative data software NVivo (version 10). The first step in the analysis 
involved initial familiarisation with the information by reading the transcript as 
a whole, then re-reading to identify the repeated pattern of thematic content. 
Secondly, the presence of these themes was checked across each transcript. 
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At this point the transcripts were read several times to confirm the meaning of 
the texts. Words and passages were highlighted and assigned a code. For 
example, passages in which a participant described how their family influences 
their condition were assigned the code “family support.” The third step involved 
identification of themes defined as a recurring set of codes or connection made 
between codes. This method was chosen for systematically identifying and 
describing features of the data which recur across participants (Marks and 
Yardley, 2004). The data were returned to on several occasions to define and 
refine the evolving themes.  
Strategies to enhance analytic rigour included constant comparison of 
categories and themes between the interviews and discussion of the emerging 
themes by the research team to ensure they were comprehensive and 
inclusive. To eliminate bias, two of the researchers met regularly to verify the 
data and reach a consensus. There were no differences in the themes to 
emerge from the interviews conducted face-to-face in the clinical environment 
and those from the home-based telephone interviews. 
4.3 Findings 
The analysis of the interviews provided three primary themes for the 
participants’ perspective of the chronic pain management process. 
(i) Impact on daily life. 
This theme relates to how chronic pain affected their lives on a day to 
day basis, subthemes include the emotional and mental impact and 
physical effects.  
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(ii) Clinical interactions. 
This theme related to factors about the patient’s experience with the 
clinicians throughout the process, subthemes included communication, 
explanation and understanding. 
(iii) Management process. 
This theme relates to positive and negative factors, which influenced 
their management process, subthemes included involvement, 
understanding, outcome and follow-up. 
4.3.1 Impact on daily life 
Participants reported a wide range of emotional and physical factors which 
influenced daily life as a result of their chronic pain. Generally, participants 
found that chronic pain changed their daily life significantly, more specifically, 
there were tasks and activities that they were no longer able to complete. 
Participants described how the physical impact of pain affected their daily 
lives, particularly, poor mobility, lack of sleep, fatigue, and difficulty standing 
or sitting. All of these factors made participants feel as though they had lost 
their independence, as others had to perform basic tasks for them.  
“… I used to be active all the time… I know it sounds stupid, but 
I can’t just get on and do things, like house cleaning, so my Mrs. 
has to do it all for me, and I really hate that because ya know if I 
see dust up on the top of the door frame, I would normally just 
sort it out.” [participant 3] 
“my parents have to miss work to take me to an appointment.” 
[participant 5] 
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The temporality of the pain experience is also important to the 
participants. Participants reported that mornings were the most difficult period 
of the day because of the amount of time it took each participant to get ready 
in the morning varied, and was often dependent on the amount of sleep the 
night before. Depending on how they felt in the morning and how long it took 
to get ready, would then have an effect on the rest of the day.  
“… something that does really annoy me is that they don’t 
listen to what I say about what time of day I want my 
appointments because the tablets really knock me out and it 
makes it difficult in the mornings for me to get up in time … 
they make an appointment for half eight  in the morning which 
just doesn’t help.” [participant 6] 
 
The temporality of the pain experience is further highlighted through 
participants reporting that they had to carefully plan the day and ensure that 
they paced themselves in order to reduce the amount of pain experienced. 
Participants also reported that if their pain was not managed they could end 
up in a vicious cycle of high pain, tension and doing too much. Using the coping 
strategies they learnt at the treatment sessions helped them avoid relapses 
and gave more consistency to daily life. 
“… you have some good days and then you try and get 
everything done that you’re trying to catch up on and then you 
wonder why you’re in bed for a week afterwards because you 
can’t move.” [participant 4]  
 “… they’ve sort of said, right well on a good day, stand, say 
…for 10 minutes but on a bad day you can stand for 3, on a 
good day stand for 3 minutes and then sit back down again and 
then you don’t have such a lull in the ups and downs, and you 
have quicker, hopefully quicker recovery times.” [participant 7] 
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 In addition to physical effects, participants reported a significant impact 
on emotional and mental aspects, such as feelings of depression, lack of self-
confidence and negative mood. Participants commented on how these 
physical and mental aspects all contributed to the extent that pain affected 
their life if they were unable to control it or implement effective coping 
strategies. 
“You can cope with it [the pain] a lot better if it’s managed. You 
will never get rid of it but if it’s managed you can have a 
reasonably normal life. But if it’s not, it basically puts a full stop 
on it” [participant 8] 
“I mean it is depressing, because it affects the quality of your 
life always.” [participant 2] 
 
 Some participants commented on feeling a sense of isolation and that 
they were under-valued due to their pain and inability to do certain tasks. A 
particular source of conflict was when patients thought that there was a lack 
of understanding by family and friends. They reported feeling that others 
thought they were ‘making it up’ and it was ‘all in their head’, invalidating the 
pain experience. 
“because you feel very, very alone, very alone, especially when 
you’ve got people in your family who don’t understand and don’t 
care and just make life really, really difficult.” [participant 4] 
 
 Although the amount of family support varied between participants, they 
all commented that this was an important factor for them and it significantly 
affected their lives, either positively or negatively. The participants reported 
that their mood was often affected by how much pain they were in and, as a 
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result, this tended to impact their social interactions with family and friends.  
4.3.2 Clinical interactions 
The participants reported on a number of characteristics in relation to their 
experiences with clinicians and their consultation preferences.  The issues 
reflected whether their consultants  were caring/friendly, the level of 
communication, whether  participants felt they were taken seriously about their 
condition and the clinician’s understanding of the impact of the pain. Generally, 
participants liked their clinician to have a caring and friendly attitude, which 
gave them more confidence in the clinician’s suggestions. 
“I liked it because they were all so friendly and so nice and so 
caring and you know it was lovely.” [participant 1] 
 
 Participants were more trusting and more likely to adhere to the self-
management suggestions of clinicians they felt were interested in them and 
listened to what they had to say. Some participants, however, felt like they had 
to pester the clinician for an appointment or more information and that their 
condition was not being taken seriously. They felt at some stages of the 
treatment process they were passed around to different practitioners, which 
led to miscommunication as patients felt their treatment was not progressing. 
The participants understood the time restrictions that clinicians were under, 
however, they often felt like the treatment sessions were too short and they 
had to push them for answers and be assertive in order to make clinicians 
listen to them. An important factor to the participants was to have more 
communication and contact with the clinician in order to help them better 
understand their condition and to address issues that arose. 
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“I still feel like I’m getting passed off from one to another and no 
one is really making a decision… they’ve not really said what’s 
going to happen, it just seems like we are going round in circles 
and I keep going back for more sessions.” [participant 8] 
 
 Participants differed in their views of how well clinicians explained their 
condition and the course of treatment that needed to be undertaken. Some 
participants reported that when they were first diagnosed they were told the 
clinical name of their condition but not what the name actually meant or the 
consequences for rehabilitation or management. It was not until they did their 
own research and attended either a pain management or living with pain 
course that they truly understood the process of their pain and the 
consequences of their condition. There were three key areas that participants 
wanted more information about; (i) the problem itself, (ii) the treatment 
process, (iii) the long-term implications of the condition. The explanation of 
their condition also helped improve patient satisfaction with treatment. The 
level of explanation that participants received varied, the provision of some 
anatomical information was found to be useful, particularly when used in 
conjunction with pictures and drawings. In addition, this approach reassured 
participants that their pain was recognized as real and being taken seriously. 
“it hadn’t really been explained, I didn’t understand my 
condition, I had no idea how to tackle it or any insight into if it’s 
going to get worse, if it’s going to get bad, or what I can do and 
the course has completely changed that. I understand what my 
body’s doing now, which I didn’t before, so I understand like how 
it’s going to behave if I do like certain things… and that was just 
Oh my god, so that is what’s going on.” [participant 7] 
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4.3.3 Management process 
Participants liked to be given an outline of what was going to happen in the 
management process, why they were having that particular treatment and how 
it was going to benefit them. Some participants became pessimistic about the 
treatments effectiveness. 
“personally, I don’t think it’s going to do anything… because the 
last time I was at physio it didn’t work.” [participant 3] 
 
Some participants found the treatment process very frustrating if they 
could not find answers for their questions, or felt as though they were just being 
passed from one clinician to another.  They also reported difficulty with 
travelling to appointments, particularly if they have to rely on family and friends 
to take them. They understood that they had to go to the hospital to see the 
clinician, however, they reported frustration if, when they arrived, 
appointments were delayed or brief. They preferred to have more time at each 
session in order to allow them to find out more information and gain a better 
understanding of their course of treatment. In addition, they reported that there 
were very few follow-up sessions to assess how the condition and the 
treatment were progressing and if there had been any changes. 
 “I would like to see someone like every 3 or 4 months or 
something, umm just so that they can get an update, umm 
because I’ve got a load of questions that I want to ask the 
specialist.” [participant 5] 
 
The majority of participants understood that they had a long-term 
condition and that they should be active in managing their pain, however, they 
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reported that the treatment process was often more prescriptive rather than a 
consultation. Participants wanted to have more involvement in planning their 
treatment so that it addressed their individual needs and, as a result, they felt 
they would be more likely to adhere to the advice. Benefits from the PMPs 
were widely reported as they gave patients the opportunity to talk to people 
who were in a similar situation to themselves. By talking with others, they were 
able to identify different strategies to manage their pain that others had found 
effective at home. In turn, this gave them more self-confidence and an 
empowerment to cope with their pain rather than letting it control their lives. All 
participants reported that the coping strategies had been a key part of their 
treatment process and would have liked to know about these strategies at an 
earlier stage of treatment. 
Participants reported that their perception of outcome changed over the 
course of the management process. When they first sought treatment, often 
their main aim was to find a cure, however, the longer the condition went on 
and the less effective they found the treatment, their main concern was to be 
better able to cope and reduce the pain. 
 “So I’ve gone from like cure/fix me to maybe, like you know, 
just calm it down a bit/reduce it.” [participant 2] 
 
It was important for participants to understand their condition as it 
changed their expectations of treatment outcome. Although the majority of 
participants reported that the intensity of their pain had not significantly 
improved, they felt better able to cope so that they had more mobility and as 
a result an improved quality of life. Improved daily life was important to all 
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participants, and they reported that the coping strategies they had learnt from 
treatment were key to helping improve their level of activity. Participants 
understood they had a long-term condition that could not be cured, however, 
they were still willing to try anything in the hope that the treatment would fix 
them and they could go back to their normal life: 
“You know you just have to hope that you’re the lucky one 
and it works, but what do you do? Do you not try it because 
it’s got a high chance it’s not going to work or do you try it, 
on the off chance that there’s a slim chance that it can like 
block some of the pain signals going down your legs and 
get you out of some of the pain, maybe off some of your 
medication, you’ve got to give it ago haven’t you.” 
[participant 1] 
 
 Even though prescribed medication was intended to provide relief or 
limit to the pain, all participants reported their dislike of them, and how 
important it was that they reduced their use of medication. Some participants 
reported that the medications worked for a while but then stopped, or were 
ineffective on days of greater pain. Several reported that they became allergic, 
and were afraid of the suggested side effects.   
4.4 Discussion 
This study provides insight into the complex nature of the impact of chronic 
pain on participants' lives and the factors they consider important in the 
management of their condition. This complements previous literature by 
providing greater richness and detail of these factors and their impact on the 
management process. In addition, the findings support previous research and 
highlight that the patients within this study are representative of the general 
100 
 
chronic pain population. The main themes which emerged were: (i) the impact 
on daily life; (ii) interactions with clinicians; and (iii) the management process.  
Although chronic musculoskeletal pain itself is not life threatening, it 
does significantly affect the individual’s quality of life. In particular, the absence 
of a diagnosis and effective coping strategies can lead to life changing 
emotional and social consequences. The complex nature of chronic pain, and 
the difficulty clinicians face in providing a clear diagnosis, present significant 
challenges, as understanding their condition is a critical step for patients to 
help them engage with the treatment process. Zanini et al. (2014) highlighted 
that enhancing the communication between patients and clinicians, by 
addressing factors from the patient’s perspective, helps to build a more critical 
discussion about the treatment options, giving the patient a greater feeling of 
control and higher patient satisfaction. Previous research has found that 
having a diagnosis for their pain is important for individuals as it gives them a 
feeling of legitimacy for their pain. Validation of their condition, through 
diagnosis, can help improve their social situations and patients feel less of a 
burden on family and friends (Toye and Barker, 2010). Participants reported 
being more satisfied if their condition had been effectively described to them. 
Particularly if diagrams were used as this gave them a greater understanding 
of the pain process. Without a valid explanation for their pain, patient’s belief 
in the linear diagnosis-treatment-cure model was disturbed, which initially 
caused feelings of worry, depression and anxiety about the future (Campbell 
and Guy, 2007). The defensive high-anxious individuals may be particularly 
affected by a lack of diagnosis and understanding, as this will broaden the 
range of ambiguous stimuli, which they may interpret as threatening. This will 
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in turn undermine their self-efficacy with daily tasks, thus, resulting in higher 
disability.  
The participants in this study also reported that their expectations 
changed over time as they learnt more about the condition. In particular, as 
treatment progressed and the pain remained, they became more interested in 
learning coping strategies, and identified that they may have accepted the 
chronicity of their condition earlier if they had known more about these 
strategies. This is particularly important for healthcare professionals to 
consider incorporating some initial short-term coping strategies for daily tasks 
into the first assessment. Satisfaction with treatment and expectations of 
outcome are key areas for clinicians to consider (Verbeek et al., 2004), 
particularly in relation to personality type. Repressors have previously been 
found to be overly optimistic about the outcome from threatening situations 
(Eysenck and Derakshan, 1997). If their expectations of treatment outcome 
are not met, this may explain why they do not remain in the care system, as 
their avoidance of negative affect may cause them to believe treatment is not 
necessary or working. In contrast, defensive high-anxious individuals have 
been found to be relatively pessimistic about future events, particularly as they 
are more likely to attend to threatening information (e.g., their pain). If they 
continue to attend to their pain, this may cause them to remain within the care 
system, with the premise that further treatment may lead to alleviation of their 
pain. Studies have shown that patients who have remained in the care system 
expect more information, and make higher demands on the interpersonal 
relationship with their health care provider (Verbeek et al., 2004). Campbell 
and Guy (2007) suggested that the reason some patients re-present is that 
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they are unwilling to accept the prospect of living with pain without some form 
of input from clinicians. It could be suggested that patients who re-present for 
treatment (e.g., defensive high-anxious individuals) become attached to the 
support from the clinician. In relation to Attachment Theory, Ainsworth and 
Bowlby (1991) suggested that  threats to the availability and responsiveness 
of an attachment figure can produce dysfunctional emotional reactions. This 
could lead to an increased attention to threatening information, which in turn 
reduces self-efficacy with particular tasks. These emotional reactions may 
cause individuals to report higher levels of disability and fear of movement 
(Kobak, 1999), and therefore, be more likely to enter back into the care 
system. In addition, clinicians have commented that some patients may not 
have a willingness to self-manage and that the concept of accepting their 
condition is long term and a readiness to change is necessary before their 
behaviours will change (Gordon et al., 2015). 
Participants reported how beneficial it was for them to talk to other 
patients about their pain and to discuss coping strategies with individuals in a 
similar situation. This gave participants the opportunity to have social 
interactions with people who would take them seriously and listen to their 
concerns about their condition as well as learning new strategies. Such inter-
patient sharing of experience and social interaction may offer an effective 
means to engage with groups of patients and facilitate more self / group help 
based approaches. In so doing, it may be possible to facilitate greater 
opportunity for patients to discuss and learn about their condition without 
increasing the clinical resource demands of treatment.  
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Support from family and friends was important to how the patients 
coped with exacerbations in their pain. Those who felt their family and friends 
understood the condition and how it impacted upon their ability to complete 
tasks found it easier to be more active and felt less isolated. On the other hand, 
those who had little or no family support reported feeling very lonely and as 
though they were not needed for anything anymore. This feeling of loneliness 
was more likely to be associated with participants becoming less active and 
social, a loss of self-confidence and increased levels of depression. Previous 
research has found that cognitive behavioural treatments which include an 
education element for family are more effective at reducing pain severity and 
increasing activity (Radojevic et al., 1993). Within this study, when family 
members had a better understanding of the patient's condition, and the 
variability in function and experienced pain, patients felt more supported and 
better able to manage their condition. Despite this, participant’s also reported 
a loss of independence with daily activities, which was evidenced through 
reliance on family members to complete daily tasks, and a role reversal with 
their children. In line with the findings in this study, previous research has 
identified a significant impact on the social and family roles for patients. 
Patients experience significant reductions in parenting, participation in family 
and social leisure activities, and role reversal (e.g., children taking their 
parents food shopping) (Strunin and Boden, 2004). These factors have also 
been associated with anxiety and worry about how the individual’s pain affects 
their family (De Souza and Frank, 2011). It is suggested that limitations in 
fulfilling normal family roles intensifies negative affect, and frustration of role 
limitations was evidenced in this study. This highlights the necessity for PMPs 
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to include an educational element for family members, as they may be 
unaware of the impact they have on the pain-affected individual. The provision 
of clear information about the pain process, not only to the patient but also to 
their immediate support networks, was vital to ensuring successful 
management.  
PMPs are designed to educate patients about their pain and to help 
them set goals which will improve the areas of their lives where pain has a 
significant negative impact. There is good evidence for the efficacy of PMPs 
(Hoffman et al., 2007; Koes et al., 2006; Williams et al., 2012), however, limited 
research has looked at the impact for patients after treatment. Whilst patients 
reported enjoying the social interactions associated with attendance on a 
PMP, they also indicated that at the end of the management programme they 
went back to a feeling of isolation. Attendance at a PMP gave participants 
something to look forward to each week, not only to have social interactions 
with people but also to feel involved in their pain management in an active 
way. This finding highlights the need to support follow-up sessions, which 
encourage individuals to be more socially active and rely less on support from 
the clinician. This suggestion is contrary to the aims of most programmes or 
guidelines which is to promote more self-management, however, it may lead 
to individuals utilising less clinical appointments and lead to greater 
independence. 
Failure to understand their condition and how best to self-manage their 
pain led many participants to report,  in the early stages of their management, 
that they were often over-doing it because they were trying to catch-up on 
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tasks on their better days. This increased the likelihood of a relapse, and 
participants found they would then feel worse for the next couple of days, both 
physically and mentally. In some cases, participants reported that this negative 
reaction to activity left them worried and fearful of future activity, causing them 
to avoid tasks due to lower self-efficacy, thereby leading to higher disability. 
This is typical of the fear-avoidance model described elsewhere in the 
literature (Vlaeyen et al., 1995). Previous studies, which have investigated 
patients with high levels of disability and fear avoidance, have identified that 
modifying attention can serve to reduce attentional biases to threatening 
information (Sharpe et al., 2012). Repressors have been shown to avoid 
negative affect and are good at self-managing pain when they perceive it to 
be under their control (Myers et al., 2005). In contrast, limited research has 
investigated the attentional biases of defensive high-anxious individuals, who 
have previously been found to make up 30-40% of the chronic pain population 
(Creswell and Chalder, 2001; Lewis, Fowler, et al., 2012). Investigating the 
attentional biases of this group may allow more targeted interventions to 
prevent the likelihood of a relapse and re-presentation.  
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CHAPTER 5 
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5.0 Study 2: Personality type influences attentional bias in individuals with 
chronic back pain. 
5.1 Introduction 
Theories of attention and pain predict that individuals with chronic pain will 
display attentional biases towards pain-related information (Schoth et al., 
2012). An attentional bias can be considered as a selective attention towards 
or away from a stimulus which is both specific and salient to the current 
environment. Attentional biases have been investigated in populations with 
anxiety disorders (Waechter et al., 2014), depression (Donaldson et al., 2007), 
chronic headache (Schoth and Liossi, 2010) and other clinical groups (Hou et 
al., 2008; Schoth et al., 2013) and they may have important therapeutic 
implications for the patient and therapist. Excessive vigilance towards pain-
related perceptual cues may be associated with a preoccupation with pain and 
lead to patients avoiding activities perceived as threatening. This behaviour 
may inhibit compliance with rehabilitation regimes and the development of a 
fear of movement and increased anxiety. Studies investigating the attentional 
biases of individuals with a chronic musculoskeletal condition have tended to 
test the population as a whole and not as differentiated groups based on 
variations in anxiety (Crombez et al., 2004; Crombez, Van Ryckeghem, et al., 
2013; Dehghani et al., 2003; Hou et al., 2008; Roelofs et al., 2005; Schoth and 
Liossi, 2010). This may be important since individual differences in attentional 
bias underlie vulnerability to clinical anxiety and vigilance for pain-related 
symptoms (Williams et al., 1997).  
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Within chronic pain patients, anxiety has been shown to be important in 
the development of pain and the associated disability. Eysenck (1997) has 
theorised that the subjective experience of anxiety is influenced by four 
sources of information: (i) the cognitive appraisal of the situation; (ii) the 
negative cognitions that arise about possible, future events (e.g. worries); (iii) 
the individual’s interpretation of their own behaviour; and (iv) the attention to 
and interpretation of the individual’s physiological activity. There are two main 
assumptions within this theory that serve to influence the processing of the 
four sources of information. First, individual differences in trait anxiety and 
defensiveness affect the operation of attentional and interpretive biases that 
serve to either magnify or minimize the processing of threat-related stimuli and 
second, the biases in cognition are affected by the prevailing level of state 
anxiety.  
Weinberger et al. (1979) suggested that low and high-trait anxious 
individuals can be split into four heterogeneous groups based on their 
defensiveness. Low trait anxiety combined with low defensiveness reflects 
truly low-anxious groups, whilst those with low trait anxiety but high 
defensiveness are defined as repressors. High trait anxious individuals can 
also be divided into two groups, high trait anxiety combined with low 
defensiveness reflect the truly high-anxious group, and those with a 
combination of high trait anxiety and high defensiveness are known as 
defensive high-anxious individuals.  
Eysenck (1997) suggested that repressors have a defensive or 
avoidance bias to threat that results in avoidance of negative or threatening 
cues. In contrast to repressors, low-anxious individuals show no cognitive bias. 
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Eysenck postulated that high-anxious individuals exhibit both attentional and 
interpretive biases that amplify potential threat and lead them to interpret 
ambiguous stimuli as threatening. Unfortunately, due to their relative scarcity 
in the general population, few studies have considered the responses of 
defensive high-anxious individuals separately from their high-anxious 
counterparts with the consequential assumption that they respond similarly to 
high-anxious individuals (Eysenck, 1997). 
Notwithstanding the concerns for the lack of a defensive high-anxious 
group, there are several studies supporting Eysenck’s predictions regarding 
attentional biases in high-anxious, low-anxious and repressors within the 
general population (Brosschot et al., 1999; Derakshan and Eysenck, 2001a; 
Derakshan and Eysenck, 2001b). There are, however, some theoretical 
inconsistencies in these studies. For example, Mogg et al. (2000) used a dot-
probe task with word pairings to assess the attentional deployment of 
repressors, high-anxious and low-anxious individuals. In line with previous 
predictions, the repressor group demonstrated avoidance of social threat but 
not physical threat words. In contrast to the theory and previous research, the 
high-anxious group demonstrated avoidance of social threat words but 
showed no bias to physical threat words. These contradictory findings could 
be due to the use of word rather than visual image stimulus pairings. Mogg et 
al. (2000) were also unable to recruit sufficient defensive high-anxious 
participants to allow separate analysis of high-anxious individuals.  Ioannou et 
al. (2004) were the first group to investigate the attentional biases of all four 
personality groups using a dot probe task with faces. Using a student 
population, they reported that high-anxious participants were vigilant to 
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threatening faces compared to both the low-anxious and defensive high-
anxious groups. Contrary to predictions, defensive high-anxious individuals 
showed an attentional bias towards happy relative to neutral faces. In addition, 
the repressor group did not follow previous predictions and demonstrated no 
attentional bias for happy or threatening faces. The variation in the findings of 
these studies highlights the need for further research to consider the 
combination of anxiety and defensiveness when investigating the attentional 
biases of individuals and for the use of clinically relevant sample populations. 
Due to their relative scarcity in the general population (7-10%), 
defensive high-anxious individuals have often been either omitted from studies 
(Jones et al., 2004), or combined into a single group with the high-anxious 
individuals (Holtgraves and Hall, 1995). In contrast, within chronic 
musculoskeletal pain groups (back pain and chronic fatigue syndrome) the 
proportion of defensive high-anxious individuals has been shown to be much 
higher (39-46%) (Creswell and Chalder, 2001; Lewis, Fowler, et al., 2012). 
Franklin et al. (2014) recently showed that defensive high-anxious individuals 
were more likely to utilise a variety of treatment options compared to the other 
three personality types; the authors suggesting that this group were likely to 
be more persistent within the care system and thus more likely to be referred 
to chronic pain management groups. Therefore, it may be helpful to identify 
whether defensive high-anxious individuals also show an attentional bias 
towards pain-related threat and are more predisposed to focus on their 
condition and potentially adopt maladaptive coping strategies. A better 
understanding of the varied attentional biases of patients from different 
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personality groups may help inform better targeting of pain management 
strategies. 
The present study aims to test Eysenck’s (1997) theory, in a clinical 
setting by examining whether the attentional biases of defensive high-anxious 
individuals to pain related threat stimuli differs to those in other personality 
groups in a population with chronic back pain. It was predicted that: (i) 
defensive high-anxious individuals would show an attentional bias towards 
back pain-related threat images and an avoidant bias to positive images; and 
(ii) repressor individuals would show an avoidant bias towards back pain-
related threat and an attentional bias towards positive images. 
5.2 Method 
5.2.1 Participants 
 
Participants were 70 volunteers (45 female) recruited from a back 
rehabilitation programme at an NHS Trust in the NW of England, UK and a 
control group of 20 asymptomatic individuals. Table 5.1 shows the 
demographic data for the patient and asymptomatic control groups. All 
participants from the back rehabilitation programme reported suffering from 
back pain for more than three months.  
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5.2.1.1 Patients 
Participants were split into personality groups based on their STAI and the 
MC-SDS scores. Based on previous research (Franklin et al., 2014) the groups 
were determined according to the following criteria: (i) defensive high-anxious 
(DHA; n= 18), trait anxiety scores 42 and above, and defensiveness 8 and 
above; (ii) high-anxious (HA; n= 11), trait anxiety scores 42 and above, and 
defensiveness 4 and below; (iii) repressors (REP; n= 9), trait anxiety scores 
30 and below, and defensiveness 8 and above; and (iv) the non-extreme 
individuals (n= 29) were participants who scored in the mid-range for trait 
anxiety and defensiveness. The low-anxious group were excluded from 
analysis because only three individuals were identified (trait anxiety scores 
below 30 and defensiveness below 4).  
5.2.1.2 Asymptomatic controls 
A control group of asymptomatic participants (n=20) was recruited from 
contacts within the university and the local area and asked to perform the 
same tasks as the patient group. Participants were all individuals who were 
either low-anxious (trait anxiety scores below 30 and defensiveness below 4) 
or scored in the mid-range for anxiety (31-41) and defensiveness (5-7). As 
participants were free from any current or past history of back pain, it was 
anticipated that the PHODA images would hold no specific or relevant 
threatening content. The recruitment of asymptomatic control participants 
enabled a comparison with any biases seen in the patient groups indicating 
either selective attention to, or avoidance of, back-pain relevant threatening 
information. 
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5.2.2 Dot probe paradigm 
Participants completed a dot probe task comprising 20 practice trials and 250 
experimental trials. The experimental trials were broken down into three blocks 
of: (i) 100 threat-neutral images; (ii) 100 positive-neutral images; and (iii) 50 
neutral-neutral image pairings. The threat images were taken from the 
Photograph Series of Daily Activities (PHODA) image bank (Kugler et al., 
1999) and were back pain specific, showing movements known to be 
associated with evoking pain or pain-related fear (e.g. lifting or bending tasks). 
These images show everyday activities, which would only represent a pain 
related threat to those with back pain rather than images of individuals in pain 
or more generally pain evoking images known to induce a response even in 
healthy individuals (Keogh et al., 2001). Although these images have not been 
rated for valence and arousal, previous research has used the images within 
dot probe studies (Leeuw, Goossens, van Breukelen, et al., 2007) and to rate 
patients’ fear of movement (Trost et al., 2009). The positive and neutral images 
were taken from the International Affective Picture System (IAPS) (Lang et al., 
2008) based on their valence and arousal ratings (Image numbers can be 
found in Appendix 5). The presentation sequence of the three blocks and the 
images within each of the blocks were randomized for each participant. Each 
trial began with a central fixation cross presented for 500ms, followed by an 
image pair, either, threat-neutral, positive-neutral or neutral-neutral pairs 
presented for 500ms. The size of each images was 12 x 20 cm, the distance 
between their inner edges was 9 cm. Images were presented to the left and 
right of the central point. Following presentation of the image pair, a probe 
stimulus (a pair of dots aligned either vertically horizontally) (diameter 7mm) 
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was presented in the location of either the emotional or neutral image and 
remained displayed until the participant responded (see Figure 5.1). 
Participants were asked to press as quickly and as accurately as possible one 
of two keys on a response button box (the right index finger for [:] and the left 
index finger for [..]) to identify the probe presented. The inter-trial interval 
varied randomly between 500 and 1250ms. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1. An example of the three stages of the dot probe task in the neutral 
threat condition. 
 
 
+ 
1) Initial presentation 
of fixation cross for 
500ms. 
2) Images are 
presented for 
500ms. 
3) A dot probe appears 
in the location of one of 
the stimuli until the 
participant responds 
(max 1500ms). 
: 
Time 
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5.2.3 Procedure 
Participants were asked to sit at a desk in a black booth facing a 23inch screen 
(HP EliteDisplay E231) positioned approximately 70cm in front of them and at 
eye level, giving a visual angle of 11° between the central fixation cross and 
the centre of the stimulus. A desk mounted chin rest was used to reduce 
participant head movements, ensuring that each participant’s eyes were level 
with the middle of the monitor and where the stimuli were presented. 
Participants were asked to attend to the fixation cross before each trial to 
standardize the starting location of their gaze. Trials were presented in three 
blocks to allow participants to rise and move around to accommodate any 
discomfort experienced by prolonged sitting. After completing the dot-probe 
task, participants completed the various self-report questionnaires described 
above.  
5.2.4 Data analysis 
5.2.4.1 Dot probe preparation 
Attentional bias scores for threatening images relative to neutral were 
calculated for each participant from the reaction time data of the dot-probe 
trials using the formula: 
 ((Trpr + Tlpl)/2)-((Nrpr + Nrpl + Nlpr + Nlpl)/4).  
Where T= threat, N= neutral, p= probe, r= right position, l= left position.  
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For example: 
Reaction times: 
Threat right, Probe right – 524.95ms; Threat left, Probe left – 540.96ms; 
Neutral right, Probe right – 566.07ms; Neutral right, Probe left – 543.14ms; 
Neutral left, Probe right – 554.66ms; Neutral left, Probe left – 533.24  
Threat attentional bias formula= ((524.95 + 540.96)/2)-((566.07 + 543.14 + 
554.66 + 533.24)/4) = -16.32 
Similarly, the attentional bias scores for positive images relative to neutral 
were calculated for each participant from the reaction time data with the 
formula: 
 ((Prpr + Plpl)/2)-((Nrpr + Nrpl + Nlpr + Nlpl)/4).  
Where P= positive, N= neutral, p= probe, r= right position, l= left position.  
Therefore, negative reaction times indicate faster reactions times, 
therefore attention to emotional image and positive values reflect avoidance 
of the emotional image. The biases were calculated using this method, rather 
than comparing congruent to incongruent trials (Ioannou et al., 2004) because 
of differences that have previously been shown in the attentional biases of the 
four groups affecting the difference between congruent and incongruent trials 
(Mogg et al., 2000). Therefore, this method provides a more stable baseline 
(neutral/neutral reactions time) from which to compare the valanced 
(threat/positive) trials and the potential to separately consider the effects of 
congruent and incongruent trials. Reaction times shorter than 200ms, or longer 
than 1200ms, were removed from the analysis. Incorrect responses were also 
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excluded. Data from one individual was excluded from the study since their 
attentional bias score for both threat and positive images was more than two 
standard deviations from the mean. Errors and outliers accounted for 2.5% of 
the data. 
5.2.4.2 Data analysis overview 
A Multivariate Analysis of Variance (MANOVA) was performed on the 
attentional bias scores, with personality group as the independent variable, 
and attentional bias to positive and threatening images as dependent 
variables. A follow-up, between-group Analysis of Variance (ANOVA) was 
used to identify any differences in attentional bias between the personality 
groups. To confirm the existence of an attentional bias, t-tests were performed 
to ensure there was a significant difference from 0 in the mean attentional bias 
score. T-tests were performed between the control and non-extreme group to 
identify any differences in attentional bias.  
5.3 Results 
5.3.1 Trait anxiety and defensiveness: heterogeneity check 
A heterogeneity check was performed on the personality groups prior to the 
main data analysis. The groups were significantly different in both anxiety (F(3, 
62) = 27.715, p< 0.01) and defensiveness (F(3, 62) = 53.015, p< 0.01).  
5.3.2 Comparisons between the non-extreme patients and control group 
Attentional bias in the control group was assessed in order to determine 
whether the PHODA images contained any emotionally relevant content other 
than that associated with back pain related movements. The t-tests 
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demonstrated that the control group’s attentional bias score to the PHODA 
images did not differ from 0 (t(19)= 1.04 p> 0.05), indicating that these images 
were not perceived as threatening by asymptomatic individuals. 
 To determine whether there was any systematic difference in attention 
towards or away from the PHODA images in the patient population, the 
attentional biases of the non-extreme patient group and control population 
were compared. This demonstrated that there was no difference between 
groups (t(46)= 0.528, p> 0.05). Indicating that any bias shown in the more 
extreme personality groups is indicative of their attention towards, or 
avoidance of, images perceived as specifically threatening to low back pain. 
5.3.3 Patient group attentional bias scores 
The mean reaction time scores for threatening and positive images for the 
defensive high-anxious, high-anxious, repressor and non-extreme groups are 
shown in Table 5.2.  
Table 5.2. Mean RTs of congruent trials (in ms; standard deviations in 
brackets) for each condition in the dot probe task for the four groups; defensive 
high-anxious, high-anxious, repressor and non-extreme individuals. 
 
Defensive 
high-anxious 
High-anxious Repressors 
Non-
extreme 
Threat 
(ms) 
549.40 
(±64.76) 
584.52 
(±56.92) 
616.45 
(±55.80) 
591.24 
(±70.60) 
Positive 
(ms) 
576.78 
(±69.56) 
589.53 
(±59.91) 
568.00 
(±46.78) 
577.48 
(±73.67) 
Neutral 
(ms) 
577.44 
(±67.47) 
578.01 
(±50.35) 
597.90 
(±54.56) 
586.65 
(±66.33) 
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The MANOVA revealed significant between group differences in 
attentional bias, (Wilks’ Lambda = 0.621, F(6, 122) = 5.459, p< 0.01). A follow-
up between group ANOVA showed a significant difference in attentional bias 
for threatening stimuli between personality groups (F (3, 62) = 4.573, p< 0.05). 
Post hoc Tukey HSD analysis showed the defensive high-anxious (M= -28.24; 
SD= ± 33.30) group differed significantly from both the high-anxious (M= 6.51; 
SD= ± 33.01; ES= 0.6) and repressor (M= 18.55; SD= ± 26.30 ES= 0.4) 
individuals (Figure 5.2). The t-tests showed the defensive high-anxious group 
had a significant attentional bias for threatening images compared to neutral 
(t(17)= 3.59, p< 0.01; ES= 0.8), whereas repressors had a significant avoidant 
bias of threatening images relative to neutral (t(8)= 2.11, p< 0.05; ES= 0.6). 
The high-anxious and non-extreme individuals showed no bias.  
Figure 5.2. Attentional bias scores (in ms) for threat images for the four groups: 
defensive high-anxious (DHA), repressor (REP), high-anxious (HA) and non-
extreme (NE) groups. 
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The second ANOVA showed a significant difference between groups in 
attentional bias for positive stimuli (F (3, 62) = 2.863, p< 0.05). Post hoc Tukey 
HSD analysis demonstrated the repressor (M= -29.90; SD= ± 22.42) group to 
be significantly different from both the high-anxious (M= 11.52; SD= ± 25.54; 
ES= 0.7) and the defensive high-anxious (M= -0.67; SD= ± 30.61; ES= 0.5) 
individuals (see Figure 5.3). The t-test analysis demonstrated that the 
repressor group had a significant attentional bias towards positive compared 
to neutral images (t(8)= 4.00, p< 0.01; ES= 0.8), while high-anxious individuals 
were shown to be avoidant of positive compared to neutral images (t(10)= 
1.51, p< 0.05; ES= 0.4). The defensive high-anxious individuals showed no 
bias for positive or neutral images.  
Figure 5.3. Attentional bias scores (in ms) for positive images for the four 
groups: defensive high-anxious (DHA), repressor (REP), high-anxious (HA) 
and non-extreme (NE) groups. 
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5.3 Discussion 
To the author’s knowledge, this is the first study to investigate the attentional 
biases demonstrated by Weinberger et al.’s (1979) personality types within a 
chronic musculoskeletal pain population. The study aimed to test and extend 
Eysenck’s (1997) Theory by examining specific hypotheses about the 
attentional biases of defensive high-anxious individuals when presented with 
pain-related stimuli. The results of this study offer support for some elements 
of Eysenck’s (1997) predictions with regard to the attentional biases exhibited 
by the different personality groups. Contrary to Eysenck’s Theory there were 
differences between defensive high-anxious and high-anxious individuals. The 
defensive high-anxious group were shown to demonstrate attention towards 
threatening information but showed no bias with respect to positive images, in 
contrast, high-anxious individuals were avoidant of positive images but 
demonstrated no bias towards the threatening information. Repressors were 
avoidant of threatening information and attended selectively to positive stimuli.  
It could be suggested, that the combination of high anxiety and 
defensiveness has an amplifying effect on the perception of threat resulting in 
the greater attentional response in this personality group. Eysenck (1997) 
suggested that defensive high-anxious individuals would be likely to 
demonstrate similar attentional biases to high-anxious individuals. This study, 
however, suggests that their biases are different when pain-related threat 
specific images are used. These findings have important implications for the 
future assessment of high-anxious and defensive high-anxious individuals 
who present for pain-related treatments.  
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Defensive high-anxious individuals are often not included as a separate 
group in research studies, defensiveness is either not measured or individuals 
are combined with high-anxious individuals to form a single group (Fox, 1993; 
Holtgraves and Hall, 1995; Jones et al., 2004; Mogg et al., 2000). This 
approach may produce contradictory findings between studies as the 
proportion of defensive high-anxious and high-anxious individuals varies 
considerably between sample populations. Given the particularly high 
proportion of defensive high-anxious individuals found within clinical pain 
populations, it is important that the behaviours of these individuals are 
investigated further to provide additional understanding of their attentional 
biases to clinically-related threatening information. It has been suggested 
(Ioannou et al., 2004) that defensiveness may affect the attentional resource 
allocation in response to threatening information differently in those with either 
high or low trait anxiety. A central tenent of Eysenck’s Theory is that high levels 
of trait anxiety cause an enhanced vigilance towards threatening information 
and that defensive high-anxious individuals attempt to utilize a defensive 
strategy, which is ineffective, and leads to elevated levels of anxiety. The 
enhanced attention to pain-related information in the defensive high-anxious 
individuals may explain why this sub-group of the population have been found 
to be more persistent in seeking treatment for their pain (Franklin et al., 2014) 
with some  studies suggesting that cognitive-behavioural treatments can help 
to reduce selective attention to pain stimuli (Dehghani et al., 2004; Sharpe et 
al., 2012). The present findings suggests that interventions within the 
defensive high-anxious group in particular should focus on educating patients 
as to how they can control their attention to pain symptoms. 
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 The data show that the high-anxious individuals do not demonstrate a 
bias towards threatening information. This finding supports Mogg et al. (2000) 
who also found that high-anxious individuals demonstrated no bias when 
presented with physical threat words. They suggested that this could be due 
to high-anxious individuals utilizing strategies to counteract their vigilant 
tendencies. The high-anxious group in this study did show avoidance of 
positive images as suggested by Eysenck (1997). Eysenck’s Four-factor 
Theory suggested that cognitive biases are more evident when state anxiety 
levels are high. Further research should investigate the attentional biases of 
chronic back pain patients in situations of elevated anxiety. This could be 
achieved, potentially, by asking participants to view the images with an 
intention to imitate the movements observed since this instructional set has 
been shown to lead to heightened motor evoked potentials in action-
observation studies (Caspers et al., 2010).  
This study provides further evidence in support of Eysenck’s (1997) 
predictions about repressors within a specific back pain population. Numerous 
studies have investigated repressor individuals within chronic illness (Frasure-
Smith et al., 2002), and the general population (Eysenck and Derakshan, 
1997; Myers, 1998). These studies have found a pattern of avoidance of 
negative information suggesting that the repressor group are consistent in 
their attentional biases, irrespective of the situation. It may be a desire to 
manage self-presentation and be perceived to experience lower anxiety, 
despite their physiological similarity to high-anxious and defensive high-
anxious individuals (Derakshan and Eysenck, 2001b).  
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There are some limitations within this study, which should be 
considered. Firstly, the PHODA images used were not assessed to confirm 
their affective impact (valence and arousal), however, these images have been 
used in previous dot probe studies, and to assess perceived harmfulness of 
daily activities (Barke et al., 2012; Leeuw, Goossens, van Breukelen, et al., 
2007). Furthermore, patients within this study reported that they could attribute 
the images to their daily life and the activities would be difficult for them to 
complete at home. Analysis of the control group demonstrated that the 
PHODA images represented a neutral image set for those without back pain, 
and thus the biases shown in the patient groups can be attributed to the pain 
specific content of the image set. Secondly, the high-anxious and repressor 
group were small, however, the effect sizes were moderate to high (0.4-0.8). 
Future research should recruit larger sample sizes to provide support for these 
differences. Due to their scarcity in the general population, it was not practical 
to recruit a control population of defensive high-anxious individuals. It is 
reasonable to assume that these groups would perceive the PHODA images 
as neutral as well. Finally, the images within this study were not matched for 
content, contrast and brightness, however, the comparisons within the control 
group give confidence that any differences in these elements did not distort 
the findings in any systematic manner. 
In summary, the present study provides evidence of an attentional bias 
to threatening information in the defensive high-anxious group. In addition, the 
different responses demonstrated by the high-anxious individuals highlight the 
need to ensure they are investigated as two heterogeneous groups and not 
conflated to create a single high-anxious population. The present findings 
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contribute to the literature and help to explain the cognitive processes of 
defensive high-anxious individuals within a musculoskeletal pain population. 
The demonstration of an attentional bias to pain specific threatening 
information could explain why defensive high-anxious individuals are more 
likely to show persistence in the pain management system. 
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CHAPTER 6 
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6.0 Study 3: Influence of defensiveness on disability in a chronic 
musculoskeletal pain population. 
6.1 Introduction 
By its nature chronic musculoskeletal pain is a complex problem to manage 
and individuals who suffer from it tend to be heavy users of the healthcare 
system. There is increasing evidence to show that cognitive factors are 
relevant to the development of, and treatment response to clinical outcome 
from chronic pain (Bair et al., 2003; Woby et al., 2008). Anxiety levels, in 
particular, can increase fear of movement and, as a result, are associated with 
differences in pain perception and disability. Pain-related state-anxiety has 
been shown to predict pain and disability at 12-months follow-up (Bair et al., 
2013), however, an individual’s trait-anxiety will also affect how they respond 
to pain. Cognitive factors such as a tendency to selectively attend to physical 
stimuli and to interpret such stimuli negatively can amplify the pain experience 
(Schoth and Liossi, 2010). The four groups proposed by Weinberger et al. 
(1979) demonstrate different attentional and interpretive biases, which 
influence their perception of threatening stimuli (Weinberger, 1990). Within the 
previous chapter, the defensive high-anxious group demonstrated an 
attentional bias towards back-pain related information, whereas the repressors 
avoided threatening information. Within some clinical populations, variations 
in trait-anxiety and defensiveness have been strongly linked to differences in 
treatment preferences and health outcome (Myers, 2010).  
Previous research has primarily investigated the way repressors 
respond to pain (Elfant et al., 2008) and cope with illnesses such as cancer 
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(Kreitler et al., 1993; Prasertsri et al., 2011). Few studies have identified all 
four personality types, with defensive high-anxious individuals often omitted 
due to their scarcity within the general population (estimated at 7%-10%). In a 
notable exception, Prasertsri et al. (2011) identified the four groups in a lung 
cancer outpatient group. The authors found that defensive high-anxious 
individuals reported higher catastrophising than repressors. This may be 
indicative that, due to their attentional bias towards threatening information, 
defensive high-anxious individuals have enhanced negative thoughts about 
their pain and adopt maladaptive coping strategies. Furthermore, in a low back 
pain population, Franklin et al. (2014) found that defensive high-anxious 
individuals were the most persistent in seeking treatment and reported higher 
depression and disability compared to repressors and low-anxious individuals. 
The tendency for these individuals to continue to seek treatment may explain 
the higher proportion of defensive high-anxious individuals found in chronic 
pain populations. These findings suggest that variations in defensiveness and 
trait-anxiety together, affect the experience of and response to pain symptoms.  
Due to the scarcity of defensive high-anxious individuals in the general 
population, there is limited evidence of how they respond to threatening 
situations (e.g., chronic pain). In light of the high proportion of defensive high-
anxious individuals identified from the limited body of research in 
musculoskeletal pain populations, it would seem important to investigate 
further how they respond to chronic pain to better understand why they appear 
to be disproportionately represented. Unlike in previous research, individuals 
who score in the mid-range on trait-anxiety and defensiveness (‘non-extreme’ 
scorers) were included in the current study to help understand how they differ 
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from more extreme defensive high-anxious individuals. Consequently, this 
study aims to identify: (i) the proportion of defensive high-anxious individuals 
as defined by Weinberger et al. (1979) within a chronic musculoskeletal pain 
population; and (ii) whether personality type affects the relationships between 
cognitive factors and disability. 
6.2 Method 
6.2.1 Participants 
Participants were 79 patients with chronic musculoskeletal pain referred to a 
hospital for treatment. Patients suffering from chronic pain for more than 3 
months were given an information pack by their clinician asking them to 
contact the Chief Investigator of the study if they wished to take part.  
Volunteer participants then completed a series of self-report measures. The 
four personality types (repressors, n= 13; defensive high-anxious, n= 26; high-
anxious, n= 11; and non-extreme, n= 29) were assessed based on criterion 
splits on the trait subscale of the State-Trait Anxiety Inventory (STAI) 
(Spielberger et al., 1983) and the Marlowe-Crowne Social Desirability Scale 
(MC-SDS) (Strahan and Gerbasi, 1972). 
6.2.2 Measures 
Participants were given questionnaires assessing current pain intensity, 
defensiveness, trait anxiety, catastrophising, depression, disability, functional 
self-efficacy and kinesiophobia (see the general method for more detail about 
each questionnaire). 
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6.2.3 Statistical analyses 
An initial heterogeneity check was performed to ensure the groups differed in 
defensiveness and trait-anxiety. Zero-order correlations were calculated to 
determine the relationships between the cognitive factors. A Multivariate 
Analysis of Variance (MANOVA) and Analysis of Variance (ANOVA) and post-
hoc Tukey Honest Significant Difference (HSD) were conducted to identify 
between-group differences on the cognitive measures. Three hierarchical 
regression analyses were performed to determine the extent to which the 
cognitive measures predicted levels of disability in the whole population, 
defensive high-anxious group and the non-extreme group. With disability as 
the outcome variable of interest, age, sex and pain duration were entered in 
step 1, pain intensity in step 2, and the cognitive variables were entered in step 
3. Due to low numbers, the repressor and high-anxious groups were excluded 
from regression and ANOVA analysis.  
6.3 Results 
6.3.1 Patient Characteristics 
Table 6.1 shows the baseline characteristics for the groups. All groups 
reported moderate levels of pain (NRS 5.5-6.4) and moderate to high levels of 
disability (RDQ 12.63-18.60). A statistical heterogeneity check was performed 
for the three personality groups prior to the main data analysis to confirm 
differences in trait-anxiety and defensiveness. The ANOVA for trait-anxiety 
revealed significant differences between the three groups, F(2, 54)= 17.603, 
p< 0.01. Post-hoc analysis confirmed the defensive high-anxious differed 
significantly from the non-extreme group. In addition, the high-anxious group 
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differed from the non-extreme group. The ANOVA of the MC-SD scores 
showed significant differences between the three groups, F(2, 54)= 52.179, p< 
0.01. Post-hoc analysis confirmed significant differences in MC-SD scores 
between the defensive high-anxious and the high-anxious and non-extreme 
individuals.   
133 
 
Table 6.1. Mean ± SD baseline characteristics of the five groups. 
 DHA 
(n= 26) 
HA 
(n= 11) 
REP 
(n= 13) 
LA 
(n= 0) 
NE 
(n=29) 
Proportions (%) 33 14 16 0 37 
Sex 
(Female/Male) 
16/2 7/3 4/1 0 20/7 
Age 
(years) 
56.56 ± 
16.00 
44.70 ± 
12.51 
44.17 ± 
11.03 
0 54.31 ± 
14.79 
Pain duration 
(years) 
11 ± 12 9 ± 9 8 ± 7 0 10 ± 14 
Pain Intensity 
 
5.7 ±  
2.72 
6.4 ±  
2.08 
6.3 ± 
1.30 
0 5.5 ± 
2.44 
Defensiveness 
 
8.33 ± 
0.59 
3.80 ±  
1.86 
9.00 ± 
0.17 
0 6.30 ± 
1.14 
Trait anxiety 
 
50.61 ±  
6.34 
55.50 ± 
16.53 
26.20 ± 
3.03 
0 40.19 ± 
8.81 
Disability 
 
16.89 ±  
4.07 
18.60 ± 
5.70 
13.40 ± 
5.98 
0 12.63 ± 
5.48 
Catastrophising 
 
28.06 ± 
13.58 
28.00 ± 
14.12 
17.40 ± 
11.19 
0 16.93 ± 
11.32 
Depression 
 
27.67 ±  
8.21 
33.70 ± 
15.05 
10.00 ± 
5.79 
0 14.44 ± 
8.58 
Self-efficacy 
 
33.72 ± 
21.13 
24.30 ± 
15.18 
39.20 ± 
24.19 
0 43.74 ± 
20.65 
Kinesiophobia 25.94 ± 
 8.08 
29.70 ± 
10.78 
21.00 ± 
7.11 
0 23.11 ± 
8.76 
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6.3.2 Distribution differences between the patient and control population 
The chi-square demonstrated a significant difference was found between the 
groups for the proportion of defensive high-anxious individuals (χ² (4)= 36.00, 
p< 0.05), reflecting a greater number of defensive high-anxious individuals in 
the patient (33%) compared to the control group (4%) (Figure 6.1). 
 
 
Figure 6.1. Percentage of individuals within the patient and control population. 
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6.3.3 Relation between the psychological measures 
Table 6.2 indicates there were significant correlations between the cognitive 
measures. Catastrophising was negatively related to self-efficacy and 
positively related to depression, kinesiophobia, trait-anxiety, depression and 
pain intensity. Depression was negatively correlated with self-efficacy and 
positively related to defensiveness, trait-anxiety, catastrophising, 
kinesiophobia, pain intensity and disability. Self-efficacy was associated 
negatively with trait-anxiety, catastrophising, depression, pain intensity and 
disability. Kinesiophobia was associated negatively associated with self-
efficacy and positively related to trait-anxiety, catastrophising, depression and 
disability.  
The MANOVA showed significant between-group differences in 
cognitive variables (Wilks’ Lambda = 0.232, F(21, 144)  p< 0.05). The ANOVA 
demonstrated a significant difference between the defensive high-anxious and 
non-extreme group and between the high-anxious and non-extreme groups 
for disability. A significant difference was found between the defensive high-
anxious and non-extreme group for catastrophising. The defensive high-
anxious and high-anxious groups both differed from the non-extreme 
individuals and repressors for depression. No significant differences were 
found between groups for pain intensity, self-efficacy or kinesiophobia. 
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6.3.4 Regression analysis 
6.3.4.1 Preliminary examination of the data 
None of the correlation coefficients (Table 6.2) exceeded 0.90, indicating the 
data were not affected by singularity. Durbin-Watson values were within 
acceptable limits for all regression analyses, suggesting that the assumption 
of independent errors was met. The predictor variables used in each of the 
regression analyses had variance inflation factors that were considerably less 
than 10 and tolerance levels that were higher than 0.2 indicating no problems 
with multicollinearity.  
 
6.3.4.2 Analyses 1- predicting disability from the cognitive measures in the 
defensive high-anxious group 
Age, sex and pain duration were not significantly related to levels of disability 
(p= 0.11). In the second step, current pain intensity was shown to be unrelated 
to levels of disability (p= 0.23). After controlling for the effects of demographics 
and pain intensity, self-efficacy, depression and catastrophising explained 
48% (p< 0.01) of the variance in levels of disability. Examination of the beta 
values (Table 6.3) revealed that lower self-efficacy (β= -0.66, p< 0.05) greater 
depression (β= 0.66, p< 0.05), and greater catastrophising (β= 0.44, p< 0.05) 
were related to greater levels of disability. 
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Table 6.3. Regression analysis on the defensive high-anxious group (n= 26) 
with disability as the dependent variable. 
Step R² R² 
change 
F 
change 
Standardised 
β 
t 
1. Demographics 0.32 0.32 2.32   
Age    -0.69 -2.37 
Sex    0.43 1.82 
Pain duration    0.27 0.99 
2. Pain intensity 0.40 0.07 1.53 0.30 1.23 
3. Cognitive 
factors 
0.88 0.48 8.73*   
Self-efficacy    -0.66 -2.89* 
Depression    0.66 2.71* 
Catastrophising    0.44 2.51* 
Kinesiophobia    -0.09 -0.55 
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6.3.4.3 Analyses 2- predicting disability from the cognitive measures in the 
non-extreme group  
Table 6.4 shows that in step 1, age, sex and pain duration were not 
significantly related to levels of disability (p= 0.25). In step 2, current pain 
intensity significantly explained 36% (p< 0.05) of the variance in disability. 
After controlling for the effects of demographics and pain intensity, the 
cognitive measures did not contribute to the variance in levels of disability. 
Examination of the beta values for the final model revealed that higher pain 
intensity (β= 0.50, p< 0.05) was related to greater levels of disability. 
 
Table 6.4. Regression on the non-extreme group (n= 29) with disability as the 
dependent variable. 
Step R² R² 
change 
F change Standardised 
β 
t 
1. Demographics 0.16 0.16 1.47   
Age    -0.21 -1.04 
Sex    0.11 0.55 
Pain duration    0.39 1.89 
2. Pain intensity 0.36 0.25 6.96* 0.50 2.64 
3. Cognitive factors 0.60 0.42 2.74   
Self-efficacy    -0.35 -1.70 
Depression    0.10 0.36 
Catastrophising    0.47 1.65 
Kinesiophobia    -0.19 -0.89 
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6.3.4.4 Analyses 3- predicting disability from the cognitive measures in the 
whole population 
Table 6.5 shows that age and pain duration were significantly related to levels 
of disability (p< 0.05) and explained 17% of the variance. In the second step, 
current pain intensity explained 11% of the variance in disability (p< 0.05). 
After controlling for the effects of demographics and pain intensity, the 
cognitive factors explained an additional 42% (p< 0.01) of the variance in 
disability. Examination of the beta values (Table 5) revealed that younger age 
(β= -0.29, p< 0.05), longer pain duration (β= 0.39, p< 0.05), higher pain 
intensity (β= 0.37, p< 0.05) and depression (β= 0.36, p< 0.05) and lower self-
efficacy (β= -0.40, p< 0.05), were related to greater levels of disability. 
 
Table 6.5. Regression on the whole population (n= 79) with disability as the 
dependent variable. 
Step R² R² 
change 
F 
change 
Standardised 
β 
t 
1. Demographics 0.17 0.17 5.01*   
Age    -0.29 -2.48* 
Sex    -0.09 -0.87 
Pain duration    0.39 3.38* 
2. Pain intensity 0.28 0.11 10.95* 0.37 3.31 
3. Cognitive 
factors 
0.71 0.42 24.40**   
Self-efficacy    -0.40 -4.04* 
Depression    0.36 3.41* 
Catastrophising    0.18 1.99 
Kinesiophobia    -0.05 -0.57 
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6.4 Discussion 
There were two aims to this study, firstly, to identify the proportion of defensive 
high-anxious individuals, as defined by Weinberger et al. (1979), within a 
chronic musculoskeletal pain population. Secondly, to identify whether 
variations in defensiveness, affect the relationships between cognitive factors 
and disability. 
 Only two studies have investigated the proportion of defensive 
personality types in a chronic low back pain (Lewis, Fowler, et al., 2012) and 
a chronic fatigue syndrome population (Creswell and Chalder, 2001). Whilst 
there is a relatively low proportion of defensive high-anxious individuals in the 
general population, this study supports previous research (Creswell and 
Chalder, 2001; Lewis, Fowler, et al., 2012), with evidence of a higher 
proportion of defensive high-anxious (33%) individuals in a chronic 
musculoskeletal pain population. This supports the notion proposed by 
Franklin et al. (2014) that defensive high-anxious individuals are more 
persistent in the care system and thus more likely to be referred to hospital 
based pain management centers. The low number of repressors in this study 
(16%) might indicate a reduced willingness to seek treatment and a preference 
to self-manage. Previous research has found repressors respond better to 
treatment when they maintain a feeling of control and tend to be overly 
optimistic regarding their own behaviours, which may influence their response 
and adherence to treatment (Jones et al., 2004; Myers, 2010).  
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An individual’s interpretation of their pain intensity is a complex 
phenomenon. Franklin et al. (2014) found that although defensive high-
anxious and repressor individuals reported similar levels of pain intensity, their 
interpretation of this pain, indicated through levels of depression and disability, 
varied. Interestingly, the defensive high-anxious and high-anxious groups in 
this study reported significantly higher catastrophising and depression and 
lower self-efficacy compared to the non-extreme group. Both groups (high-
anxious and defensive high-anxious), reported similar levels of pain intensity, 
and there were no differences in their pain duration. These findings support 
the suggestion by Eysenck (1997) that defensive high-anxious individuals 
have similar interpretive biases to threat as high-anxious individuals, and also 
highlights important individual differences when treating patients. 
Defensiveness and trait-anxiety are both assumed to be relatively stable traits. 
Therefore, the corroboration of findings of a high proportion of defensive high-
anxious individuals found in this study, and the increased likelihood of re-
presenting for treatment would suggest this group might differ in their approach 
to managing chronic pain from the high-anxious group.  
 The second aim of this study was to identify whether the level of 
defensiveness affected the relationships between cognitive factors, pain 
intensity and disability. To the author’s knowledge, there are no studies which 
have investigated the effect of cognitive factors on disability using Weinberger 
et al.’s (1979) personality types in a chronic musculoskeletal pain population. 
When the population was analysed as a whole, pain intensity explained 11% 
of the variance in disability and the cognitive factors (depression and self-
efficacy) explained 42%. The present study showed distinct differences 
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between the influence of pain intensity and cognitive factors on disability when 
the population were stratified based on defensiveness and anxiety. Higher 
levels of depression, catastrophising and lower levels of self-efficacy had a 
greater effect on the prediction of disability in the defensive high-anxious 
group. However, within the non-extreme group no such relationship was 
shown. Interestingly, whilst the cognitive variables did not influence disability 
for the non-extreme group, pain intensity explained 36% of the variance in 
disability.  
 Identifying individuals with high defensiveness and trait-anxiety has 
provided interesting insights into the relationship between pain and disability. 
Within the defensive high-anxious group, pain intensity had no significant 
relationship with disability, whereas, cognitive factors (catastrophising, 
depression and self-efficacy) explained 48% of the variance. Previous 
research within a cancer population (Prasertsri et al., 2011)  found that 
defensive high-anxious individuals engaged in significantly more 
catastrophising and reported greater depression compared to those with lower 
trait-anxiety. The difference in the influence of catastrophising on disability, 
shown between the defensive high-anxious group and the other patients, may 
provide insight into the variability of this relationship in previous literature. 
Interestingly, previous studies in which  catastrophising failed to  predict 
disability have primarily drawn participants from primary care, acute pain 
groups (George et al., 2006; Hirsh et al., 2008). Based on the work by Franklin 
et al. (2014), it may be reasonable to assume that the proportion of defensive 
high-anxious individuals in these populations would be much lower than that 
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seen in the hospital-based interventions. It could thus indicate that the 
differentiator between these studies is the degree of defensiveness. 
Catastrophising is a maladaptive cognitive method of coping with pain 
(Keefe et al., 1989), high catastrophising can lead individuals to be more 
pessimistic about coping strategies, to worry and be more likely to anticipate 
negative outcomes. Research has shown that vigilance to threatening stimuli 
(e.g., disability) is related to catastrophic thinking (Crombez et al., 2004). If 
defensive high-anxious individuals are more likely to focus on their condition 
and utilise maladaptive strategies, this could explain why they re-present for 
treatment and may perceive no improvement in treatment outcome. Therefore, 
for defensive high-anxious individuals, strategies that focus on pain-related 
outcomes may not be as beneficial as those focused on reduced worry about 
future events, such as disability and daily functioning.  
Although cognitive factors explained a large proportion of variance in 
disability for the defensive high-anxious group, it is surprising that 
kinesiophobia was not linked with changes in disability. This finding is 
consistent with Thompson et al. (2010) who suggested that self-efficacy is 
likely to emerge as a stronger predictor of disability when investigated 
alongside pain-related fear in patients with chronic pain. Findings of the 
present study are in agreement that low self-efficacy was a significant predictor 
of disability alongside depression and catastrophising (Denison et al., 2004; 
Woby, Roach, et al., 2007). 
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 Notably, within the non-extreme group, pain intensity showed a 
stronger relationship with disability compared with cognitive factors. This 
supports previous studies which have shown pain intensity to describe a 
moderate amount of variance within these factors (Vlaeyen et al., 1995). This 
is in line with the strong correlation between pain intensity and disability 
previously reported within acute pain populations (Glombiewski et al., 2010). 
Within the non-extreme individuals, pain coping strategies learnt at pain 
management programmes may allow them to effectively reduce levels of pain 
intensity. In turn, this may lead to lower levels of disability and greater 
satisfaction with treatment. 
Based on the findings of this study, it can be concluded that the 
interaction of defensiveness and trait anxiety plays an important role in 
determining the progression and outcome of chronic pain. Differentiating the 
defensive high-anxious group revealed different patterns of relationship 
between a range of cognitive factors and disability. This may explain some of 
the variance evident from previous literature where trait-anxiety was the sole 
focus.  This has important clinical implications, which highlight the necessity 
of assessing personality characteristics that include defensiveness in order to 
identify individuals whose characteristic patterns of cognition influence their 
levels of disability. Future research of a longitudinal nature should aim to 
examine the mechanisms of causality implied by these findings. If personality 
type can be identified as a predictor of poor adjustment in chronic pain 
populations, long term, and early interventions could be customized to meet 
the unique needs of this group (e.g., in high defensive and trait-anxious 
individuals).  
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7.0 Study 4: Longitudinal associations between personality type, psychological 
variables, disability and treatment satisfaction in chronic pain patients. 
7.1 Introduction 
The previous chapter demonstrated that considering the interactions between 
defensiveness and trait-anxiety provides interesting insights into the 
relationship between pain and disability. Within the defensive high-anxious 
group, pain intensity had no significant relationship with disability, but the 
cognitive factors (catastrophising, depression and self-efficacy) explained 
48% of the variance in disability. Whereas within the non-extreme group the 
reverse was true with the cognitive factors shown to not affect the variance in 
disability while pain intensity explained 36%.  
A cross-sectional study looks at a snap shot in time and the 
relationships identified in the previous study are informative, however, it is 
important to investigate whether cognitive factors are predictive of outcome. A 
longitudinal study allows for patients to be tracked over time, providing 
additional evidence of how cognitive factors, pain and disability and the 
relationships between them develop during the pain management process. 
A critical consideration when investigating treatment outcome is the 
minimal clinical important change (MCIC). Ostelo and de Vet (2005) suggested 
that MCIC is defined as the smallest change in an outcome measure 
necessary to yield a clinically important change in the health status of the 
patients. Therefore, for the purpose of this study, the MCIC of patient’s pain 
intensity and disability will be used. For pain intensity, a reduction of 2 points  
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(Salaffi et al., 2004) and for disability a reduction of 3 points in RDQ (Ostelo 
and de Vet, 2005) are classed as improvement. 
 The aims of this study were (i) to identify whether personality type 
affects the relationships between pain intensity, cognitive factors and disability 
at three and six months post baseline; and (ii) to identify whether personality 
type affects the likelihood of achieving a MCIC in pain intensity or disability at 
three and six months. 
7.2 Method 
7.2.1 Participants 
Participants were recruited from the patient pool used in the cross-sectional 
study. If patients responded to the first questionnaire in the cross-sectional 
study (Chapter 6), they were then sent a second questionnaire at three 
months. From the first study sample of 79, 58 (73%) patients responded to the 
second questionnaire. Patients who responded to the second questionnaire 
were then sent a third questionnaire six months post baseline (n= 47 
completed (59% from the first study). Patients who responded to the six month 
questionnaire were then sent the final questionnaire pack at 12 months (n= 31 
completed (39% from the first study). If participants had not responded to a 
questionnaire pack within three weeks, they were sent a reminder letter and 
questionnaire pack. If they did not respond to the reminder, they were 
assumed to have withdrawn from the study. 
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7.2.2 Measures 
At each time point, participants completed the same questionnaire pack as 
used at baseline assessing defensiveness, trait-anxiety, current pain intensity, 
satisfaction with treatment, disability, catastrophising, depression, functional 
self-efficacy and kinesiophobia. Two additional questions were added at three, 
six and 12 months, assessing satisfaction with ability to cope with pain and 
satisfaction with current pain intensity.  
7.2.3 Statistical analyses 
Heterogeneity checks were completed to ensure the groups differed in 
defensiveness and trait-anxiety. Analysis of variance (ANOVA) and post-hoc 
Tukey honest significant difference (HSD) tests were conducted to identify 
between-group differences in the cognitive measures, pain intensity, and the 
three measures of satisfaction. In order to identify the influence of personality 
type on the relationships between baseline cognitive measures and their ability 
to predict disability at three and six months, hierarchical regressions were 
performed on the whole population, and on the defensive high-anxious and 
non-extreme groups separately. With disability as the outcome variable of 
interest, age, sex and pain duration were entered in step 1, pain intensity in 
step 2, and the baseline cognitive variables were entered in step 3. All tests 
were conducted on both the three and six month data. Due to low power, no 
statistical analysis was carried out on the 12 month data. Furthermore, Due to 
low numbers, the repressor (three month, n= 8; six month, n= 6) and high-
anxious (three month, n= 8; six month, n= 8) individuals were excluded from 
separate regression analysis. 
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The MCIC from baseline to three and six months for disability and pain 
intensity were calculated for the defensive high-anxious and non-extreme 
groups separately. T-tests were used to identify differences from baseline to 
three months and six months in psychological measures and satisfaction in 
the defensive high-anxious and non-extreme groups.  
7.3 Results 
A statistical heterogeneity check was performed for the four groups (defensive 
high-anxious, high-anxious, repressor and non-extreme) at three and six 
months post baseline which indicated that they continued to differ on 
measures of anxiety and defensiveness. 
7.3.1 Differences between the personality types at three and six months 
At three months, the defensive high-anxious individuals reported significantly 
higher disability than the repressors (F(3, 57)= 2.54, p< 0.05). The high-
anxious individuals reported significantly higher depression than the 
repressors at both three (F(3, 57)= 3.05, p< 0.05) and six months (F(3, 46)= 
2.54, p< 0.05). The high-anxious group also reported significantly lower 
satisfaction with ability to cope than either the defensive high-anxious or 
repressor groups F(3, 46)= 3.67, p< 0.05. No significant differences were 
found between the four groups for pain intensity, satisfaction with treatment, 
satisfaction with current pain, disability, catastrophising, self-efficacy or 
kinesiophobia. 
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7.3.2 Patient characteristics 
7.3.2.1 Defensive high-anxious individuals 
Table 7.1. Mean (±SD) for the defensive high-anxious group at each time point 
(* indicates significantly different from baseline). 
 Baseline 
(n= 26) 
3 month 
(n= 20) 
6 month 
(n= 16) 
12 month 
(n= 7) 
% of whole 
population  
33 34 34 23 
Age (years) 
55.19 
(16.73) 
56.35 
(16.63) 
55.38 
(17.05) 
58.71 
(17.81) 
Sex 
20 Females 
6 Males 
16 Females 
4 Males 
12 Females 
4 Males 
5 Females 
2 Males 
Pain duration 
(years) 
9.28  
(11.98) 
9.02  
(11.62) 
5.90  
(5.95) 
8.86  
(6.89) 
Satisfaction- 
treatment 
5.38 (3.13) 6.25 (3.26) 7.56 (2.58) 5.43 (1.51) 
Satisfaction- 
ability to cope 
Not 
measured 
5.60 (3.25) 6.19 (2.99) 4.43 (2.70) 
Satisfaction- 
current pain 
Not 
measured 
5.55 (2.99) 5.81 (3.15) 4.00 (2.71) 
Pain intensity 
6.08  
(2.54) 
5.50  
(2.96) 
5.00 
 (2.92) 
5.00  
(2.89) 
Disability 
17.35 
(4.87) 
15.20  
(6.58) 
13.94  
(7.66) 
14.43 
(6.70) 
Catastrophising 
28.77  
(13.07) 
25.65 
(12.17) 
22.88 
(12.58) 
27.43 
(9.93) 
Depression 
25.58 
(10.29) 
22.80 
(11.30)* 
19.06 
(13.60)* 
21.86 
(9.87) 
Self-efficacy 
32.50 
(20.77) 
31.00 
(22.90) 
41.00 
(22.73) 
35.00 
(22.29) 
Kinesiophobia 
26.85 
(7.49) 
26.80  
(6.90) 
25.50  
(8.73) 
28.43 
(7.48) 
 
The t-tests for the characteristics of the defensive high-anxious group 
demonstrate significant reductions in depression (t(19)= 2.86, p> 0.01) and 
disability (t(19)= 2.19, p> 0.05) from base to both three months and to six 
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months (depression, t(15)= 2.39, p> 0.05; disability, t(15)= 2.29, p> 0.05) 
(Table 7.1). At 12 months levels of disability, catastrophising, depression and 
kinesiophobia increased and satisfaction with pain, ability to cope and 
treatment and self-efficacy decreased. The only measure to remain consistent 
is pain intensity. No statistical tests were performed between baseline and 12 
month measures.  
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7.3.2.2 Non-extreme individuals 
Table 7.2. Mean (±SD) for the non-extreme group at each time point. 
 
Baseline 
(n= 29) 
3 month 
(n= 22) 
6 month 
(n= 17) 
12 month 
(n= 14) 
% of whole 
population 
38 37 36 46 
Age (years) 
54.41 
(14.19) 
55.23 
(14.56) 
54.12 
(15.01) 
53.57 
(14.05) 
Sex 
21 Females 
8 Males 
15 Females 
7 Males 
11 Females 
6 Males 
8 Females 
6 Males 
Pain duration 
(years) 
10.62 
(13.34) 
11.34 
(14.27) 
14.09 
(15.60) 
13.33 
(13.76) 
Satisfaction -
treatment 
6.38 (2.61) 7.05 (2.82) 6.76 (2.93) 5.21 (2.42) 
Satisfaction - 
ability to cope 
Not 
measured 
5.81 (2.86) 4.71 (2.91) 4.57 (2.34) 
Satisfaction -
current pain 
Not 
measured 
5.14 (2.63) 4.12 (3.24) 4.07 (2.84) 
Pain intensity 
5.83  
(2.39) 
5.95  
(2.65) 
6.06  
(2.63) 
5.50  
(2.93) 
Disability 
14.69  
(5.59) 
13.45  
(5.16) 
14.94  
(5.99) 
13.64  
(5.08) 
Catastrophising 
21.52 
(14.62) 
18.05 
(14.23) 
20.53 
(14.42) 
16.00 
(12.89) 
Depression 
20.41 
(13.44) 
16.77 
(10.96) 
20.82 
(13.47) 
22.07 
(15.14) 
Self-efficacy 
35.52 
(20.55) 
37.18 
(22.45) 
33.76 
(22.55) 
32.57 
(20.26) 
Kinesiophobia 
24.83  
(9.62) 
24.00  
(6.36) 
26.29  
(8.56) 
24.93  
(6.71) 
In contrast to the defensive high-anxious individuals, the non-extreme group 
demonstrated a mixed pattern of results over time (Table 7.2). From baseline 
to three months; disability, catastrophising, depression, and self-efficacy 
improved marginally and participants were more satisfied with treatment. At 
six months, all measures became worse, and patients reported they were less 
satisfied overall. At 12 months, participants continued to report low levels of 
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satisfaction with treatment, ability to cope and current pain, however, they 
reported lower disability, catastrophising and kinesiophobia.  
7.3.2.3 Repressor individuals 
Table 7.3. Mean (±SD) for the repressor individuals at each time point. 
 Baseline 
(n= 13) 
3 month 
(n= 8) 
6 month 
(n= 6) 
12 month 
(n= 5) 
% of whole 
population  
17 14 13 16 
Age (years) 
48.00 
(15.29) 
42.50 
(12.59) 
47.67  
(9.50) 
48.80 
(10.15) 
Sex 
9 Females 
4 Males 
5 Females 
3 Males 
4 Females 
2 Males 
3 Females 
2 Males 
Pain duration 
(years) 
4.44 (6.02) 5.00 (7.05) 5.50 (8.11) 6.40 (8.73) 
Satisfaction - 
treatment 
7.00 (2.24) 6.13 (2.47) 8.33 (0.82) 6.40 (3.65) 
Satisfaction - 
ability to cope 
Not 
measured 
5.13 (1.96) 6.50 (3.02) 4.80 (3.42) 
Satisfaction - 
current pain 
Not 
measured 
4.88 (3.04) 6.00 (3.52) 5.00 (2.83) 
Pain intensity 
6.00  
(2.65) 
5.25  
(2.55) 
5.67  
(3.61) 
7.40  
(0.89) 
Disability 
10.00  
(6.88) 
8.25  
(4.45) 
6.83  
(8.64) 
9.40  
(6.23) 
Catastrophising 
14.31  
(9.53) 
14.25 
(13.63) 
13.50 
(18.85) 
17.60 
(18.34) 
Depression 
9.08  
(5.41) 
11.13  
(7.90) 
6.17  
(6.71) 
17.00 
(11.94) 
Self-efficacy 
51.77 
(20.85) 
52.50 
(17.73) 
55.67 
(20.29) 
48.00 
(21.13) 
Kinesiophobia 
22.38  
(7.29) 
21.13  
(7.12) 
17.33  
(3.67) 
19.80  
(4.38) 
 
In contrast to the defensive high-anxious and non-extreme group, the 
repressors reported higher self-efficacy, lower disability and cognitive factors 
at each time point (Table 7.3). They reported similar levels of pain intensity 
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and satisfaction as those reported by the defensive high-anxious and non-
extreme groups (Tables 7.1 & 7.2).  
7.3.2.4 High-anxious individuals 
Table 7.4. Mean (±SD) for the high-anxious individuals at each time point. 
 Baseline 
(n= 11) 
3 month 
(n= 8) 
6 month 
(n= 8) 
12 month 
(n= 4) 
% of whole 
population  
14 14 17 13 
Age (years) 
44.00 
(11.71) 
46.50 
(17.17) 
46.50 
(17.17) 
43.75 
(24.17) 
Sex 
8 Females 
3 Males 
6 Females 
2 Males 
6 Females 
2 Males 
3 Females 
1 Males 
Pain duration 
(years) 
11.28  
(8.79) 
11.25 
(11.67) 
11.25 
(11.67) 
17.25 
(14.36) 
Satisfaction - 
treatment 
5.80 (2.36) 4.75 (3.45) 4.88 (2.85) 3.75 (2.99) 
Satisfaction - 
ability to cope 
Not 
measured 
3.88 (3.52) 3.00 (2.83) 2.75 (2.06) 
Satisfaction - 
current pain 
Not 
measured 
4.88 (3.14) 4.63 (2.77) 4.00 (2.16) 
Pain intensity 
6.50  
(1.04) 
5.13  
(2.85) 
6.50  
(2.45) 
7.50  
(1.00) 
Disability 
16.70  
(6.26) 
14.75  
(7.15) 
13.50  
(8.65) 
19.50  
(3.87) 
Catastrophising 
25.73 
(12.53) 
26.75 
(16.25) 
21.25 
(16.26) 
24.75 
(12.84) 
Depression 
31.18 
(15.62) 
26.88 
(19.31) 
27.13 
(19.28) 
26.00  
(9.45) 
Self-efficacy 
34.64 
(18.96) 
34.38 
(22.82) 
35.25 
(26.04) 
20.50 
(16.34) 
Kinesiophobia 
27.55  
(5.73) 
22.63  
(5.78) 
23.88  
(7.92) 
27.75  
(8.85) 
 
The high-anxious individuals reported that they were less satisfied with their 
treatment, ability to cope and current pain over the 12 months. Similarly to the 
non-extreme group, pain intensity, disability and cognitive factors varied over 
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time, with slight initial improvements at three months, then a decline from six 
to 12 months (Table 7.4). 
7.3.2.5 Whole population  
Table 7.5. Mean (±SD) for the whole population at each time point. 
 Baseline 
(n= 79) 
3 month 
(n= 58) 
6 month 
(n= 47) 
12 month 
(n= 30) 
Age (years) 
52.16 
(15.26) 
52.66 
(16.03) 
52.43 
(15.52) 
52.67 
(15.86) 
Sex 
58 Females 
21 Males 
42 Females 
16 Males 
33 Females 
14 Males 
19 Females 
11 Males 
Pain duration 
(years) 
9.20  
(11.44) 
9.65  
(12.29) 
9.41  
(11.93) 
11.65 
(11.78) 
Satisfaction - 
treatment 
6.08 (2.72) 6.32 (3.07) 6.91 (2.76) 5.27 (2.53) 
Satisfaction - 
ability to cope 
Not 
measured 
5.37 (3.02) 5.15 (3.09) 4.33 (2.47) 
Satisfaction - 
current pain 
Not 
measured 
5.21 (2.85) 5.02 (3.17) 4.20 (2.62) 
Pain intensity 
6.04  
(2.32) 
5.59  
(2.75) 
5.72  
(2.80) 
5.97  
(2.61) 
Disability 
15.08  
(6.13) 
13.52  
(6.42) 
13.32  
(7.60) 
13.90  
(5.97) 
Catastrophising 
23.30 
(13.82) 
21.34 
(14.31) 
20.55 
(14.54) 
20.10 
(13.55) 
Depression 
21.75 
(13.39) 
19.47 
(12.91) 
19.43 
(14.79) 
21.70 
(12.58) 
Self-efficacy 
37.08 
(21.16) 
36.78 
(22.79) 
39.28 
(23.31) 
34.10 
(20.88) 
Kinesiophobia 
25.47  
(8.16) 
24.38  
(6.77) 
24.47  
(8.35) 
25.13  
(7.10) 
 
If changes over time are looked at for the population as a whole (Table 7.5), 
the group differences, described in the preceding sections, are conflated and 
no significant improvements can be seen in any of the measures. When 
looking at the group as a whole they report declining satisfaction with 
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treatment, ability to cope with pain and increasing current pain intensity from 
three to 12 months.  
7.3.3 Regression analysis 
7.3.3.1 Preliminary examination of the data 
None of the correlation coefficients exceeded 0.90, indicating the data were 
not affected by singularity. Durbin-Watson values were within acceptable limits 
for all regression analyses, suggesting that the assumption of independent 
errors was met. The predictor variables used in each of the regression 
analyses had variance inflation factors that were considerably less than 10 
and tolerance levels that were higher than 0.2 indicating  no problems with 
multicollinearity.  
7.3.3.2 Analysis 1- predicting three-month disability from baseline cognitive 
factors in the whole population 
As shown at baseline, age and pain duration were significantly related to levels 
of disability (p< 0.05) and explained 18% of the variance. In the second step, 
current pain intensity explained 21% of the variance in disability (p< 0.05). 
After controlling for the effects of demographics and pain intensity, the 
cognitive factors explained an additional 41% (p< 0.01) of the variance in 
disability. Examination of the beta values (Table 7.6) revealed that similarly to 
baseline, younger age (β= -0.35, p< 0.05), longer pain duration (β= 0.38, p< 
0.05), higher pain intensity (β= 0.50, p< 0.05) and depression (β= 0.42, p< 
0.05) and lower self-efficacy (β= -0.47, p< 0.05), were related to greater levels 
of disability. 
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Table 7.6. Regression analysis of baseline factors predicting three-month 
disability within the whole population (n=58). 
Step R² R² 
change 
F 
change 
Standardised 
β 
t 
1. Demographics 0.18 0.18 3.99*   
Age    -0.35 -2.55* 
Sex    -0.10 -0.75 
Pain duration    0.38 2.86* 
2. Pain intensity 0.39 0.21 18.57** 0.50 4.31 
3. Cognitive 
factors 
0.81 0.41 27.25**   
Catastrophising    -0.06 -0.73 
Depression    0.42 3.95** 
Self-efficacy    -0.47 -4.86** 
Kinesiophobia    -0.00 -0.03 
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7.3.3.3 Analysis 2- predicting six-month disability from baseline cognitive 
factors in the whole population 
Sex and pain duration were not related to disability, however, age was 
significantly related to levels of disability (p< 0.05) and explained 19% of the 
variance. In the second step, current pain intensity explained 21% of the 
variance in disability (p< 0.05). After controlling for the effects of demographics 
and pain intensity, the cognitive factors explained an additional 39% (p< 0.01) 
of the variance in disability. Examination of the beta values (Table 7.7) 
revealed that younger age (β= -0.37, p< 0.05), higher pain intensity (β= 0.47, 
p< 0.05) and depression (β= 0.42, p< 0.05) and lower self-efficacy (β= -0.32, 
p< 0.05), were related to greater levels of disability. 
 
Table 7.7. Regression analysis of baseline factors predicting six-month 
disability within the whole population (n= 47). 
Step R² R² 
change 
F 
change 
Standardised 
β 
t 
1. Demographics 0.19 0.19 3.50*   
Age    -0.34 -2.31* 
Sex    0.00 0.01 
Pain duration    0.42 2.87 
2. Pain Intensity 0.41 0.21 15.06** 0.47 3.88 
3. Cognitive 
factors 
0.80 0.39 18.11**   
Catastrophising    0.15 1.26 
Depression    0.42 3.20** 
Self-efficacy    -0.32 -2.76** 
Kinesiophobia    0.00 0.11 
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7.3.3.4 Analysis 3- predicting 12-month disability from baseline cognitive 
factors in the whole population 
As seen at six months, sex and pain duration were not related to disability, 
whereas age (p< 0.05) explained a greater proportion (38%) of the variance 
than at the previous time points. In the second step, current pain intensity was 
not related to levels of disability at 12 months. After controlling for the effects 
of demographics and pain intensity, the cognitive factors explained an 
additional 34% (p< 0.01) of the variance in disability. Examination of the beta 
values (Table 7.8) revealed that younger age (β= -0.63, p< 0.05), and 
depression (β= 0.38, p< 0.05) were related to greater levels of disability, 
however, pain intensity and self-efficacy were no longer shown to be 
significant. 
 
Table 7.8. Regression analysis of baseline factors predicting 12-month 
disability within the whole population (n= 30). 
Step R² R² 
change 
F 
change 
Standardised 
β 
t 
1. Demographics 0.38 0.38 5.41*   
Age    -0.63 -3.75* 
Sex    0.29 1.83 
Pain duration    0.20 1.15 
2. Pain intensity 0.39 0.01 0.48 0.12 0.69 
3. Cognitive 
factors 
0.70 0.34 6.70**   
Catastrophising    -0.08 -0.55 
Depression    0.38 1.91* 
Self-efficacy    -0.21 -1.11 
Kinesiophobia    0.23 1.09 
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7.3.3.5 Analysis 4- predicting three-month disability from baseline cognitive 
factors in the defensive high-anxious group 
As at baseline, age, sex and pain duration were not significantly related to 
levels of disability (p= 0.53). In contrast to the findings at baseline, current pain 
intensity explained 28% of the variance in disability (p< 0.01). After controlling 
for the effects of demographics and pain intensity, the cognitive factors 
explained an additional 43% (p< 0.01) of the variance in disability. Examination 
of the beta values (Table 7.9) revealed that higher pain intensity (β= 0.62, p< 
0.05) and kinesiophobia (β= 0.28, p< 0.05) and lower self-efficacy (β= -0.65, 
p< 0.05), were related to greater levels of disability. Compared to baseline, 
depression and catastrophising were no longer significantly linked.  
 
Table 7.9. Regression analysis of baseline factors predicting three-month 
disability within the defensive high-anxious group (n=20). 
Step R² R² 
change 
F 
change 
Standardised 
β 
t 
1. Demographics 0.18 0.18 1.18   
Age    -0.21 -0.73 
Sex    -0.24 -0.90 
Pain duration    0.37 1.48 
2. Pain Intensity 0.68 0.28 7.92* 0.62 2.81 
3. Cognitive 
factors 
0.89 0.43 11.41**   
Catastrophising    -0.18 -1.22 
Depression    0.14 0.85 
Self-efficacy    -0.65 -3.90* 
Kinesiophobia    0.28 -2.33* 
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7.3.3.6 Analysis 5- predicting six-month disability from baseline cognitive 
factors in the defensive high-anxious group 
As at three months, age, sex and pain duration were not significantly related 
to levels of disability (p= 0.52). In the second step, current pain intensity 
explained 32% of the variance in disability (p< 0.05). After controlling for the 
effects of demographics and pain intensity, the cognitive factors explained an 
additional 42% (p< 0.05) of the variance in disability. Examination of the beta 
values (Table 7.10) revealed that higher pain intensity (β= 0.65, p< 0.05) and 
kinesiophobia (β= 0.49, p< 0.05) were related to greater levels of disability, 
however self-efficacy was no longer significantly linked. 
 
Table 7.10. Regression analysis of baseline factors predicting six-month 
disability within the defensive high-anxious group (n= 16). 
Step R² R² 
change 
F 
change 
Standardised 
β 
t 
1. Demographics 0.16 0.16 0.78   
Age    -0.24 -0.70 
Sex    -0.12 -0.30 
Pain duration    0.37 1.23 
2. Pain Intensity 0.48 0.32 6.67* 0.65 2.58 
3. Cognitive 
factors 
0.90 0.42 7.42*   
Catastrophising    -0.13 -0.82 
Depression    0.29 1.22 
Self-efficacy    -0.25 -1.12 
Kinesiophobia    0.49 3.27* 
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7.3.3.7 Analysis 6- predicting three-month disability from baseline cognitive 
factors in the non-extreme group 
Unlike within the defensive high-anxious group, age and pain duration were 
significantly related to levels of disability (p< 0.05) and explained 53% of the 
variance. Differing from the defensive high-anxious individuals, in the second 
step, current pain intensity was not related to levels of disability (p= 0.27). After 
controlling for the effects of demographics and pain intensity, the cognitive 
factors explained an additional 26% (p< 0.05) of the variance in disability. 
Examination of the beta values (Table 7.11) revealed as with the defensive 
high-anxious group, lower self-efficacy (β= -0.41, p< 0.05) was related to 
greater levels of disability but kinesiophobia was not. In contrast, to the 
defensive high-anxious individuals, for the non-extreme group, younger age 
(β= -0.71, p< 0.05) and higher pain duration (β= 0.44, p< 0.05) were 
associated with higher levels of disability.  
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Table 7.11. Regression analysis of baseline factors predicting three-month 
disability within the non-extreme group (n= 22). 
Step R² R² 
change 
F 
change 
Standardised 
β 
t 
1. Demographics 0.53 0.53 6.82**   
Age    -0.71 -4.27* 
Sex    -0.11 -0.65 
Pain duration    0.44 2.60* 
2. Pain intensity 0.56 0.03 1.26 0.28 1.12 
3. Cognitive 
factors 
0.82 0.26 4.92**   
Catastrophising    -0.21 -1.39 
Depression    0.14 0.52 
Self-efficacy    -0.41 -2.23* 
Kinesiophobia    0.21 1.02 
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7.3.3.8 Analysis 7- predicting six-month disability from baseline cognitive 
factors in the non-extreme group 
Table 7.12 shows that in step 1, none of the demographic factors were 
significantly related to levels of disability. Similarly, in step 2 and 3, neither pain 
intensity nor the cognitive factors explained any of the variance in disability. 
 
Table 7.12. Regression analysis of baseline factors predicting six-month 
disability within the non-extreme group (n= 17). 
Step 
R² R² 
change 
F 
change 
Standardised 
β 
t 
1. Demographics 0.45 0.45 3.56   
Age    -0.67 -2.99 
Sex    0.15 0.70 
Pain duration    0.41 1.80 
2. Pain Intensity 0.52 0.06 1.63 0.40 1.28 
3. Cognitive 
factors 
0.87 0.35 5.32   
Catastrophising    0.46 0.67 
Depression    -0.49 0.63 
Self-efficacy    -1.62 -0.14 
Kinesiophobia    1.43 0.19 
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7.3.4 Responders and non-responders 
7.3.4.1 Pain intensity 
A comparison of the baseline to three month and baseline to six month MCIC 
for pain intensity (improvement= -2 points) (Salaffi et al., 2004) is 
demonstrated in Figure 7.1 for the defensive high-anxious and non-extreme 
groups. Both the defensive high-anxious (25%) and the non-extreme group 
(23%) had similar levels of improvement in pain intensity from baseline to three 
months. In contrast, at six months, the defensive high-anxious group, 
demonstrated a greater proportion (38%) achieving a MCIC in pain intensity. 
Whereas within the non-extreme group, there was relatively little change with 
only 24% having a MCIC. 
 
Figure 7.1. The percentage of individuals within each personality who reported 
MCIC in pain intensity from baseline to three months and six months (DHA= 
defensive high-anxious; NE= non-extreme). 
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7.3.4.2 Disability 
A comparison of the baseline to three and six month MCIC for disability 
(improvement= -3 points) (Jordan et al., 2006) is demonstrated in Figure 7.2 
for the defensive high-anxious and non-extreme groups. Of the defensive 
high-anxious individuals, 35% had lower disability at three months compared 
to baseline. In contrast, only 14% of the non-extreme individuals had a MCIC. 
The defensive high-anxious individuals continued to improve with 50% having 
a MCIC from baseline to six months. The non-extreme individuals continued 
to show little change with only 6% of the non-extreme individuals having lower 
disability at six months compared to baseline.  
 
 
Figure 7.2. The percentage of individuals within each personality who have 
shown MCIC in disability from baseline to three months and six months (DHA= 
defensive high-anxious; NE= non-extreme). 
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7.4 Discussion 
The aims of this study were: (i) to identify whether personality type affects the 
relationships between pain intensity, cognitive factors and disability at three 
and six months post baseline; and (ii) to identify whether personality type 
affects the likelihood of achieving a MCIC in pain intensity and disability at 
three and six months. The results from this study highlighted the importance 
of considering personality type in the management and assessment of chronic 
pain.  
The majority of research within chronic pain populations has 
investigated the population as either a single homogenous group or stratified 
only on the basis of anxiety. There are inconsistencies between studies 
investigating the relationship between pain and disability. Some have shown 
that pain intensity only accounts for 0-10% of the variance in disability (Kamper 
et al., 2012; Waddell et al., 1992), whereas others have found pain intensity to 
be a stronger predictor (e.g., 24%) (Thompson et al., 2010; Woby et al., 
2004b). The present study found that baseline pain intensity accounted for 
21% of the variance in disability at three and six months when the population 
was looked at homogenously. When the population was split, based on anxiety 
and defensiveness, pain intensity was seen to have different effects on 
disability in the different groups. Within the defensive high-anxious group, pain 
intensity accounted for 28% of the variance in disability at three months, and 
30% at six months. In contrast, within the non-extreme group, unlike at 
baseline, pain intensity was found to not predict disability at three or six 
months. This is of particular interest as many pain management programmes 
focus primarily on reducing participants’ disability rather than their pain 
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intensity. Although pain intensity appears to be an important factor that may 
influence disability within the defensive high-anxious group, treatments aimed 
at pain relief are often unsuccessful, especially when the cause of pain cannot 
be identified (Ung et al., 2012). The greater importance of pain intensity within 
the defensive high-anxious group can be explained as a consequence of their 
attentional bias towards pain related information as shown in Chapter 5.  
 After controlling for demographic factors and pain intensity, the present 
study found that the cognitive factors had a different influence on disability 
depending on how the population was stratified. Within this study, the results 
for the whole population indicated that cognitive factors accounted for 41% 
and 39% of the variations in disability at three and six months respectively. In 
particular, higher levels of depression and lower levels of self-efficacy at 
baseline predicted three and six month disability. These findings support 
previous research that has shown a lack of belief in ability to cope with 
persistent pain, and higher depression, contribute to the development of 
disability in chronic pain patients (Arnstein et al., 1999; Linton, 2000; Pincus 
et al., 2002). Of particular interest in this study is the different influence of 
cognitive factors when the defensive high-anxious and non-extreme group are 
analysed separately. At three months, lower self-efficacy explains 24% of the 
variance in disability in the non-extreme group, whereas within the defensive 
high-anxious group the cognitive factors (lower self-efficacy and higher 
kinesiophobia) explain 43%. The significant influence of self-efficacy is 
consistent with previous research in chronic pain populations, which has 
identified self-efficacy to be a robust predictor for long term outcome for 
perceived disability (Rasmussen-Barr et al., 2012).  
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Conceptually, self-efficacy is related to Behaviourist Theory and refers 
to the way individuals set goals and the anticipation of outcome (Bandura, 
1977). The extent to which patients are disabled by pain, may depend on their 
level of self-efficacy, whereby, patients with higher self-efficacy (e.g., 
repressors) may more easily find strategies to prevent further recurrences. 
Whereas individuals with lower self-efficacy may be more likely to avoid 
particular situations, a pattern which has been associated with helplessness 
and pessimistic thoughts (Benjaminsson et al., 2007; Denison et al., 2004). 
Defensive high-anxious individuals have previously been found to be more 
pessimistic about outcome in threatening situations than other personality 
types (Eysenck and Derakshan, 1997; Franklin et al., 2015), thereby reducing 
the likelihood that they will engage in physical activities, which they perceive 
will be harmful. In contrast to the pattern at baseline shown in the last chapter, 
kinesiophobia was found to influence disability at both three and six months 
within the defensive high-anxious group. In line with the fear-avoidance model, 
Woby et al. (2007) suggested that when there is a reduction in functional self-
efficacy and higher fear of movement, individuals are more likely to avoid 
certain activities which ultimately leads to greater disability, disuse and 
depression. The fear-avoidance model suggest that how individuals interpret 
their pain will influence whether they carry on with daily activities or enter into 
a vicious cycle. This may be further exacerbated within the defensive high-
anxious group as the results from the attentional bias study (Chapter 5), 
highlight that they are more likely to attend to threatening information. Graded 
exposure to activities which may be perceived as threatening or harmful, has 
been shown to be an effective treatment (Vlaeyen et al., 2001; Vlaeyen et al., 
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2002). This type of intervention may be particularly beneficial for defensive 
high-anxious individuals, as their attentional and interpretive cognitive biases 
will be enhanced when levels of state anxiety are high. This may help clinicians 
to better target interventions and potentially decrease the rate of sick leave 
and influence adjustment to chronic pain, leading to lower healthcare 
utilisation (Jackson et al., 2014). The differences between the personality 
types highlight the need for defensiveness to be included in future 
assessments of individuals with chronic pain. 
The primary goal of treatment is to see an improvement in patients’ pain 
intensity and disability, resulting in an improvement in daily living. Numerous 
studies have investigated the MCIC to the patient (Beaton et al., 2002; Ostelo 
and de Vet, 2005; Wells et al., 2001), using standard outcome measures such 
as pain intensity and disability. A higher percentage of the defensive high-
anxious individuals demonstrated an improvement in disability compared to 
the non-extreme group from baseline to three months (DHA= 35%; NE= 14%) 
and baseline to six months (DHA= 50%; NE= 6%). Interestingly, from baseline 
to three months, both the defensive high-anxious and the non-extreme groups 
had a similar percentage of individuals who improved in pain intensity (DHA= 
25%; NE= 23%). From baseline to six months, the defensive high-anxious 
individuals continued to improve (DHA= 38%; NE= 24%), however there was 
no change for the non-extreme group. All of the individuals within this study 
had been receiving treatment at their treating hospital throughout the six month 
period. The distinct differences between the two groups have important 
implications for assessing the effectiveness of treatment. Based on the 
recommended outcome measures (Dworkin et al., 2008) used in this study, it 
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could be suggested that current treatment is more effective for defensive high-
anxious individuals compared to the non-extreme group. Differentiating these 
two groups in future may allow for more targeted and cost-effective 
interventions. 
Surprisingly, the defensive high-anxious individuals continued to 
reduce their reported level of pain intensity and disability from baseline to three 
and six months. Compared to the non-extreme group who had a low 
percentage of individuals reducing their pain intensity and disability over this 
time. The majority of studies investigating clinical interventions analyse group 
differences between treatment and control conditions, whereby it is assumed 
that if there is no difference in the means, or the mean is less than the MCIC 
then the treatment effect is unimportant. We can see that by stratifying the 
population by personality type, more of the defensive high-anxious individuals 
perceive an improvement compared to the non-extreme individuals. Current 
pain management programmes do not focus on directly reducing pain intensity 
but are based on cognitive-behavioural principles to improve coping 
strategies, potentially resulting in reductions in pain intensity and disability. 
Other cognitive elements such as depression, self-efficacy and kinesiophobia 
have been shown to influence pain behaviour and pain intensity (Linton, 2000), 
which are factors that, within this study, influence the disability of defensive 
high-anxious individuals over time.  
One of the most important findings within this study is the distinct 
difference between the defensive high-anxious and non-extreme group in the 
percentage of individuals improving in disability. The defensive high-anxious 
group continued to report reduced levels of disability, whereas the non-
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extreme group had fewer individuals reporting improvement. The non-extreme 
individuals did not have any significant changes in their cognitive factors, 
compared to the defensive high-anxious group who reported significant 
reductions in depression at both time points. Previous research has shown 
that changes in depression from pre- to post-treatment account for a significant 
amount of variance in changes in disability (Glombiewski et al., 2010). In 
addition, comorbid depression and chronic pain have been associated with 
more pain complaints, functional limitations and greater healthcare utilization 
(Bair et al., 2003; Linton, 2000). The defensive high-anxious individuals may 
be reporting lower depression and better outcome over time because as 
treatment progresses it is becoming effective by addressing cognitive factors 
and their defensiveness is partially protecting them from experiencing 
enhanced negative affect.  
The majority of research investigating Weinberger et al.’s (1979) 
personality types in health research has focussed on repressor individuals. 
Repressors have been found to answer health related questionnaires in an 
overly positive fashion (Myers and Vetere, 1997) and in threatening situations 
will report low levels of distress, however, physiologically they are similar to 
defensive high-anxious individuals (Derakshan and Eysenck, 1997). 
Defensiveness is characterised as a general orientation away from threatening 
self-relevant information, and a denial of negative affect. It has been 
suggested that self-relevant information which is perceived as being 
inconsistent with personal goals and beliefs is likely to trigger defensive coping 
reactions (Croyle et al., 1997). For example, high defensive individuals may 
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unconsciously deceive themselves into believing treatment is improving their 
symptoms. 
The interaction between varying levels of anxiety and defensiveness 
has a distinctly different influence upon cognitive biases towards threatening 
information. The combination of low anxiety and high defensiveness causes 
repressor individuals to fail to recognise their own affective responses. In 
addition, they employ various strategies to maintain low levels of negative 
affect and avoid conscious knowledge of their genuine reactions (e.g., 
physiological responses such as increased galvanic skin response) 
(Weinberger, 1990), which may explain why relatively few remain in the care 
system. In contrast, a high number of defensive high-anxious individuals were 
found within this population in a pain management programme. Within this 
thesis, there is a potential paradox within the defensive high-anxious 
individuals, who have been found to attend to pain related information, 
however, they report an improvement in their levels of disability. These 
responses can only be partially explained by the individual’s cognitive biases, 
other factors include treatment, environment (e.g., family support) and 
behaviour. The current treatment (e.g., cognitive behavioural 
therapy/physiotherapy) could be more effective for defensive high-anxious 
individuals, which may explain why their reports of disability and pain reduced. 
Their improvement may have been quicker or more pronounced if they were 
not attending to their pain and experiencing negative affect, which in turn 
influenced their behaviour (e.g., avoidance of activities). 
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CHAPTER 8 
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8.0 Epilogue 
8.1 Conclusions 
This thesis investigated whether personality type influences clinical outcome 
in individuals with chronic pain and the mechanisms by which the combination 
of anxiety and defensiveness influence pain and disability. The main 
conclusions of this thesis are discussed in relation to the objectives originally 
stated in chapter two. 
Objective 1: To identify the key factors that influence patient satisfaction in the 
management of chronic pain. 
The qualitative patient interview study gave an insight into factors which 
affected patient satisfaction. These included factors such as clinician attitudes 
to their condition, how caring clinicians were and how well their condition was 
explained despite remaining in the care system. The longitudinal study 
identified that, over time, defensive high-anxious individuals were more 
satisfied with their treatment and ability to cope with pain compared to the high-
anxious and non-extreme groups. These findings suggest that defensive high-
anxious individuals are satisfied with the process of treatment, however, they 
may remain within the care system because they perceive the need for 
continuous support from clinicians and their greater attentional focus to pain 
related stimuli.  
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Objective 2: To establish the attentional biases of defensive high-anxious 
individuals to threatening stimuli in a chronic back pain population. 
In Chapter 5, the dot probe study demonstrated that defensive high-anxious 
individuals have an attentional bias towards pain-related information. This 
finding may partially explain why defensive high-anxious individuals are more 
likely to remain in the care system. These individuals are more likely to attend 
to their painful symptoms and other pain-related information compared to the 
other groups, therefore, it would be expected that they would report higher 
disability and be referred through the care system. This study also identified 
differences between the high-anxious and defensive high-anxious individuals. 
The high-anxious individuals did not demonstrate the same attentional bias 
towards threatening information, suggesting that it would be beneficial to 
differentiate these individuals in their treatment programmes. The 
mechanisms behind the high-anxious and defensive high-anxious attention to 
pain related information were different, indicating that they may respond 
differently to management strategies. 
Objective 3: To identify whether there are differences in the distribution of 
personality type between those with and without chronic pain.  
In line with previous research, the findings from the third study (Chapter 6) 
identified that there was a significantly greater proportion of defensive high-
anxious individuals within the patient population compared to that found in the 
asymptomatic control population. The higher percentage of defensive high-
anxious individuals reflects their persistence within the care system. This 
highlights the need for earlier referral to PMPs for this group as other 
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interventions are unlikely to be successful for these individuals. Targeting 
treatments to meet their unique needs may be more beneficial for both the 
individual and the cost to the health service. The attentional bias towards pain 
in defensive high-anxious individuals would indicate the greater need for 
psychologically based interventions for this group. 
Objective 4: To determine whether personality type affects the relationships 
between cognitive factors and both pain and disability. 
Within both the cross-sectional and longitudinal studies differences were 
shown between the personality types in the influence of cognitive factors on 
the variation of disability over time. In particular, the cognitive factors had a 
greater influence upon disability within the defensive high-anxious group than 
for the non-extreme individuals. From a treatment perspective, these studies 
highlight the necessity of including defensiveness in initial assessment to more 
effectively target treatment, and to stratify the population when investigating 
changes over time. 
Objective 5: To identify whether there are any differences between personality 
types in the minimally clinical important change from baseline to three and six 
months for pain and disability. 
One of the most important findings arising from the study is the difference 
between the proportions of defensive high-anxious and non-extreme 
individuals reporting improvements in disability and pain.  
A higher percentage of the defensive high-anxious individuals 
demonstrated an improvement in disability compared to the non-extreme 
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group between baseline and three months (DHA= 35%; NE= 14%) and six 
months (DHA= 50%; NE= 6%). Interestingly, from baseline to three months, 
both the defensive high-anxious and the non-extreme group had a similar 
percentage of individuals who improved in pain intensity (DHA= 25%; NE= 
23%). From baseline to six months, the proportion of defensive high-anxious 
individuals reporting reduced pain continued to increase (DHA= 38%; NE= 
24%), whereas there was no change for the non-extreme group. This 
difference between the defensive high-anxious and non-extreme groups has 
important implications for assessing the effectiveness of treatment. Disability 
and pain intensity are both commonly used as outcome measures to assess 
the effectiveness of treatment. Based on the results from this study it could be 
suggested that current treatments are more effective for defensive high-
anxious individuals compared to the non-extreme patients. Furthermore, the 
higher proportion of defensive high-anxious individuals found within study 3, 
highlights the need for these interventions to be delivered earlier. 
Differentiating these two groups may allow for more targeted interventions, 
which could be more cost effective and reduce the number of patients 
remaining in the care system. 
8.2 Limitations 
Inevitably, the studies within this thesis have some limitations. Firstly, data in 
the third and fourth studies were based on self-report measures which are 
potentially subject to bias and shared method variance. This study, however, 
explored the role of cognitive factors, which can only be measured by self-
report. Secondly, there was no objective measure of disability and studies 
relied solely on self-report measures. Every effort has been made to ensure 
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that validated and reliable self-report tools have been used to maximise the 
validity and reliability of the measures presented. Thirdly, the way participants 
were recruited may lead to self-selection bias, particularly in relation to 
participants remaining within the longitudinal study. At each time point the 
distribution of personality types remained relatively stable, suggesting that the 
sample were representative at each stage of analysis. In addition, the analysis 
minimises the adverse effect of drop-outs because data were retained and 
utilised from individuals until the point of withdrawal. A further limitation is the 
small number of repressors, high-anxious and low-anxious individuals within 
the questionnaire studies. This prevented a more detailed comparison 
between all personality types at each time point within the longitudinal study. 
A further consideration is the modest sample size within the regressions in 
chapters six and seven. Some caution should be taken in interpreting the 
results when the population is split based on personality type. A general rule 
is that approximately 10 cases per factor is an adequate sample size. 
However, the cognitive factors and the demographics were entered into the 
regression model together, which suggests that approximately 30 participants 
are required. Future research with larger initial sample sizes and randomised 
controlled trials would add greater weight to these findings. This will provide 
more confidence in the relationships between variables when the population 
is split based on personality type and allow for the researcher to infer causal 
mechanisms. Based on previous research, there is often a relatively low 
number of repressor and low-anxious individuals in particular, because they 
tend not to remain in the care system. Finally, key themes from the qualitative 
study were not presented to the interview participants for their confirmation or 
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feedback. Although, the themes to emerge from the study were similar to those 
found in previous studies, providing confidence in the outcomes. 
8.3 Clinical Implications 
There are a number of clinical implications which follow on from these findings. 
The main finding from this thesis was the difference between analysing the 
group homogenously or heterogeneously. By analysing the group as a whole, 
differences in the influence of cognitive factors on disability were masked. 
Clinicians should consider including screening for both defensiveness and trait 
anxiety within initial patient assessments in order to better target treatment 
services, in order to decrease costs for the health service. 
There was a significantly higher proportion of defensive high-anxious 
individuals within the PMP population, suggesting that earlier parts of the care 
pathway failed for this group of patients. Which in turn, caused them to 
continue to present for treatment and to be referred on to tertiary care services. 
Considering defensive high-anxious individuals made up such a high 
proportion within the PMP, it was surprising that these individuals were more 
likely to report an improvement in their pain intensity and disability over the six 
month period than other groups. Factors within the environment may 
contribute to the persistence of defensive high-anxious individuals, however, 
it may be beneficial to accelerate this group into PMP based interventions. 
Furthermore, the defensive high-anxious group may benefit from 
interventions, which include attentional bias modification. Van Damme et al.’s 
(2010) motivational account of pain proposes that understanding attention to 
pain requires the motivational context to be taken into account. When pain 
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management becomes the patient’s focus, attentional biases towards pain-
related information may become enhanced, because the ultimate goal is to 
reduce levels of pain. The patient may worry about the future consequences 
of pain, try to avoid particular activities that cause pain and carefully monitor 
other signals. As a result of this enhanced attention to their pain, it is likely that 
the attentional processing of other information (e.g. tasks at work) is inhibited 
leading to a lower standard of performance and the individual experiencing 
feelings of inadequacy, possibly leading to higher levels of depression. If 
defensive high-anxious individuals are predisposed to attend to pain related 
information, this bias may be exacerbated as they continue to remain within 
the care system. Attentional bias modification and more specific goal setting 
may help to reduce the number of patients remaining within the care system. 
Attentional bias modification research is still developing and is only beginning 
to be included within pain research. The theoretical assumption of attentional 
bias modification is that negative biases play a crucial role in the onset and 
maintenance of clinical symptoms (Fox et al., 2014). Eysenck’s (1997) Four-
factor Theory proposes that defensive high-anxious individuals are more likely 
to attend to threatening stimuli in their environment, which in turn exacerbates 
or maintains fear and anxiety. Attentional bias modification for defensive high-
anxious individuals may serve to not only reduce their attention to threatening 
information but, as a consequence, reduce their fear of movement. 
Furthermore, interventions should challenge the way in which patients 
interpret threatening stimuli as this may have an influence upon their reaction 
to particular activities. 
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In relation to the fear-avoidance model, graded exposure to activities 
has been shown to reduce fear of movement and improve self-efficacy with 
daily tasks. The central concept of these types of interventions is that patients 
believe that physical activity will cause (re)injury. When there is no somatic 
pathology that can be identified, patients respond to activities either by 
‘confrontation’ or ‘avoidance’. When there is attention to pain related stimuli 
(e.g., such as the defensive high-anxious individuals), patients will often avoid 
activities, thereby enhancing fear of movement, resulting in higher disability. 
In contrast, repressors have an avoidant bias of pain related stimuli and are 
more likely to confront activities and have been found to be better at self-
managing their pain.  
Current screening tools within clinical environments utilise a range of 
psychological markers, such as fear of movement (kinesiophobia), however, 
this analysis is based upon research within un-stratified populations. The 
studies within this thesis highlighted that the relationships between 
psychological factors and outcome differ between personality types. When the 
population is analysed as a whole, some of these differences may be masked. 
Furthermore, the differences between attentional biases suggest that some 
individuals are better able to avoid negative affect compared to others. The 
interest in attentional biases to pain is increasing within current research and 
clinical environments. Although attention to pain is important, a greater 
understanding of the role of interpretational and memory biases within 
attention to pain is required. The distinct differences between the personality 
types suggest that the current screening criteria for referrals is flawed and the 
treatment process may be improved if the population is stratified based on 
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personality type. By targeting interventions to particular personality types, this 
may result in greater improvements in quality of life and treatment outcome.  
Currently, within clinical treatment settings, patient populations are 
frequently considered as undifferentiated groups. The findings from this thesis 
highlight that although there are some factors which can improve the treatment 
experience for everyone, it would be beneficial to stratify the population. By 
stratifying the population based on anxiety and defensiveness we were able 
to identify important differences in the associations between cognitive factors 
and outcome. In particular, cognitive behavioural and attention modification 
treatments may be more beneficial for defensive high-anxious compared to 
non-extreme individuals. Although the defensive high-anxious individuals did 
report an improvement in levels of disability and pain intensity, they had all 
been within the care system for a long period of time. If the population had 
been stratified when they first presented with the problem, they could have 
been referred earlier and this improvement may have been seen at an earlier 
stage. Cognitive behavioural treatments provide clear explanations in relation 
to negative cognitive biases and some strategies on how to eliminate them. 
Without tackling the underlying mechanisms behind these biases it is likely 
that these individuals will continue to attend to threatening information. If the 
population were stratified, defensive high-anxious individuals may benefit from 
a combination of cognitive behavioural treatment and bias modification. 
Furthermore, if clinicians are going to include assessment of personality type 
into the treatment environment it would seem important to develop a screening 
tool which will effectively identify personality type. By using this method it may 
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serve to give clinicians at primary, secondary and tertiary care a clearer path 
of referral, thereby reducing the number of incorrect appointments. 
The non-extreme group in particular did not report an improvement in 
pain or disability compared to the defensive high-anxious individuals. The 
failure of the PMP for these non-extreme individuals does suggest the need 
to identify more effective interventions for these patients. The non-extreme 
group made up a significant proportion of the population within this thesis, and 
these individuals may account for some of the conflicting findings previously 
reported about the effectiveness of interventions. Current PMPs primarily 
focus on reducing levels of disability through cognitive behavioural principles, 
and do not focus on directly reducing pain intensity. Initial levels of pain 
intensity were more influential on the non-extreme group’s levels of disability 
compared to cognitive factors. The mechanisms behind these factors need to 
be investigated further, in particular, the interpretation of their pain intensity 
may provide greater insights. In addition, the non-extreme group reported 
lower levels of satisfaction on all three measures (pain, treatment, ability to 
cope), suggesting that current treatment does not address these underlying 
issues. Further research needs to be done to identify the most effective 
treatment for this group of individuals. 
 The qualitative study highlighted some more general treatment factors, 
from which all patients would benefit. The patient interviews suggested that 
the treatment process and clinician interactions would influence the 
individual’s ability to develop effective coping strategies and their satisfaction 
with treatment. Improving factors surrounding the treatment environment, may 
lead to an improved patient experience. In relation to the treatment process 
186 
 
and clinical interactions, the participants suggested that more information 
relating to their condition and coping strategies at an earlier stage of treatment 
may be more beneficial. Therefore, changing clinical practice guidelines to 
give short-term coping strategies may improve levels of satisfaction in all of 
the personality types.  
One particular finding from the qualitative study is the suggestion of 
including a family support day within PMPs to give the patients’ relatives or 
other carers/supporters a better understanding of the effect pain can have on 
the patient. Some hospital PMPs already include a support day, however it 
would be beneficial to include this as an essential element. Giving relatives an 
active involvement in the treatment programme may provide more support by 
relatives as they are made to feel included and a sense of justification in their 
input. 
The clinical implications suggested within this thesis may help to 
improve current clinical practice guidelines and referral process to reduce the 
demands on health care services, resulting in more efficient and beneficial 
appointments and lower costs. 
8.4 Directions for future research 
There are several directions for future research that emerge from the 
outcomes of this thesis that would help inform the development of healthcare 
services. Future studies should aim to identify how treatment can best be 
differentiated for the different personality types to maximize treatment 
outcomes. In particular, if PMPs are offered to defensive high-anxious 
individuals earlier, whether this leads to a lower proportion re-presenting for 
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treatment and thus more cost effective care. Furthermore, levels of disability 
reported by defensive high-anxious individuals were influenced more by fear 
of movement and self-efficacy. Therefore, they may benefit from graded 
exposure to particular activities, which they perceive as threatening. Future 
studies should assess whether these interventions are more beneficial for 
defensive high-anxious individuals compared to current methods, and the 
mechanisms affecting outcome. 
Secondly, the regression analyses within this thesis have demonstrated 
that there are important differences between the personality types. Follow-up 
studies are needed in order to understand the mechanisms behind these 
differences. It would be interesting for future studies to examine the ways in 
which the key cognitive factors influence treatment outcome over a longer 
period of time (e.g., 12-18 months). It is likely that we would see similar 
differences between the personality groups to the ones found in this thesis, 
however, it is necessary to recruit larger populations to enhance statistical 
power. Furthermore, within this thesis there were not enough high-anxious 
individuals to be able to run regression analyses on the data. Therefore, further 
research should recruit a larger patient population to be able to recruit these 
individuals and identify any differences. 
Finally, the dot probe study highlighted some interesting differences 
between personality types. Analysing the eye gaze patterns of the four 
personality types, using contextually relevant images, may provide greater 
insight into what aspects of the images they are attending to (e.g., the back, 
or the activity the person is doing). Using an ecologically valid environment will 
allow for the assessment of both attentional and interpretive biases. In 
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addition, investigating the attentional biases of chronic back pain patients in 
situations of elevated anxiety may provide greater insight into why certain 
individuals remain within the care system. By giving particular instructions 
such as asking participants to view the images with an intention to imitate the 
observed action may provide greater insights into activities they are 
uncomfortable with and improve graded exposure treatments.  
8.5 Global research conclusion 
Based on the findings from this thesis it can be concluded that pain 
management programmes would be improved if treatment pathways were 
stratified based on personality type. This will allow clinicians to target 
interventions to address the attentional and interpretive biases of specific 
personality types. Not only would this benefit the quality of life for the individual 
but could also have a societal impact for the wider economy and the British 
National Health Service.  
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Miss Zoë C Franklin, 
Manchester Metropolitan University, 
MMU Cheshire, 
Crewe Green Road, 
Crewe, 
Cheshire, 
CW1 5DU.  
 
 
Dear Sir/Madam, 
We would like to invite you to take part in a research study being conducted by 
Manchester Metropolitan University investigating some of the factors that may 
affect the way you respond to pain and its treatment. The study only requires you 
to complete a short questionnaire at four points the next year at a place 
convenient for you. We estimate each one will only take you 20 minutes to 
complete.  
 
Within this envelope you will find an information sheet, providing you with 
more detail about the study. This study is very easy to complete and does not 
require you to attend any additional sessions nor will it affect the treatment you 
receive. After reading the information sheet, please sign the attached consent 
form and indicate the way you would like to receive the questionnaires (post or 
email). A pre-paid envelope is enclosed for your reply.  
 
If you would like to ask further questions about the study then please contact Zoë 
Franklin at z.franklin@mmu.ac.uk or by phone 0161 247 5528. 
 
Kind Regards, 
Zoe Franklin 
Zoë Franklin 
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MANCHESTER METROPOLITAN UNIVERSITY 
 
Department of Exercise and Sport Science 
Information Sheet for Participants  
  
Title of Study: 
The role of coping styles in the management of chronic pain. 
 
Participant Information Sheet 
 
1) This is an invitation to take part in a piece of research.  
You are being invited to take part in a research study. Before you decide whether or 
not to take part, it is important for you to understand why the research is being done 
and what it will involve. Please take time to read the following information carefully 
and discuss it with others if you wish. Ask us if there is anything that is not clear or if 
you would like more information. Please take time to decide whether or not you wish 
to take part. 
 
2) What is the purpose of the research? 
The purpose of the study is to determine if the way people interpret and react to 
stresses (coping style) has an impact on the way they experience and respond to 
chronic pain and its treatment. 
 
3) Why is the study being performed? 
 
Earlier research suggests that there may be a link between the way people cope 
with stresses (their coping style) and the way they respond to pain and its treatment. 
This would mean that people who have some coping styles may tend to do better 
after treatment than others and also that different types of treatment may work 
better for certain people.  It is hoped that, through this and other related studies, we 
will better understand whether coping styles are important in determining the most 
successful ways to manage chronic pain. Our research will involve people who are 
having treatment for chronic pain and also people who do not have any pain, so that 
we can compare the two groups.   
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4) Why am I being asked to take part? 
We have asked you to take part in this study because you are either attending a 
chronic pain management programme or you are not suffering from any chronic pain 
condition and will form part of our control group.  
 
5) Do I have to take part? 
You are under no obligation to take part in this study. If, after reading this information 
sheet and asking any additional questions, you do not feel comfortable taking part in 
the study you do not have to. If you do decide to take part you are free to withdraw 
from the study at any point, without having to give a reason. If you do withdraw from 
the study you are free to take any personal data with you and this will not be included 
when the research is reported. If you decide not to take part or withdraw from the 
study it will not affect the medical care that you receive now or in the future.  
If you do decide to take part you will be asked to sign an informed consent form stating 
your agreement to take part and you will be given a copy together with this information 
sheet to keep.  
 
6) What will happen to me if I agree to take part?  
If you agree to take part you will be asked to complete a number of questionnaires 
either on paper or electronically. These questionnaires will ask a series of questions 
about how you feel or respond to different situations, this will allow us to classify your 
coping style. We anticipate that it would take about 20 minutes to complete the 
questionnaires. All individual responses will be anonymous. Questionnaires will be 
administered on four occasions across a twelve month period.  
A small sample of individuals will also be asked to participate in interviews across the 
study period. These interviews will explore similar issues to the questionnaires and 
give us a deeper insight into the participants’ views. At the time of the interviews you 
will be written to and asked whether you would be willing participate. If you are willing, 
then a new consent form will be sent to you to complete. Interviews will take place 
either at your treating clinic or via telephone and will be recorded and transcribed for 
analysis purposes, a copy of the transcript will be sent to you and the original 
recording destroyed once transcription has been completed. No comments will be 
ascribed to individuals and outcomes treated anonymously. 
 
7) Are there any disadvantages or risks in taking part? 
There are no disadvantages to taking part in the study. The questionnaires are not 
intended to be intrusive to your personal life and you are free to miss out any 
questions that you do not wish to answer. 
 
8) What are the possible benefits of taking part? 
It is unlikely that you will benefit directly from taking part in this research as we are at 
an early stage of investigating the importance of coping styles in chronic pain. 
However, the study does aim to improve our understanding of the factors that 
influence pain management and may contribute to future improvements in this area. 
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9) Who are the members of the research team? 
The Principal Investigator is Zoe Franklin. If you require further information then 
please do not hesitate to email on z.franklin@mmu.ac.uk 
The research Supervisors are Dr. Sandra Lewis, Prof Neil Fowler and Dr. Nickolas 
Smith from the Department of Exercise and Sport Science at MMU Cheshire 
(s.lewis@mmu.ac.uk / n.fowler@mmu.ac.uk/ n.c.smith@mmu.ac.uk ).   
 
10) Who is funding the research? 
The research has been funded by the Institute for Performance Research at 
Manchester Metropolitan University and is being undertaken as part of a postgraduate 
degree research project. 
 
11) Who will have access to the data? 
All of the information collected will be kept confidential and used only for the purposes 
of this study and any associated publications. The data will be stored in a coded 
format, participant names and codes will not be kept in the same location and the 
storage system will be password protected. Only the Principal Investigator and named 
members of the research team will have access to the data. The data will be kept for 
the duration of the study and for any necessary period associated with resulting 
publications.   
If the results of the study are used in conferences or published in scientific journals at 
some point in the future, participants will not be identified in any way. As a participant 
you have the right to obtain a copy of any publication resulting from the research. 
 
12) Who do I contact if I feel my rights have been violated? 
If you feel that your rights have been violated then please contact the address 
provided below: 
Registrar & Clerk to the Board of Governors 
Head of Governance and Secretariat Team 
Manchester Metropolitan University, 
All Saints Building, All Saints,  
Manchester, M15 6BH  
Tel: 0161 247 1390. 
 
I confirm that the insurance policies in place at Manchester Metropolitan University 
will cover claims for negligence arising from the conduct of the University’s normal 
business, which includes research carried out by staff and by undergraduate and 
postgraduate students as part of their course.  This does not extend to clinical 
negligence.  
 
13)  Finally, a thank you! 
Thank you very much for considering participating in this study. I hope that the 
information I have provided is in enough detail for you. If you have any questions 
before you agree please do not hesitate to ask.    
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Department of Exercise and Sport 
Science 
 
Informed Consent Form 
 
Project Title: The role of coping styles in the management of chronic pain 
 
Chief Investigator:  Zoë Franklin 
Name:     
 
Date of Birth:  
 
Participant Statement 
 
 I have read the participant information sheet for this study and 
understand what is involved in taking part. Any questions I have about 
the study, or my participation in it, have been answered to my 
satisfaction.  
 
 I understand that I do not have to take part and that I may decide to 
withdraw from the study at any point without giving a reason and this 
will have no effect on my medical care and legal rights.  
 
 Any concerns I have raised regarding this study have been answered 
and I understand that any further concerns that arise during the 
time of the study will be addressed by the investigator. I therefore 
agree to participate in the study. 
 
It has been made clear to me that, should I feel that my rights are being 
infringed or that my interests are otherwise being ignored, neglected or 
denied, I should inform the The University Secretary and Clerk to the 
Board of Governors, Manchester Metropolitan University, Ormond 
Building, Manchester, M15 6BX. Tel: 0161 247 3400 who will undertake 
to investigate my complaint.  
Signed (Participant)           Date 
 
Signed (Investigator)  Date 
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MANCHESTER METROPOLITAN UNIVERSITY 
Department of Exercise and Sport Science 
MMU Cheshire 
Crewe 
CW1 5DU 
Tel: 0161 247 5528 
 
Participant Information Sheet 
  
Does personality type influence attentional bias in 
individuals with low back pain? 
 
You are being invited to take part in a research study. Before you decide whether or 
not to take part, it is important for you to understand why the research is being done 
and what it will involve. Please take time to read the following information carefully 
and discuss it with others if you wish.  
Part 1 tells you the purpose of this study and what will happen to you if you 
take part. 
Part 2 gives you more detailed information about the conduct of the study. 
Ask us if there is anything that is not clear or if you would like more information. Please 
take time to decide whether or not you wish to take part. 
 
Part 1 
What is the purpose of the research? 
The purpose of the study is to determine if characteristics of your personality, 
particularly the way in which you interpret and respond to anxiety, are associated with 
the way you look at and attend to different types of images.  
 
Why have I been invited? 
We have asked you to take part in this study because you are either attending a 
chronic back pain management programme or you are not suffering from any chronic 
pain condition and will form part of our control group.  
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Do I have to take part? 
It is up to you to decide if you would like to join the study. We will describe the study 
and go through this information sheet with you. If you agree to take part, we will then 
ask you to sign a consent form. You are free to withdraw at any time, without giving 
a reason. This would not affect the standard of care you receive. 
 
What will happen to me if I agree to take part?  
If you agree to take part in the study you will be asked to attend two testing sessions 
with the researcher at Kingsgate House in addition to your prescribed programme. 
The first session will take approximately 30 minutes and the second session should 
take no more than one hour. The testing sessions will have no impact on your normal 
treatment and will have no impact on the care you receive. 
 
Expenses and payments 
As compensation for your time, we are offering participants who take part in both 
testing sessions a £10 high street shopping voucher. The voucher will be given to 
participants at the end of the second testing session.  
 
What will I have to do? 
The first session will take approximately 30 minutes and is to allow you to practice on 
a computer, the reaction time task that will be used in the main experimental session. 
On your first visit, you will also be asked to fill in three questionnaires about you 
personality (the Marlowe-Crowne Social Desirability Scale), how you feel about 
completing everyday tasks (the Tampa scale of Kinesiophobia), and about your 
anxiety (the State Trait Anxiety Inventory). 
  In the second session, you will be ask to sit in front of a TV screen and will be 
presented with a series of images showing activities, people, animals or nature 
scenes. Following each image you will be asked to respond as fast as possible, by 
pressing appropriate buttons on a computer keyboard to a stimulus that will appear 
on the screen. Trials will be presented to you in blocks and you can move around 
between each block to accommodate any discomfort you may experience while 
sitting. At the end of the session you will be asked to complete a short anxiety 
questionnaire similar to the one completed on the first visit. This session should take 
no more than two hours. 
During the second trial, we will also monitor your eye movement to determine 
where you were looking during each trial. The equipment for monitoring eye 
movement will be mounted onto a set of glasses for you to wear. The glasses will not 
restrict the movement of your eyes or head and there will be no contact with your eye. 
 
Are there any disadvantages or risks in taking part? 
There are no disadvantages to taking part and participation will not interfere with or 
influence the quality or type of care you will receive for your back pain. Some of the 
images presented to you will show people performing movements and activities that 
are commonly associated with back pain, for example lifting or twisting movements. 
It is possible that looking at these images may cause you some anxiety or to attend 
more to your own symptoms. In the unlikely event you do experience any enhanced 
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anxiety or worry as a result of seeing the images, at the end of the session you will 
be able to discuss this with your physiotherapist who will be able to address this in 
your treatment programme. You can stop the experiment at any time and withdraw 
from the study. 
 
What are the side effects of any treatment received when taking part?  
There are no side effects of the testing session. 
 
What are the possible benefits of taking part? 
We cannot promise the study will help you but hope that the information we get from 
this study could one day help improve the treatment of people with chronic low back 
pain. 
 
What happens when the research study stops? 
Once you have attended the two testing sessions that is the end of your involvement 
in the research study. Your treatment programme will remain the same if you’re 
involved in this study and will not change after the study has finished. 
 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any 
possible harm you might suffer will be addressed. The detailed information on this is 
given in part 2. 
 
Will my taking part in the study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will be 
handled in confidence. The details are included in Part 2. If the information in Part 1 
has interested you and you are considering participation, please read the additional 
information in Part 2 before making any decision 
 
Part 2 
What will happen if I don’t want to carry on with the study? 
You are under no obligation to complete the study and are free to withdraw from the 
study at any time. If you withdraw from the study, we will destroy all your identifiable 
samples, but we will use the data collected up to your withdrawal. 
 
What if there is a problem? 
If you have a concern about any aspect of this study you should ask to speak to the 
researchers who will do their best to answer any questions (tel: 0161 247 5528). If 
you remain unhappy and wish to complain formally, then please contact the 
researchers university through the address provided below: 
Registrar & Clerk to the Board of Governors 
Head of Governance and Secretariat Team 
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Manchester Metropolitan University, 
All Saints Building, All Saints,  
Manchester, M15 6BH  
Tel: 0161 247 1390. 
I confirm that the insurance policies in place at Manchester Metropolitan University 
will cover claims for negligence arising from the conduct of the University’s normal 
business, which includes research carried out by staff and by undergraduate and 
postgraduate students as part of their course.  This does not extend to clinical 
negligence.  
 
Will my taking part in this study be kept confidential? 
If you join the study, all of the information collected will be kept confidential and used 
for the purposes of this study and any associated publications. The data will be stored 
in a coded format, participant names and codes will not be kept in the same location 
and the storage system will be password protected. Only the Chief Investigator and 
named members of the research team will have access to the data. The data will be 
kept for the duration of the study and for any necessary period associated with 
resulting publications.   
If the results of the study are used in conferences or published in scientific journals 
at some point in the future, you will not be identified in any way. As a participant you 
have the right to obtain a copy of any publication resulting from the research. 
 
Involvement of the General Practitioner. 
There is no reason for us to inform your GP of your involvement in the study. 
 
What will happen to any samples I give? 
If you decide to take part in the study, all the data which is collected will be stored 
on a computer in a coded format and only accessed by the research team. Data will 
be kept in a coded format throughout the study and participant names and codes 
will not be kept in the same location. If you decide to withdraw from the study, you 
can request for all data to be removed from the study. If the data from this study is 
published in scientific journals or presented at conferences you will not be identified 
in any way. 
 
Will any genetic tests be done? 
There will be no genetics test involved in this study. 
 
What will happen to the results of the research study? 
Once the study has ended, we aim to publish and present the results from this study 
in scientific journals and conferences once the study has ended, you will not be 
identified in any way. As a participant you have the right to obtain a copy of any 
publication resulting from the research. 
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Who is organizing and funding the research? 
The research has been funded by the Institute for Performance Research at 
Manchester Metropolitan University and is being undertaken as part of a postgraduate 
degree research project. 
 
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been reviewed 
and given a favorable opinion by Greater Manchester Central Research Ethics 
Committee. 
 
Further information and contact details 
If you would like general or specific information about the research project the 
Principal Investigator is Zoe Franklin. Please do not hesitate to email her on 
z.franklin@mmu.ac.uk or telephone on 0161 247 5528. If you are unhappy with the 
principal investigator or would like to make a complaint about the research then 
please contact the address below: 
 
Registrar & Clerk to the Board of Governors 
Head of Governance and Secretariat Team 
Manchester Metropolitan University, 
All Saints Building, All Saints,  
Manchester, M15 6BH  
Tel: 0161 247 1390. 
 
The research Supervisors for this project are Prof Neil Fowler and Dr. Nickolas Smith 
from the Department of Exercise and Sport Science at MMU Cheshire 
(n.fowler@mmu.ac.uk/ n.c.smith@mmu.ac.uk). 
 
Finally, a thank you! 
Thank you very much for considering participating in this study. I hope that the 
information I have provided is in enough detail for you. If you have any questions 
please do not hesitate to ask.    
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Patient Identification Number for this trial: 
CONSENT FORM 
Title of Project: Does personality type influence attentional bias in 
individuals with low back pain? 
 
Name of Researcher: Zoe Franklin 
Please initial all 
boxes  
1. I confirm that I have read and understand the information sheet dated 20th May 
(version 2.0) for the above study.  I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily. 
   
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time without giving any reason, without my medical care or legal rights being 
affected. 
 
3. I agree to take part in the above study.    
 
 
 
            
Name of Participant   Date    Signature 
                                
            
Name of Person taking consent  Date    Signature  
.  
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Participant No:   
 
The role of coping styles in the management of chronic pain 
 
Chief investigator: Zoe Franklin, MSc 
Director of Studies: Prof Neil Fowler  
 
Dear participant, 
 
Thank you for agreeing to participate in this study. Enclosed you will find a pack 
containing a number of questions about different aspects of your personality and 
pain. Please can you complete these and return to me in the reply paid envelope 
provided. You can complete the questionnaire whenever and wherever is 
convenient to you. 
 
Please read each item carefully but try not to spend too much time on any one 
statement as we are interested in your first response to the question. There are no 
right or wrong answers, please select the box which is the best fit for you. There 
are instructions at the top of each page, which will help you to answer the 
questions. 
 
In order to preserve your anonymity, your questionnaire has been assigned a 
number (see above). Your responses to the questionnaire will not be connected in 
any way to your identity or any personal information provided in your consent 
form. 
 
Many thanks for taking the time to complete this questionnaire. If you have any 
questions please contact me either by email (z.franklin@mmu.ac.uk) or telephone 
0161 247 5528. 
 
Zoë Franklin. 
 
Zoë Franklin 
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Personal Characteristics 
 
Today’s date: …………………………………………….. 
 
Approximately, how long have you had your pain? 
....................................................... 
 
 
Employment situation: 
 
   Currently working / studying 
   Unemployed – not due to health issues 
   Unemployed – due to health issues 
   Housewife / House husband 
   Retired not due to health reasons 
   Retired due to health reasons 
 
How would you rate your satisfaction with the most recent treatment you have 
received on a scale of 0 to 10, where 0 is ‘not satisfied at all’ and 10 is ‘very 
satisfied’ 
0 1 2 3 4 5 6 7 8 9 10 
           
Not          Very 
satisfied at all                  satisfied 
 
 
How would you rate your pain on a scale of 0 to 10 in the past 24 hours, where 
0 is ‘no pain’ and 10 is ‘pain as bad as could be’? 
 
0 1 2 3 4 5 6 7 8 9 10 
           
No Pain         Pain as 
bad as 
could be 
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Three month satisfaction and pain intensity questions 
How would you rate your satisfaction with the treatment you have received over 
the last three months on a scale of 0 to 10, where 0 is ‘not satisfied at all’ and 10 is 
‘very satisfied’ 
0 1 2 3 4 5 6 7 8 9 10 
           
Not          Very 
satisfied at all                 satisfied 
 
Reflecting on the treatment you have received over the past 3 months how 
satisfied are you with the improvement in your ability to cope with pain on a scale 
of 0 to 10, where 0 is ‘not satisfied at all’ and 10 is ‘very satisfied’ 
0 1 2 3 4 5 6 7 8 9 10 
           
Not          Very 
satisfied at all                 satisfied 
How satisfied are you with your current level of pain on a scale of 0 to 10, where 0 
is ‘not satisfied at all’ and 10 is ‘very satisfied’ 
0 1 2 3 4 5 6 7 8 9 10 
           
Not          Very 
satisfied at all                 satisfied 
 
How would you rate your pain on a scale of 0 to 10 in the past 24 hours, where 0 is ‘no 
pain’ and 10 is ‘pain as bad as could be’? 
0 1 2 3 4 5 6 7 8 9 10 
           
No Pain         Pain as 
bad as 
could be 
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Six and twelve month satisfaction and pain intensity questions 
How would you rate your satisfaction with the treatment you have received over 
the last three months on a scale of 0 to 10, where 0 is ‘not satisfied at all’ and 10 is 
‘very satisfied’ 
0 1 2 3 4 5 6 7 8 9 10 
           
Not          Very 
satisfied at all        
 satisfied 
 
Reflecting on the treatment you have received over the past 3 months how 
satisfied are you with the improvement in your ability to cope with pain on a scale 
of 0 to 10, where 0 is ‘not satisfied at all’ and 10 is ‘very satisfied’ 
0 1 2 3 4 5 6 7 8 9 10 
           
Not          Very 
satisfied at all                satisfied 
How satisfied are you with your current level of pain on a scale of 0 to 10, where 0 
is ‘not satisfied at all’ and 10 is ‘very satisfied’ 
0 1 2 3 4 5 6 7 8 9 10 
           
Not          Very 
satisfied at all                 satisfied 
How would you rate your pain on a scale of 0 to 10 in the past 24 hours, where 0 
is ‘no pain’ and 10 is ‘pain as bad as could be’? 
 
0 1 2 3 4 5 6 7 8 9 10 
           
No Pain         Pain as 
bad as 
could be 
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Treatment Characteristics 
The next questions ask about appointments offered to you concerning the 
management of your pain.  
 
I remind you that your responses are confidential and for research purposes only, 
they will not be shared with your care team or influence your future care in any way. 
 
1)    Over the past 6 months approximately how many sessions of treatment / 
appointments have you been offered? 
  None  1-3    4-6    7-9       10+ 
 
2)    Of those sessions offered to you, approximately what proportion did you attend? 
  All    Most (more than half)   about half   some (less than half)      None 
3)    If you missed any of the sessions offered to you would you state / describe the 
reason? 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………….  
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Marlowe-Crowne Social Desirability Scale (Strahan and Gerbasi, 1972). 
 
Listed below are a number of statements concerning personal attitudes and traits. 
Read each item and decide whether the statement is true or false as it relates to you 
personally. 
 
 
 True False 
I never hesitate to go out of my way to help someone in 
trouble 
 
  
I have never intensely disliked anyone 
 
  
There have been times when I was quite jealous of the 
good fortune of others 
  
I would never think of letting someone else be punished 
for my wrong doings 
  
I sometimes feel resentful when I don’t get my way 
 
  
There have been times when I felt like rebelling against 
people in authority even though I knew they were right 
  
I am always courteous, even to people who are 
disagreeable 
 
  
When I don’t know something I don’t at all mind 
admitting it 
 
  
I can remember “playing sick” to get out of something 
 
  
I am sometimes irritated by people who ask favours of 
me 
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Trait subscale of the State-Trait Anxiety Inventory (Spielberger et al., 1983). 
 
A number of statements which people have used to describe themselves are given 
below. Read each statement and then mark the appropriate box to indicate how you 
generally feel. There are no right or wrong answers. Do not spend too much time on 
any one statement but give the answer which seems to describe how you generally 
feel. 
 
 
 Not at all Somewhat Moderately 
so 
Very 
much so 
I feel pleasant Not at all 
 
Somewhat 
 
Moderately so 
 
Very much so 
 
I feel nervous and restless Not at all 
 
Somewhat 
 
Moderately so 
 
Very much so 
 
I feel satisfied with myself Not at all 
 
Somewhat 
 
Moderately so 
 
Very much so 
 
I wish I could be as happy as 
others seem to be 
Not at all 
 
Somewhat 
 
Moderately so 
 
Very much so 
 
I feel like a failure Not at all 
 
Somewhat 
 
Moderately so 
 
Very much so 
 
I feel rested Not at all 
 
Somewhat 
 
Moderately so 
 
Very much so 
 
I am calm, cool and collected Not at all 
 
Somewhat 
 
Moderately so 
 
Very much so 
 
I feel that difficulties are piling 
up so that I cannot overcome 
them 
Not at all 
 
Somewhat 
 
Moderately so 
 
Very much so 
 
I worry too much over something 
that doesn’t really matter 
Not at all 
 
Somewhat 
 
Moderately so 
 
Very much so 
 
I am happy Not at all 
 
Somewhat 
 
Moderately so 
 
Very much so 
 
I have disturbing thoughts Not at all 
 
Somewhat 
 
Moderately so 
 
Very much so 
 
I lack self confidence Not at all 
 
Somewhat 
 
Moderately so 
 
Very much so 
 
I feel secure Not at all 
 
Somewhat 
 
Moderately so 
 
Very much so 
 
I make decisions easily Not at all 
 
Somewhat 
 
Moderately so 
 
Very much so 
 
I feel inadequate Not at all 
 
Somewhat 
 
Moderately so 
 
Very much so 
 
I am confident Not at all 
 
Somewhat 
 
Moderately so 
 
Very much so 
 
Some unimportant thoughts run 
through my mind and bother me 
Not at all 
 
Somewhat 
 
Moderately so 
 
Very much so 
 
I take disappointments so keenly 
that I can’t put them out of my 
mind 
Not at all 
 
Somewhat 
 
Moderately so 
 
Very much so 
 
I am a steady person Not at all 
 
Somewhat 
 
Moderately so 
 
Very much so 
 
I get in a state of tension or 
turmoil as I think over my recent 
concerns and interests 
Not at all 
 
Somewhat 
 
Moderately so 
 
Very much so 
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The Roland Morris Disability Questionnaire (Roland and Morris, 1983). 
 
 
When you have chronic pain you may find it difficult to do some things. This list contains sentences that 
people use to describe themselves when they are in pain. As you read the list, think of yourself today and 
mark true or false, whichever describes you TODAY. 
1 I stay at home most of the time because of my pain. 
True
 
False
 
2 I change position frequently to try and get myself comfortable. 
True
 
False
 
3 I walk more slowly than usual because of my pain. 
True
 
False
 
4 Because of my pain, I am not doing any of the jobs that I usually do around the house. 
True
 
False
 
5 Because of my pain, I use a handrail to get upstairs. 
True
 
False
 
6 Because of my pain, I lie down to rest more often. 
True
 
False
 
7 Because of my pain, I have to hold on to something to get out of an easy chair. 
True
 
False
 
8 Because of my pain, I try to get other people to do things for me. 
True
 
False
 
9 I get dressed more slowly than usual because of my pain. 
True
 
False
 
10 I only stand up for short periods of time because of my pain. 
True
 
False
 
11 Because of my pain, I try not to bend or kneel down. 
True
 
False
 
12 I find it difficult to get out of a chair because of my pain. 
True
 
False
 
13 I am in pain almost all of the time. 
True
 
False
 
14 I find it difficult to turn over in bed because of my pain. 
True
 
False
 
15 My appetite is not very good because of my pain. 
True
 
False
 
16 I have trouble putting on my socks / tights because of the pain. 
True
 
False
 
17 I only walk short distances because of my pain. 
True
 
False
 
18 I sleep less well because of my pain. 
True
 
False
 
19 Because of my pain, I get dressed with help from someone else. 
True
 
False
 
20 I sit down for most of the day because of my pain. 
True
 
False
 
21 I avoid heavy jobs around the house because of my pain. 
True
 
False
 
22 Because of my pain I am more irritable than usual. 
True
 
False
 
23 Because of my pain I go upstairs more slowly. 
True
 
False
 
24 I stay in bed most of the time because of my pain. 
True
 
False
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The Pain Catastrophising Scale (Sullivan et al., 1995). 
 
We are interested in the types of thoughts and feelings you have when you are in pain. Listed below are 
thirteen statements describing different thoughts and feelings that may be associated with pain.  
 
Please mark the degree to which you have these thoughts and feelings when you are experiencing 
pain. 
 
 
 
 
 
  
 
Not at 
all 
To a 
slight 
degree 
Sometimes 
To a great 
degree 
All the 
time 
1 I worry all the time about whether 
the pain will end 
 
     
2 I feel I can’t go on 
 
     
3 It’s terrible and I think it’s never 
going to get any better 
 
     
4 It’s awful and I feel that it 
overwhelms me 
 
     
5 I feel I can’t stand it anymore 
 
     
6 I become afraid that the pain may 
get worse 
 
     
7 I think of other painful 
experiences 
 
     
8 I anxiously want the pain to go 
away 
 
     
9 I can’t seem to keep it out of my 
mind 
 
     
10 I keep thinking about how much it 
hurts 
 
     
11 I keep thinking about how badly I 
want the pain to stop 
     
12 There is nothing I can do to 
reduce the intensity of the pain 
     
13 I wonder if something serious may 
happen 
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The Centre for Epidemiologic Studies Depression Scale (Radloff, 1977). 
 
Below is a list of the ways you might have felt or behaved. Please cross the box that 
describes how often you have felt this way during the past week. 
 
 
 
 
Rarely or none 
of the time (less 
than 1 day) 
Some or a little of 
the time (1-2 
days) 
Occasionally or a 
moderate amount 
of time (3-4 days) 
Most or all of the 
time (5-7 days) 
1. I was bothered by things 
that don’t usually bother 
me. 
    
2. I did not feel like eating: 
my appetite was poor. 
    
3. I felt that I could not 
shake off the blues even 
with help from my 
family or friends. 
    
4. I felt I was just as good 
as other people. 
    
5. I had trouble keeping 
my mind on what I was 
doing. 
    
6. I felt depressed. 
 
    
7. I felt that everything I 
did was an effort. 
    
8. I felt hopeful about the 
future. 
    
9. I thought my life had 
been a failure. 
    
10. I felt fearful. 
 
    
11. My sleep was restless. 
 
    
12. I was happy. 
 
    
13. I talked less than usual. 
 
    
14. I felt lonely. 
 
    
15. People were unfriendly. 
 
    
16. I enjoyed life. 
 
    
17. I had crying spells. 
 
    
18. I felt sad. 
 
    
19. I felt that people dislike 
me. 
    
20. I could not get “going.” 
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The Chronic Pain Self-efficacy Scale (Anderson et al., 1995). 
 
We would like to know how confident you are in performing certain daily activities.  For each of the 
following questions, please put a cross in the box that reflects how confident you are that you can 
perform the task as of now without help from another person.  Please note that we are not assessing 
whether you actually engage in the specific activity, we are just interested in the confidence you have 
in your ability to perform the activity. 
 
AS OF NOW, HOW CONFIDENT ARE YOU THAT YOU CAN 
 
 
 
 
 0 1 2 3 4 5 6 7 8 
1. Walk ½ mile on 
flat ground 
 
         
2. Lift a 10lb box? 
 
 
         
3. Perform a daily 
home exercise 
programme? 
 
         
4. Perform your 
household chores 
 
         
5. Shop for groceries 
or clothes? 
 
         
6. Engage in social 
activities 
 
 
         
7. Engage in hobbies 
or recreational 
activities? 
 
         
8. Engage in family 
activities? 
 
         
9. Perform the work 
duties you had 
prior to the onset of 
chronic pain? 
         
 
  
Totally 
Unconfident 
Moderately 
Confident 
Totally 
Confident 
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The Tampa Scale of Kinesiophobia (Miller et al., 1991). 
 
This is a list of phrases which other patients have used to express how they view 
their condition. Please indicate the extent to which you agree with each 
statement. 
 
 Strongly 
Disagree 
Somewhat 
Disagree 
Somewhat 
Agree 
Strongly 
Agree 
    
1 I’m afraid that I might injure 
myself if I exercise. 
    
2 If I were to try and overcome it, 
my pain would increase. 
    
3 My body is telling me I have 
something dangerously wrong. 
    
4 People aren’t taking my medical 
condition seriously enough. 
    
5 My pain has put my body at risk 
for the rest of my life. 
    
6 Pain always means I have injured 
my body. 
    
7 Simply being careful that I do not 
make unnecessary movements is 
the safest thing I can do to prevent 
my pain from worsening. 
    
8 I wouldn’t have this much pain if 
there wasn’t something potentially 
dangerous going on in my body. 
    
9 Pain lets me know when to stop 
exercising so that I don’t injure 
myself. 
    
10 I can’t do all the things normal 
people do because it’s too easy for 
me to get injured. 
    
11 No one should have to exercise 
when he/she is in pain. 
    
 
 
 
End of questions. 
 
Thank you for taking the time to answer these questions. 
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APPENDIX 4 
INTERVIEW GUIDE 
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Semi-structured interview guide 
Introductory: 
1) To begin, could you give, me a bit more detail about your pain. 
Specifically, where are you experiencing your pain and when the 
problem first started?  
2) What type of treatment have you been attending? 
Probe- Is this the first type of treatment you have sought for you pain? 
Treatment: 
1) Is there anything you expected to be involved with the treatment 
experience? 
Probe- What led you to these expectations? 
2) Over the course of treatment, did your expectations change? 
3) In what ways did your expectations change? 
4) Are you satisfied with the level of contact with the clinicians? 
5) What type of treatment have you found most useful in improving your 
control of your pain?  
6) Have you been given strategies to help you cope with your pain? 
7) For you, what is the most important outcome from treatment? 
Thinking now about your interactions with the clinicians: 
1) How well did you feel your condition was explained to you? 
Probe: Did the explanation help you to understand your condition and 
cope with it? 
2) What type of communication did you find most effective? 
3) To what extent do you feel you are involved in planning your 
treatment? 
4) How do you feel about the approach taken to managing your pain? 
 Thinking now about the activities you undertake in Daily life: 
1) How did the course of treatment affect your chronic pain symptoms 
and the impact it had on everyday life? 
2) Has your daily life changed since your chronic condition started? 
3) In what ways does your post-treatment levels of pain affect your ability 
to complete activities in daily life? 
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APPENDIX 5 
IAPS IMAGE NUMBERS 
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IAPS neutral images: 
1122, 1333, 1350, 1390, 1419, 1450, 1505, 1616, 1645, 1675, 1903, 1908, 
1935, 2032, 2038, 2309, 2377, 2446, 2487, 2514, 2518, 2521, 2575, 2580, 
2840, 2880, 2980, 3005, 5390, 5395, 5455, 5471, 5500, 5510, 5520, 5531, 
5532, 5533, 5535, 5661, 5731, 5740, 5900, 5940, 5950, 6150, 6570.2, 6900, 
7000, 7001, 7002, 7003, 7004, 7006, 7009, 7010, 7011, 7012, 7013, 7014, 
7016, 7017, 7018, 7019, 7020, 7021, 7025, 7026, 7030, 7031, 7032, 7033, 
7034, 7035, 7036, 7037, 7038, 7039, 7040, 7041, 7042, 7043, 7044, 7045, 
7046, 7050, 7052, 7053, 7054, 7055, 7056, 7057, 7058, 7059, 7060, 7061, 
7062, 7077, 7080, 7081, 7090, 7092, 7095, 7096, 7100, 7130, 7140, 7150, 
7160, 7161, 7170, 7175, 7179, 7180, 7182, 7184, 7185, 7187, 7207, 7211, 
7217, 7233, 7235, 7236, 7242, 7247, 7255, 7509, 7547, 7590, 7632, 7640, 
7700, 7705, 7710, 7820, 7830, 7950, 8211, 8325, 9210, 9360, 9422, 9469. 
 
IAPS positive images: 
1410, 1440, 1441, 1460, 1463, 1500, 1510, 1540, 1590, 1600, 1603, 1604, 
1610, 1620, 1630, 1710, 1721, 1722, 1731, 1740, 1750, 1999, 2045, 2058, 
2070, 2071, 2260, 5000, 5001, 5010, 5199, 5200, 5201, 5202, 5210, 5220, 
5260, 5270, 5300, 5450, 5460, 5470, 5480, 5551, 5594, 5600, 5611, 5623, 
5629, 5631, 5660, 5700, 5711, 5725, 5750, 5760, 5764, 5779, 5780, 5781, 
5811, 5814, 5820, 5825, 5829, 5830, 5831, 5833, 5836, 5890, 5891, 5910, 
5982, 7200, 7220, 7230, 7260, 7270, 7280, 7325, 7330, 7350, 7400, 7405, 
7430, 7470, 7480, 7492, 7502, 7545, 7580, 8162, 8163, 8170, 8190, 8501, 
8502, 8503, 8510, 8531. 
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